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ABSTRACT 
The KCNH potassium channel family includes EAG, ERG and ELK channels. These 
channels are voltage-gated and are involved in important physiological roles such as 
cardiac repolarization, neuronal excitability, tumor proliferation and hormone secretion. 
KCNH channels have large N- and C-terminal cytoplasmic domains that include a PAS 
domain at the N-terminus and a cyclic nucleotide binding-homology domain (CNB-
homology domain) at the C-terminus. It has been well established that the PAS domain 
interacts with CNB-homology domain and that this interaction is important for the 
channel’s gating properties. 
Calcium inhibits EAG1 currents, an effect that is mediated by calmodulin binding to the 
channel. Three calmodulin binding sequences have been identified: BDN, after the PAS 
domain; BDC1 and BDC2, after the CNB-homology domain.  Channels with disrupting 
mutations at BDN, BDC1 and BDC2 are nearly insensitive to Ca2+-calmodulin, supporting 
the functional importance of all three sequences for Ca2+-calmodulin regulation. However, 
the physiological relevance of the BDC1 has been questioned by several studies. In 
accordance, our structure of the isolated CNB-homology domain and another lab’s 
structure of the PAS/CNB-homology domain complex reveal that BDC1 is partially 
occluded due to the self-liganded conformation of the domain. Through mutations as well 
as through the use of the ligand calmodulin we have provided evidence that an 
unliganded state exists. 
Using calorimetry and X-ray crystallography we have dissected the calmodulin binding 
properties of all three calmodulin binding sites which revealed very distinct binding modes. 
We propose that BDC1 is not directly involved in CaM binding but might have a role 
through the interaction with the PAS domain. Also, based on structural, biochemical and 
functional data we have redefined the limits of the CaM BDC2 as being extended towards 
the N terminus. 
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SUMÁRIO 
A família de canais de potássio KCNH inclui os canais EAG, ERG e ELK. Estes canais 
são regulados por voltagem e estão envolvidos em importantes processos fisiológicos 
como a repolarização cardíaca, excitabilidade neuronal, proliferação tumoral e secreção 
de hormonas. Os canais da família KCNH têm zonas citoplasmáticas extensas que 
incluem um domínio PAS no N-terminal e um homólogo a domínios que ligam 
nucleotideos cíclicos (CNBhD) no C-terminal. É sabido que o domínio PAS interage com 
o CNBhD e que esta interacção é importante para as propriedades de activação do canal. 
O cálcio inibe as correntes dos canais EAG1, um efeito mediado pela ligação da 
calmodulina ao canal. Foram identificadas três sequencias de ligação à calmodulina: 
BDN, depois do domínio PAS; BDC1 e BDC2 depois do CNBhD. Canais com mutações 
em qualquer uma destas sequências são praticamente insensíveis a Ca2+-calmodulina, 
indicando que as três sequências são importantes para a regulação por Ca2+-calmodulin. 
No entanto, a relevância fisiológica do BDC1 foi questionada por vários estudos. De 
acordo, a nossa estrutura de um CNBhD e a estrutura do complexo entre o domínio PAS 
e CNBhD resolvida por outro laboratório revelaram que o BDC1 está parcialmente 
obstruído devido à conformação “auto-ligada” do domínio. Através de mutações e do uso 
do ligando calmodulin mostramos evidencias da existência de um estado não ligado do 
CNBhD. 
Utilizando calorimetria e cristalografia de raios-X, dissecamos as propriedades de ligação 
à calmodulina dos três locais de ligação que revelam modos de ligação à calmodulina 
distintos. Propomos que o BDC1 não está directamente envolvido na ligação à calmodulin 
mas poderá ter um papel regulatório através da interacção com o domínio PAS. 
Redefinimos os limites da sequencia de ligação à calmodulina BDC2, que se extende 
para o N-terminall, baseado em dados estruturais, bioquímicos e funcionais. 
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I. INTRODUCTION 
 
Potassium channel architecture 
In the 1950’s, Hodgkin and Keynes performed the first studies on ion permeation across 
squid giant axon membranes (Hodgkin & Keynes 1955). They observed that K+ flowed 
down its electrochemical gradient, that their movement was affected by other ions and 
that they interacted with each other when crossing the membrane. They suggested that 
ions should move in a single file and that there would be several ions passing through the 
membrane at the same time. 
In the following decades, Armstrong and Hille demonstrated that K+ and Na+ cross cell 
membranes through protein pores - K+ and Na+ channels (MacKinnon 2004). 
Advances in molecular biology allowed for the cloning and study of the Shaker K+ channel 
from Drosophila melanogaster. Before high resolution structures of K+ channel became 
available, many aspects of K+ channel architecture had been inferred through the use of 
pore blockers and mutagenesis, including mapping of the pore, selectivity filter region and 
an activation gate (Aggarwal & MacKinnon 1996; Ranganathan et al. 1996; Hidalgo & 
MacKinnon 1995; Liu et al. 1997; Holmgren et al. 1997). 
The typical potassium channel is an assembly of four subunits surrounding a central pore 
through which potassium ions flow down their electrochemical gradient. Each subunit can 
have two or six transmembrane helices as well as cytoplasmic domains with regulatory 
roles (MacKinnon 2003; MacKinnon 2004). 
Potassium channels contain a highly conserved signature sequence (TTVGYG or 
TTVGFG) in the selectivity filter, a region that forms the coordinating shell for potassium 
ions in the channel. Potassium ions flow through the pore at rates of 107-108 per second, 
which is close to the rate of unrestricted diffusion of ions in water. The selectivity filter is 
responsible for the high selectivity of K+ ion over the Na+ ion by a factor of over 1000 
(Doyle et al. 1998) and mutation of these residues disrupts the channel’s ability to 
discriminate between K+ and Na+ ions (MacKinnon 2004; MacKinnon 2003; Kim et al. 
2015). 
The first high resolution structure of a potassium channel belonged to the Streptomyces 
lividans KcsA (Doyle et al. 1998). The structure confirmed many of the predictions that 
had been made and shed further light into the molecular basis of K+ conduction and 
2 
 
permeation. KcsA is tetrameric, with 4-fold symmetry and has two transmembrane helices 
and one tilted pore helix (P-helix) per subunit, Figure 1. In the center of the membrane the 
ion conduction pathway is 10 Å wide, forming a water-filled cavity that harbors a hydrated 
K+, Figure 1b (Doyle et al. 1998; Zhou et al. 2001). This ion is stabilized by keeping its 
hydration shell and by the dipole at the C terminus of the P-helix. 
At the selectivity filter region, the narrowest part of the pore, there are four sites for K+ 
binding, S1 to S4; each K+ is coordinated by eight oxygen atoms, four above and four 
below, in a cage-like structure that mimics the water coordination of the ion in the central 
cavity, Figure 1. Importantly, it has been shown that K+ adopts two alternating 
configurations, each with two ions (S1-S3 or S2-S4) in this filter, separated by a water 
molecule (Morais-Cabral et al. 2001); the crystal structure represents an average of these 
two configurations (Figure 1b). 
 
Ion channels can contain several gates that constitute a barrier to the passage of ions, the 
most common of which is the cytoplasmic gate (Figure 1b). Gating is the process that 
allows channels to go from a non-active (closed) to an active (open) state in response to 
an external signal. This signal can be a ligand (ligand-gated channels), changes in the 
 
Figure 1 – Structure of the KcsA potassium channel (PDB code: 1K4C) (Zhou et al. 2001). 
a) Top view of the tetramer in cartoon representation, K+ ions are depicted as purple 
spheres and selectivity filter in orange. b) Side view of two subunits of KcsA.  K+ ions are 
purple spheres, water molecules are red spheres and the selectivity filter is in stick 
representation. 
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transmembrane potential (voltage-gated channels), pressure (mechanosensitive 
channels) or temperature (temperature-gated channels). 
 
Classification of potassium channels 
Potassium channels can be grouped into four classes, taking into account the stimulus 
that they respond to, the conductance properties and their structural organization (Pardo 
& Stühmer 2014). Voltage-gated potassium channels (Kv1-12, in mammals) respond to 
changes in voltage and are tetrameric; they contain six transmembrane helices (TM), the 
first four of which compose the voltage-sensor domain and the last two the pore domain. 
Calcium-activated potassium channels (KCa) are also tetrameric with six transmembrane 
segments but are activated by calcium. There are also the inward-rectifier potassium 
channels (Kir1-7) that contain two transmembrane helices corresponding to the pore 
forming domain and are regulated by multiple factors such as G-proteins, phospholipids, 
pH or ATP. Finally, the two-pore domain potassium channels (K2P1-18), also known as 
“leak” channels, are dimeric and composed of two pore-forming domains in tandem, 
resulting in a channel subunit with four transmembrane segments. 
 
Voltage-gated channels 
Structures of voltage-gated potassium channels show a pore region surrounded by four 
voltage sensor domains (Long et al. 2005), Figure 2. One particularity is that the fourth 
helix (TM4) adopts a long 310 helical conformation; these helices are rare and less stable 
due to being packed more tightly  (Vieira-Pires & Morais-Cabral 2010). TM4 contains 4-8 
arginines, spaced by two residues and these arginines are called the “gating charges”. 
Upon a change in membrane voltage, these gating charges move across the membrane 
through the translation and rotation of the TM4 helix (Tombola et al. 2006; Li et al. 2014). 
During this process, the arginines change electrostatic partners with countercharges from 
TM1 and TM3 (Li et al. 2014). The conformational change is coupled to the cytoplasmic 
gate of the channel which is present on the cytoplasmic end of the pore domain (Figure 
1b), shifting the equilibrium from closed to open channels (Tombola et al. 2006). 
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Figure 2 - Structure of the 
mammalian voltage-gated 
potassium channel Kv1.2 (PDB 
code: 2A79). Top view of the 
tetramer in cartoon representation, 
channel subunits are depicted in 
alternate colors for clarity purposes. 
K+ ions are depicted as purple 
spheres. 
 
 
KCNH potassium channel family 
The KCNH K+ channel family (or EAG K+ channel family) includes EAG (ether-a-go-go), 
ERG (eag-related gene) and ELK (eag-like) K+ channels (Warmke & Ganetzky 1994). The 
eag gene was first identified through a mutant Drosophila melanogaster that displayed a 
leg shaking phenotype when under ether anesthesia, hence the name (Warmke et al. 
1991). Using homology screens of cDNA libraries, three related gene subfamilies have 
been found - eag, elk and eag – and eight genes have been identified in mammals that 
belong to the KCNH family – eag1-2, elk1-3 and erg1-3 (Bauer & Schwarz 2001). 
Sequence alignments show that members of the EAG family are closely related to cyclic 
nucleotide-gated cation channels as well as voltage-gated K+ channels (Warmke & 
Ganetzky 1994).  
KCNH channels are voltage-gated potassium channels that are involved in important 
physiological processes such as cardiac repolarization (Tristani-Firouzi & Sanguinetti 
2006), neuronal excitability (Becchetti et al. 2002) and cellular proliferation (Pardo & 
Sühmer 2008). They are composed of four subunits of six transmembrane helices 
surrounding a central pore as well as characteristic large cytoplasmic regions (Figure 3) 
that have a role in channel regulation, serving as interfaces for external cues such as 
phosphorylation (Wang et al. 2002), interaction with kinases (Sun et al. 2004), integrins 
(Cherubini et al. 2005) and calmodulin (Schönherr et al. 2000). 
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Figure 3 - Schematic representation of an EAG1 channel subunit. From the N to C 
terminus it is composed by a PAS domain, calmodulin binding site BDN, transmembrane 
helices S1-S6, C-linker helices that connect S6 to the CNB-homology domain, followed by 
calmodulin binding sites BDC1 and BDC2. Adapted from S.H.Heinemann. 
 
KCNH channels have been associated with several pathologies: epilepsy, schizophrenia, 
cancer and long QT syndrome (LQTS). The human ERG1 (hERG) channel has been 
extensively studied; it is expressed in the heart and is responsible for the last phase of the 
repolarization ventricular action potential (Tristani-Firouzi & Sanguinetti 2006). This 
channel is linked to LQTS, a condition characterized by arrhythmia, seizures and sudden 
death which results from disruptions of normal channel function due to either inheritable 
hERG channel mutations or block of the channel by pharmaceutical drugs (Tristani-Firouzi 
& Sanguinetti 2006). The severity of LQTS is the reason behind the routine testing of 
pharmaceutical compounds on hERG channel activity early in the drug-development 
process. In contrast, human EAG1 (hEAG1) channel expression occurs exclusively in the 
central nervous system, more specifically in the presynaptic terminals. hEAG1 channels 
have been suggested to regulate action potentials during high-frequency stimulus, 
modulating synaptic strength by acting as an intermediate between fast high-voltage 
activated channels and slow low-voltage activated channels (Mortensen et al. 2015). 
Whereas hEAG1 expression in healthy individuals is mostly confined to the brain, it is 
overexpressed in more than 70% of cancers (Urrego et al. 2014) which makes it a good 
tumour biomarker and a potential target for cancer treatments. Overexpression of hERG1 
has also been associated with several types of cancer (Crociani et al. 2003; Urrego et al. 
2014). 
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KCNH cytoplasmic domains 
KCNH channel cytoplasmic regions include two globular domains, a PAS domain at the N 
terminus and a domain with homology to cyclic nucleotide binding domains (CNB-
homology domain) on the C terminus (Figure 3), although these channels do not respond 
to cyclic nucleotides. 
EAG1 channels, in particular, also include several calmodulin binding sites, located after 
the PAS domain and the CNB-homology domain (Figure 3) and are inhibited by 
calmodulin (Schönherr et al. 2000; Ziechner et al. 2006). 
PAS domain 
PAS (Per-Arnt-Sim) domains can be found in all kingdoms of life. Although their primary 
sequences vary, the PAS domain fold is conserved. It usually functions as a regulatory 
domain, either by binding small molecules such as FAD or heme, or mediating protein-
protein interactions (Henry & Crosson 2011). 
KCNH channels have a PAS domain on the N terminus which is considered an orphan 
receptor, given that so far no ligand has been identified. The first solved structure of an 
eukaryotic PAS domain belonged to the hERG channel (Morais Cabral et al. 1998). It is 
composed of a β-sheet with five strands (βA-βE) tightly packed against a set of helices - a 
highly flexible N-terminal CAP region, αA-αC and a short 310 helix (Figure 4a). Structures 
of PAS domains from the other KCNH subfamilies (EAG and ELK) have also been solved 
by X-ray crystallography and are very similar to each other (Adaixo et al. 2013). They 
share a conserved hydrophobic patch in the β-sheet and small cavities where other PAS 
domains bind small molecules (Adaixo et al. 2013). Solution structures of hERG PAS 
domains have revealed that the CAP region has high structural variability (Figure 4b) (Ng 
et al. 2011; Li et al. 2010; Muskett et al. 2011). 
It is known that the KCNH PAS domains have a role in channel function through the 
interaction with other parts of the channel. Truncation of hERG1 PAS domain, for 
example, speeds up the channel’s characteristic slow deactivation. These changes can be 
reversed if purified soluble PAS domain is added to the cell expressing the truncated 
channel (Morais Cabral et al. 1998). Furthermore, in EAG channels, gating changes 
caused by deletion of the N-terminal CAP could be reverted by mutations on the S4-S5 
linker (Terlau et al. 1997), suggesting that there is an interaction of the CAP region with 
the gating machinery in KCNH channels.  
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Figure 4 – KCNH PAS domains. a) Structure of the mEAG1 PAS domain in cartoon 
representation. b) Structural variability of the PAS CAP region (cartoon). Superposition of 
four NMR and X-ray PAS domain structures (in grey ribbon) from the hERG1 channel: 
PDB codes 4HP9 (green), 2L1M (red), 2L0W (orange), 2L4R (blue). 
 
Cyclic nucleotide binding(-homology) domain 
Cyclic nucleotide binding domains (CNB domains, Figure 5) are involved in signaling 
pathways, both in eukaryotes and prokaryotes. Cyclic nucleotide binding induces a 
conformational change that is propagated to the effector domain - a nucleotide exchange 
factor, a transcription factor, a kinase or an ion channel. CNB domain structure is 
composed by an antiparallel -roll preceded by α-helix αA and followed by helices αB and 
αC (Figure 5). An additional short α-helix, P-helix that is located between -strands 6 and 
7 is part of the “phosphate binding cassette” that coordinates the cyclic phosphate 
(Rehmann et al. 2007). In cyclic-nucleotide regulated channels extra helices (C-linker) 
connect the channel pore to the CNB domain and are responsible for the transmission of 
the conformational change to the pore. The main difference between bound and unbound 
states is the overall rearrangement of the helices (Figure 5). Upon binding of the ligand, 
the phosphate binding cassette and helix αC collapse around the ligand. In the unbound 
state helix αC can occupy multiple positions (Clayton et al. 2004; Altieri et al. 2008; 
Rehmann et al. 2007). Particularly important for ion channels is the repositioning of the C-
linker that is thought to lead to changes in the gate (Craven & Zagotta 2006). 
8 
 
Figure 5 - Superposition through -roll of 
bound and unbound CNB domains from 
MlotiK1 channel. In green is the bound 
structure (PDB code 1VP6) with cAMP in 
stick model and in red the unbound 
structure (PDB code 1U12). -roll is in 
grey. Large arrows point to two positions 
of loop between αA’-αA.  
  
 
The CNB-homology domain in KCNH channels has strong homology to CNB domains of 
Cyclic Nucleotide Gated (CNG) channels and Hyperpolarization-activated Cyclic 
Nucleotide-gated (HCN) channels. KCNH channels also show homology to CNG and 
HCN channels in the C-linker region that connects the CNB-homology domain to the pore 
(Warmke & Ganetzky 1994). However, it has been shown that the in vitro affinity of CNB-
homology domain for cyclic nucleotides is very low (KD ≥ 50 µM) and that the function of 
KCNH channels is not altered upon exposure to cyclic nucleotides (Brelidze et al. 2009). 
We have determined the structure of the CNB-homology domain from the mouse EAG1 
(mEAG1) channel at 2.2 Å (PDB code 4F8A) (Marques-Carvalho & Morais-Cabral 2012); 
it shows the typical fold of a CNB domain, with 3 helices (αA, αB and αC) lying on the 
surface of a β-roll (Figure 6) (Marques-Carvalho et al. 2012). Residues immediately after 
the αC helix (residues 696 to 707), which we designate as the C-terminal tail of the 
domain, adopt an extended conformation and snake over the surface of the structure.  
The structure also includes part of the C-linker (helices αD´, αE´ and αF´) that connects 
the domain to the last transmembrane helix of the channel.  
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Figure 6 - Structure of the CNB-homology 
domain from mouse EAG1 channel. 
Cartoon representation with the C-linker 
stretch depicted in cyan, CNB-homology 
domain helices in dark blue and β-roll in 
grey. 
 
Structures for CNB-homology domains of all three KCNH subfamilies (mouse EAG1 
(mEAG1) PDB code 4F8A, zebrafish ELK (zELK) PDB code 3UKN and mosquito ERG 
(agERG) PDB code 4L11) have been solved and share many similarities. Superposition 
through the β-roll shows that the CNB-homology domain helices are differently positioned 
on the surface of the β-roll but maintain the same relative disposition (Figure 7a) 
(Marques-Carvalho et al. 2012; Brelidze et al. 2012; Brelidze et al. 2013). In contrast, the 
C-linker region in these structures displays a large structural variability (Figure 7b) and it is 
not clear if any of the observed conformations are functionally meaningful. 
Figure 7 – a) Superpositions of CNB-homology domains from mEAG1 (blue, PDB code 
4F8A), zELK CNB-homology domain (orange, PDB code 3UKN) and agERG (green, PDB 
code 4L11) through the β-roll. b) Different dispositions of the C-linker region, coloring 
scheme is maintained. 
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To better understand the structural underpinnings of the low affinity of cyclic nucleotides 
for the CNB-homology domain we compared the structures of CNB-homology domain and 
CNB domains. Like in CNB domains, there is a shallow “binding pocket” in CNB-homology 
domains (Figure 8a, 8b). This pocket is more open than the CNB domain binding pockets. 
There is also an interesting aspect in the conservation of residues of the pocket. Many of 
the residues that surround the base of the nucleotide in the MlotiK1 CNB domain (Figure 
8b), and which are fairly conserved across CNB domains, are basically unchanged in the 
CNB-homology domain (Figure 8a). In contrast, the key arginine that interacts with the 
phosphate group in CNB domains and determines much of the affinity for the ligand 
(Altieri et al. 2008) is not present in the homology domains. 
Overall, the differences in the structure and amino acid composition of the pocket of CNB-
homology domains relative to CNB domains explain the very low affinity of the homology 
domains for cyclic nucleotides. 
 
 
Figure 8 - Comparing binding pockets. a) Close up view of binding pocket in CNB-
homology domain. b) Close up view of cAMP binding pocket in CNB domain from MlotiK1; 
cAMP in yellow stick. PDB code: 1VP6. Some of the residues that line the cAMP binding 
pocket in MlotiK1, and corresponding residues in CNB-homology domain, are shown in 
stick and are labeled. Dotted lines indicate distances measured across the pockets, 
between equivalent residues: 10.6 Å for MlotiK1 domain and 12.5 Å for mEAG1 domain.   
11 
 
 
Importantly, the pocket is not empty in the CNB-homology domain structures. All the 
structures adopt the same “self-liganded” conformation: two residues in the C-terminal tail 
which are conserved across KCNH channels (Y699 and L701 in the mEAG1 channel; 
Y740 and L742 in zELK and Y727 and M729 in agERG) occupy the volume taken up by 
cAMP in the CNB domains of the HCN and MlotiK1 channels (Figure 9a and 9b). These 
residues are therefore known as the “instrinsic ligand”. The intrinsic ligand residues 
establish an extensive network of interactions with residues in the pocket (Figures 9b) and 
some of these interactions are similar to the ones established by cyclic nucleotides in 
CNB domains. In mEAG1, the aromatic ring of the tyrosine is roughly at the same position 
as the aromatic base of the cyclic nucleotide and interacts with some of the residues 
conserved across CNB domains and CNB-homology domain; the leucine side-chain 
overlaps with the cyclic phosphate group and interacts with Y609 and V615 that take up 
the position of the arginine conserved in CNB domains (Figure 8a). In occupy the volume 
of the nucleotide base and cyclic phosphate, respectively (Brelidze et al. 2012; Brelidze et 
al. 2013). 
 
The presence of the same self-liganded conformation in the three different crystal 
structures, determined from domain constructs with very different limits (the mEAG1 
domain includes only part of the C-linker while the domain from zELK and agERG have 
 
Figure 9 – a) Close up view (viewed from binding pocket) of intrinsic-ligand residues in 
CNB-homology domain from mEAG1 (blue), zELK (orange) and agERG (green) 
superimposed with cAMP molecule (in lines) from MlotiK1 CNB DOMAIN (PDB code: 
1VP6). Superposition of structures was done through residues in β-roll. b) Residues of 
CNB-homology domain binding pocket interacting with Y699 and L701 (in white). 
Residues were selected with a 4 Å radius. View is rotated 180° relative to c). 
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the whole linker) and originating from different KCNH channel sub-families (with just ~40% 
identity over the domain sequence), supports the proposal that this conformation is a 
significant feature of KCNH channels. However, mutations in the intrinsic ligand residues 
have very different effects on the channel’s gating properties, depending on the subfamily 
(Brelidze et al. 2012; Marques-Carvalho et al. 2012; Brelidze et al. 2013). 
PAS/CNB-homology domain complex 
Several studies have shown that PAS and CNB-homology domains interact with each 
other. An in-cell fluorescence study in hERG1 channels showed that the PAS domain only 
alters gating in channels that contain a CNB-homology domain. Moreover, PAS only 
interacts with a truncated channel if the CNB-homology domain is present. The study also 
showed that the PAS/CNB-homology domain interactions occur across different channel 
subunits (Gianulis et al. 2013). In addition, it was shown that PAS domain and CNB-
homology domain from mEAG1 interact with a KD of 13 µM (Haitin et al. 2013a). The 
structure of this complex (Figure 9) reveals an extensive binding interface that includes 
interactions between: the CNB-homology domain intrinsic ligand and helix αB from the 
PAS domain; PAS domain strands βA and βB and the post-CNB-homology domain region 
(that comprises the calmodulin binding sequence BDC1); and the PAS-CAP helix with the 
β-roll from the CNB-homology domain (Figure 10). Many mutations associated with 
diseases (LQTS or cancer) lie on this interface, suggesting that perturbation of the 
interaction between PAS domain and CNB-homology domain is related to the 
pathophysiology of KCNH-related diseases (Haitin et al. 2013b). 
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Figure 10 – Structure of the mEAG1 PAS/CNB-homology domain complex. PAS in cyan 
and CNB-homology domain (CNBhD) in dark blue. Intrinsic ligand is in stick 
representation. There are no structural changes relative to the isolated domains. 
 
EAG1 calmodulin binding sites 
It has been well established that, besides being regulated by voltage, the EAG1 channel 
activity is inhibited by Ca2+ (Stansfeld et al. 1996), an effect that is mediated through 
calmodulin (CaM) binding to the channel (Schönherr et al. 2000). With a half maximal 
inhibitory concentration (IC50) of ~100 nM for Ca
2+ (Schönherr et al. 2000) and 6 nM for 
calmodulin (Sahoo et al. 2010), EAG1 channels undergo inhibition just above basal 
cytosolic Ca2+ concentrations. 
Three calmodulin binding sequences have been identified using a peptide array screen 
that spanned the entire human EAG1 cytoplasmic regions. BDN is found in the N-terminal 
cytoplasmic region, between the PAS domain and transmembrane helix TM1, BDC1 and 
BDC2 (Ziechner et al. 2006) are in the C terminus, immediately after the CNB-homology 
domain (Figure 3 and 11a). The in vitro affinity for Ca2+-calmodulin was determined for the 
three sites using fluorescence correlation spectroscopy: 100-200 nM for BDN and BDC2, 
whereas for BDC1 the affinity varied between ~300 nM and more than 5 μM, depending 
on the fluorophore used. Deletion of the entire N-terminus renders the channel insensitive 
to CaM and affects the channel’s gating properties (Ziechner et al. 2006; Carlson et al. 
2013). Furthermore, it has also been shown that mutations that reduce calmodulin affinity 
at each of the three sites drastically reduce channel inhibition by Ca2+-calmodulin (Figure 
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11a), supporting the functional importance of all three sites for Ca2+-calmodulin regulation 
(Ziechner et al. 2006). 
An in-cell fluorescence study has raised the possibility that a resident calmodulin is bound 
to BDN in the absence of Ca2+, since FRET (Förster resonance energy transfer) could be 
observed between calmodulin and hEAG1 with mutated BDC2 (Gonçalves & Stühmer 
2010); contradicts previous results that did not detect binding of apo-CaM to BDN or 
BDC2 peptides. The same fluorescence study demonstrated that, in the presence of Ca2+, 
channels with disrupting mutations on BDN or BDC2 are still able to interact with 
calmodulin, although channels with mutated BDN, BDC2 and intact BDC1 no longer bind 
calmodulin (Gonçalves & Stühmer 2010). These results have raised the hypothesis that 
the lower affinity site BDC1 might not be physiologically relevant. More recently, the 
structure of mEAG1 CNB-homology domain, alone and in complex with the PAS domain, 
revealed BDC1 in a partially occluded conformation (Haitin et al. 2013b), supporting the 
idea that this site may not be relevant for CaM binding. Nevertheless, (Schönherr et al. 
2000; Ziechner et al. 2006) have shown that all sites (BDN, BDC1 and BDC2) need to be 
intact and present in order for CaM to exert its inhibitory function. 
The importance of the Ca2+ binding sites in CaM for the inhibition of EAG1 was also 
explored. Mutations on CaM’s EF-hand motifs were introduced to disrupt Ca2+ binding 
(Ziechner et al. 2006). CaM N-lobe mutants showed a drop in affinity for BDN and BDC2 
between 7 and 9-fold whereas C-lobe mutations abolished binding to the same peptides. 
The functional impact of these mutant calmodulins on EAG1 currents was compared to 
wild-type CaM; while the CaM N-lobe mutants showed big effects on inhibition, the C-lobe 
mutants failed to affect the channel currents (Figure 11b). This implies that CaM with just 
Ca2+ bound to the C-lobe is still able to inhibit EAG1 currents, although with less potency 
than wild-type CaM. 
15 
 
 
 
 
Figure 11 - a) EAG1 channel sequences corresponding to the peptides with the highest 
binding of fluorescently-labeled CaM - CaM binding sites BDN, BDC1 and BDC2. On the 
right, the funtional impact of mutations on BDN, BDC1 or BDC2 is depicted (mutant 
hEAG1 channels currents,  in the absence and presence of Ca2+-CaM). b) Functional 
impact on mutations in CaM’s EF-hands (N-lobe and C-lobe) on wild-type hEAG1 channel 
currents. 
16 
 
Calmodulin 
Calmodulin structure and plasticity 
Calmodulin (CaM) is a highly conserved acidic protein, ubiquitous in eukaryotes, and it is 
composed by two globular domains – the N- and C-lobe – connected by a flexible linker 
(Figure 12a and b). In eukaryotic cells CaM is the main Ca2+ signaling protein, reaching 
concentrations between 10-100 µM; deletion of the CaM gene is lethal because of its 
involvement in numerous cellular processes (Yamniuk & Vogel 2004). CaM has been 
reported to interact with over 300 proteins, making calmodulin a limiting factor in calcium 
signaling in the cell since its total concentration is significantly lower than that of its targets 
(Persechini & Stemmer 2002). 
Each CaM lobe contains two EF-hand motifs (named EF 1-4), helix-loop-helix motifs that 
can bind one Ca2+ each, up to a maximum of four Ca2+ ions per CaM molecule (Villarroel 
et al. 2014; Tidow & Nissen 2013). In the absence  of target proteins, Ca2+ binds 
cooperatively to the C-lobe’s EF-hands first, and then to the N-lobe’s, with affinities of 
about 1 µM and 10 µM, respectively (Yamniuk & Vogel 2004). Ca2+ binding to CaM 
induces a conformational change that expose hydrophobic patches, increasing CaM’s 
affinity to its targets (Yamniuk & Vogel 2004). However, CaM can also bind with high 
affinity to some targets in the absence of Ca2+ (e.g. IQ domains). In addition, binding to a 
target is reflected in increased affinity of CaM for Ca2+ (Villarroel et al. 2014; Yamniuk & 
Vogel 2004). 
CaM contains an unusually high percentage of methionines in its composition; these are 
very flexible and highly polarizable residues which, together with many other hydrophobic 
residues, create very adjustable and sticky interaction surfaces. This feature, together with 
the very flexible interlobe linker that allows CaM to orient the lobes independently of each 
other, account for its ability to bind protein fragments with low sequence conservation 
(Yamniuk & Vogel 2004). Despite the lack of a consensus CaM binding sequence, CaM 
binding targets share some features such as high propensity to form amphipathic helices, 
net positive charge (basic residues), and a few hydrophobic residues that act as “anchors” 
(Rhoads & Friedberg 1997).  
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Figure 12 - Structures of calmodulin and CaM in complex with target peptides. CaM and 
peptides are in cartoon representation (red and grey, respectively) and Ca2+ is 
represented by black spheres. a) apo-CaM (PDB code 1CFD). b) Ca2+-CaM (PDB code 
3CLN). c) Ca2+-CaM in complex with Cav IQ domain (PDB code 2BE6). d) Ca2+-CaM in 
complex with an Orai channel fragment (PDB code 4EHQ). 
 
The interaction of CaM with its targets is very diverse. In the canonical binding modes, the 
central linker unwinds allowing N- and C-lobe to be in close contact with the CaM binding 
sequence, adopting a collapsed conformation (Figure 12c). The canonical modes are 
classified by the spacing between the hydrophobic anchors that dock into CaM’s 
hydrophobic pockets (e.g. the complex on Figure 12b has a 1-10 spacing). The non-
canonical binding modes are very diverse in nature and do not involve “wrapping” of CaM 
around the target. CaM is in an elongated (or extended) conformation with either the N- or 
C-lobe engaging with the target (Figure 12d) and often the lobe that is not engaged with 
the target will not have Ca2+ bound. 
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CaM regulation of ion channels (CaM modulation) 
Many ion channels are regulated by calmodulin (Saimi & Kung 2002). These include 
voltage-gated calcium (Cav), sodium (Nav) and potassium channels (Kv), small 
conductance calcium-activated potassium channels (SK), inwardly rectifying potassium 
channels (Kir), cyclic nucleotide-gated ion channels (CNG), ryanodine receptors (RyR), 
transient receptor potential channels (TRP) and calcium release activated channel (Orai). 
High resolution structures of CaM in complex with full-length ion channels have not yet 
been reported. Instead, there is an increasing number of structures of channel fragments 
in complex with CaM; however, despite extensive functional studies on CaM regulation in 
different ion channels, the molecular mechanisms of CaM action are not well understood. 
CaM regulation differs between different isoforms of the same channel family and 
depends on the cellular context (neuronal vs. cardiac channels, for example). This 
variation has prevented the formulation of a mechanism of CaM modulation for a 
particular channel family. 
 Voltage-gated Ca2+ channels and voltage-gated Na+ channels 
Voltage-gated calcium channels (Cav) are responsible for the transduction of membrane 
potential changes into transient increases in intracellular Ca2+ concentration, initiating 
many important physiological processes (Catterall 2011). Several sites for CaM binding 
have been identified in the N and C termini of these channels, although one CaM 
molecule seems to suffice for CaM modulation (Mori et al. 2004). The IQ domain present 
in the C-terminal cytoplasmic region is critical for this regulation (Van Petegem et al. 2005; 
Kim et al. 2010); in low calcium, apo-calmodulin is bound to the IQ domain of Ca2+-
channels and increases the channel’s open probability (Adams et al. 2014). CaM 
functions as a resident Ca2+ sensor, with the C-lobe sensing local large Ca2+ oscillations 
due to ion influx through the Ca2+-channel, while the N-lobe senses smaller changes in the 
global intracellular concentration of Ca2+ (Tadross et al. 2008). Upon Ca2+ entry through 
the Ca2+-channels, CaM binds Ca2+ and the CaM conformational change presumably 
leads to subtle rearrangements in the C-terminal region of the channel that result in 
channel inhibition, a phenomenon called Ca2+-dependent inactivation (CDI) (Ben-Johny & 
Yue 2014). 
Several parallels have been drawn between CaM modulation of Cav channels voltage-
gated sodium channels (Nav). Still, CaM regulation of Nav channels is less understood and 
the literature is inconsistent. Recently, it was reported that the skeletal muscle Nav isoform 
exhibits fast CDI and that the CaM N-lobe functions as the Ca2+ sensor, similar to what 
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happens in Ca2+-channels. However, the same report refuted previous studies by showing 
that the cardiac Nav isoform is not modulated by Ca
2+ (Ben-Johny et al. 2014), despite the 
high sequence similarity in the IQ region. 
 KCNQ (Kv7) voltage-gated K+ channels 
CaM affects the function of all channels in the Kv7 voltage-gated potassium channel 
family. CaM interacts with two regions in the C terminus of this channel – an IQ motif and 
a 1-5-10 motif, that are 135 residues apart (Alaimo et al. 2014; Xu et al. 2013; Mruk et al. 
2012). CaM binding regulates channel assembly, trafficking and function. Apo-CaM is 
bound constitutively to Kv7 channels through the IQ-domain and Ca2+-CaM regulates 
these channels by altering their voltage-dependent activation, resulting in an increase or 
decrease in current, depending on the channel isoform.  
 Small conductance Ca2+-activated K+ (SK) channels 
SK channels contain a CaM binding site after the last transmembrane helix. CaM is bound 
to SK channels, even in the absence of Ca2+; the channel is activated upon Ca2+ binding 
to CaM. SK channels co-expressed with CaM mutated in the N-lobe’s EF-hands (not able 
to bind Ca2+ on the N-lobe) showed no activity whereas SK channels co-expressed with 
CaM mutated in C-lobe’s EF-hands were still activated by Ca2+ (Adelman 2015). 
Structural studies on the interaction between CaM and the SK2 CaM binding site showed 
that apo-CaM is bound via the C-lobe, leaving the N-lobe free to interact with other 
binding sites from neighboring subunits (Schumacher et al. 2004). In the presence of 
Ca2+, solution studies and an X-ray structure showed that there is CaM-induced 
dimerization of this channel region. CaM is in an elongated form, interacting with three 
different helices from two different CaM binding sites (Schumacher et al. 2001). The N-
lobe has Ca2+ and interacts with one CaM binding site while the C-lobe interacts with two 
helices from the other CaM binding site monomer; the C-lobe has its EF-hands distorted, 
without Ca2+. 
It has been proposed that gating involves Ca2+ binding to the N-lobe, inducing this lobe to 
interact with the distal part of a CaM binding site from another channel subunit. This 
conformational change is then transmitted to the adjacent TM6 helix in the gate region, 
resulting in channel opening. 
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II. AIMS OF THE STUDY 
 
The aim of this work is to gain insights into: 1) the structure and function of the CNB-
homology domain; and 2) the interaction of calmodulin with the cytoplasmic regions of the 
EAG1 channel. 
Some of the questions we are asking are: 
 Does the CNB-homology domain have an unliganded conformation? 
 Does the CNB-homology domain have a role in KCNH channel gating? 
 Does calmodulin bind to the EAG1 CaM binding sites in a lobe-specific manner? 
 Do the neighboring globular domains PAS and CNB-homology domain alter the 
affinity of calmodulin for the calmodulin binding sites?  
To address these questions I have performed a thorough structural, biochemical and 
functional characterization of the cytoplasmic regions of EAG channels that surround the 
CaM binding sites BDN, BDC1 and BDC2. The work has two focal points: the biochemical 
and thermodynamic characterization of the interaction between calmodulin and different 
channel regions and the structural characterization of these interactions. This 
characterization was pursued using biophysical techniques such as isothermal titration 
calorimetry, x-ray crystallography and fluorescence spectroscopy as well biochemical 
analysis. 
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III. CHARACTERIZATION OF THE CYCLIC NUCLEOTIDE BINDING 
HOMOLOGY-DOMAIN FROM EAG1 CHANNEL 
The work described in this section has been published in: 
Marques-Carvalho, M.J.; Sahoo, N.; Muskett, F.W.; Vieira-Pires, R.S.; Gabant, G; 
Cadene, M.; Schönherr, R.; Morais-Cabral, J.H.,. “Structural, biochemical, and functional 
characterization of the cyclic nucleotide binding homology domain from the mouse EAG1 
potassium channel.” Journal of Molecular Biology, 423(1), pp.34–46, 2012. 
 
INTRODUCTION 
The structures of the CNB-homology domains from all KCNH subfamilies revealed a 
common feature – a short β-strand after the αC helix that includes the “intrinsic ligand”, 
two residues that occupy the cavity where cyclic nucleotides bind in bona fide CNB 
domains. We call this a “self-liganded” conformation since the intrinsic ligand is bound in 
the β-roll pocket keeping the helix αC and the C-terminal tail tightly packed against the 
domain. 
In this section, we set out to characterize biochemically and functionally this self-liganded 
conformation. In addition, we explored the possible existence of an unliganded 
conformation. We tried to destabilize the self-liganded state either by mutating the intrinsic 
ligand residues or by assessing if CaM binding to BDC1 displaces the C-terminal tail away 
from the domain. 
 
METHODS 
Expression and purification of mEAG1 channel fragments 
mEAG1 residues 552–724 and 552–736 were cloned into co-expression vector 
pRSFDuet-1 (Novagen). A fusion of maltose‐binding protein with mEAG1 BDC1 (residues 
696–736) was also cloned into pRSFDuet-1. Mutants were created using the QuikChange 
Site-Directed Mutagenesis Kit (Stratagene). 
Escherichia coli BL21 (DE3) competent cells transformed with an expression vector were 
grown at 37 ºC with agitation in Luria broth medium supplemented with kanamycin (50 
mg/L) until the 600 nm optical density (OD600) reached 0.6–0.8. At this point, cultures 
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were placed on ice for 30 min (to induce cold-shock chaperones). Ethanol was then added 
dropwise to a final concentration of 2%(v/v) (to induce expression of heat-shock 
chaperones); IPTG was added to a final concentration of 0.5 mM for overnight induction at 
18 ºC (12–16 h). Cultures were harvested by centrifugation at 4785xg for 20 min at 4 ºC 
and the resulting pellet was resuspended in buffer A (1 L pellet in 20 mL of 50 mM Tris-
HCl pH 8, 150 mM NaCl, 5 mM imidazole) supplemented with protease inhibitors: 1 mM 
PMSF, 1 mg/mL leupeptin, 1 mg/mL pepstatin. Cell lysis was performed in a cooled cell 
cracker (Emulsiflex-C5, Avestin) and the lysate was centrifuged at 32 800xg for 45 min at 
4 ºC to remove cell debris. The supernatant was loaded onto His-select Nickel Affinity Gel 
(Sigma) pre-equilibrated with buffer A and washed with buffer A until the 280 nm optical 
density (OD280) stabilized. While monitoring the OD280 of the eluate, the beads were first 
washed with buffer A + 300 mM NaCl and buffer A containing 20 mM imidazole. Protein 
was eluted with buffer A containing 150 mM imidazole. 
To remove the imidazole, the eluted protein was dialyzed against buffer B containing 50 
mM Tris-HCl pH 7.5, 150 mM NaCl and 5 mM DTT and loaded into an S200 size-
exclusion chromatography column (GE Healthcare), pre-equilibrated with the same buffer. 
Protein for fluorescence binding assays was dialyzed against fluorescence buffer [50 mM 
Tris–HCl, pH 7.5, 150 mM NaCl, 5 mM MgCl2, 0.1mM ethylene glycol bis(β‐aminoethyl 
ether) N,N′‐tetraacetic acid (EGTA), and 2 mM CaCl2 (1.9 mM free Ca
2+)] 
Expression and purification of calmodulin 
Escherichia coli BL21(DE3) competent cells were transformed with expression vector 
(pT7-7 hCaM) and plated on LB agar+ampicillin; the following day resuspended colonies 
were grown in liquid LB+ampicillin at 37 °C, 160 rpm until they reached an OD600 
between 0.6-0.8. 0.5 mM IPTG was added followed by a 3h induction at 37 °C. 
Cultures were harvested by centrifugation at 4785xg, 20 min, 4 °C (Beckman rotor JLA 8-
1000) and the resulting pellet was either stored at -20 °C or immediately resuspended in 
lysis buffer (refer to table 1 for buffer composition) supplemented with the protease 
inhibitors PMSF (1 mM), leupeptin (1 µg/mL) and pepstatin (1 µg/mL). Cells were lysed in 
a cooled cell cracker (Emulsiflex-C5, AVESTIN). The lysate was centrifuged at 32 800xg 
(Beckman rotor JA-25.50) for 45 min at 4 °C to remove cell debris. Supernatant was 
loaded into a Phenyl Sepharose CL-4B (Sigma-Aldrich) column equilibrated in EDTA 
buffer to retain proteins that bind in a calcium-independent manner. The flow-through that 
contains CaM was collected and CaCl2 was added to a final concentration of 5 mM. The 
calcium supplemented flow-through was loaded onto another phenyl sepharose column 
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equilibrated in calcium buffer. This second step allows CaM to interact with the phenyl 
sepharose matrix. Washes were made with calcium buffer + NaCl and calcium buffer. 
Calmodulin was eluted with EDTA buffer. Protein purity was evaluated by SDS-PAGE and 
concentration was determined by measuring absorbance at 277 nm (calmodulin does not 
have any tryptophans in the sequence, using the extinction coefficient ε277=3029 M
-1 cm-1 
(Strasburg et al. 1988). Calmodulin was dialyzed against storage buffer using a dialysis 
membrane with 3.5 KDa cutoff and stored at -80 °C. 
Table 1 – Composition of the buffers used for calmodulin purification 
 
Tris HCl pH 
7.5 (mM) 
NaCl 
(mM) 
EDTA 
(mM) 
DTT 
(mM) 
CaCl2 
(mM) 
NaN3 
(mM) 
Lysis buffer (EDTA 
buffer + NaCl) 
50 100 2 5 0 0 
EDTA buffer 50 0 2 5 0 0 
Calcium buffer 50 0 0 5 1 0 
Calcium buffer + 
NaCl 
50 100 0 5 1 0 
Storage buffer 20 150 0 0 0 1 
Derivatization of calmodulin with the fluorophore Dansyl-Cl  
Wild-type human calmodulin was derivatized with 5-(dimethylamino) naphthalene-1-
sulfonyl chloride (Dansyl-Cl, Molecular Probes), a reagent that reacts with primary 
amines, as previously described (Kincaid et al. 1988; Kincaid et al. 1982). 
Briefly, calmodulin was passed through a desalting column equilibrated in in a buffer 
containing 20 mM sodium bicarbonate pH 10, 100 mM NaCl, 250 µM CaCl2. Desalted 
CaM was incubated with 1.5-fold molar excess of Dansyl-Cl dissolved in dry acetone for 
90 min at room temperature. The reaction was stopped by the addition of 50 mM Tris-HCl 
pH 8. The derivatized protein was desalted in fluorescence buffer (50 mM Tris HCl pH 7.5, 
150 mM NaCl, 5 mM MgCl2, 0.1 mM EGTA and 2 mM CaCl2 (1.9 mM free Ca
2+)). 
Fluorescence assay  
Dansylated-calmodulin at 400 nM was incubated with increasing protein concentrations at 
room temperature, for at least 20 min, in fluorescence buffer (50 mM Tris HCl pH 7.5, 150 
mM NaCl, 5 mM MgCl2, 0.1 mM EGTA and 2 mM CaCl2 (1.9 mM free Ca
2+)). Fluorescent 
measurements were performed at 26 °C using a Horiba Fluoromax-4 spectrofluorimeter. 
All emission spectra were recorded with an excitation wavelength of 340 nm and slit 
widths of 4 or 5 nm 18. For each titration curve, fluorescence intensity was measured at 
the wavelength corresponding to the maximum shift in the emission spectra. Data were 
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normalized using Fnorm = (F-F0)/(Fmax-F0). Where F is the measured fluorescence value for 
each protein concentration, Fmax is the maximum measured fluorescence and F0 is the 
measured fluorescence before adding any mEAG1 protein fragment. Fnorm was plotted as 
a function of total protein concentration using OriginPro8. Data were fitted to a modified 
hyperbolic function of the form: Fnorm = α/(1+2/(-1-(1/KD)[dansyl-CaM]+(1/KD)[mEAG1]+sqrt 
((1+(1/KD)[dansyl-CaM]-(1/KD)[mEAG1])
2+4(1/KD)[mEAG1]))),where KD is the dissociation 
constant, [dansyl-CaM] is the total concentration of dansylated-calmodulin, [mEAG1] is 
the total concentration of mouse EAG1 domain and α is an adjusting factor. 
Competition experiments were performed in the presence of 4 µM of WT calmodulin and 
data were fitted to the function 35: 
Fnorm = α(2cos(d/3)sqrt(a
2-3b)-a)/(3(1/KDdansyl)+(2cos(d/3)sqrt(a
2-3b)-a)). 
a = (1/KDdansyl)+(1/KDWT)+[dansyl-CaM]+[WT-CaM]+[mEAG1]; 
b = (1/KDWT)([dansyl-CaM]-[mEAG1])+(1/KDdansyl)([WT-CaM]-
[mEAG1])+(1/KDdansyl)(1/KDWT); 
c = -(1/KDdansyl)(1/KDWT)[mEAG1]; 
d = acos((-2a3+9ab-27c)/(2sqrt((a2-3b)3))). 
, where KDdansyl is the dissociation constant for dansylated-calmodulin, KDWT is the 
dissociation constant for wild-type calmodulin, [dansyl-CaM] is the total concentration of 
dansylated-calmodulin, [WT-CaM] is the total concentration of wild-type calmodulin, 
[mEAG1] is the total concentration of mouse EAG1 domain and α is an adjusting factor. 
Pegylation assay  
Wild type mEAG1 552-724 was diluted to 2 μM in fluorescence buffer with 1mM TCEP, 
and incubated at room temperature for 1h in the presence and absence of 50 μM 
calmodulin. Methoxypolyethylene glycol maleimide (MAL-PEG, Fluka/Sigma-Aldrich) was 
added to the protein mixture at 5 mM and incubated at 4 °C for 5, 10 min. Reactions were 
stopped by addition of DTT to a final concentration of 200 mM, incubation for 30 minutes 
and addition of SDS-PAGE loading buffer. Samples were run on a 15% SDS-PAGE and 
analyzed by Western Blot. Proteins were probed with an anti-His-tag monoclonal antibody 
(Qiagen).  
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Mass spectrometry  
Proteins were analyzed by MALDI-TOF MS. The matrix solution consisted of saturated 4-
hydroxy-α-cyano-cinnamic acid in 66.5% H2O, 33.3% CH3CN, 0.1% TFA. Analytes in the 
micromolar range were prepared by twenty-fold to two hundred-fold dilution into the matrix 
solution. The analyte-matrix samples were spotted onto a gold-plated sample probe using 
the ultra-thin layer method as described (Cadene & Chait 2000; Gabant & Cadene 2008) 
and analyzed in linear positive ion mode. Spots were washed with 0.1% TFA before 
acquisition. Analyses were performed using an Autoflex I or an Ultraflex I mass 
spectrometer (Bruker Daltonics, Germany) equipped with a 337 nm nitrogen laser and a 
gridless delayed extraction ion source. An accelerating voltage of 20kV was used and 
delay was optimized between 500 and 650 ns to achieve a mass resolution greater than 
1000 over the mass range of interest (10000–20000 Da). A deflection of matrix ions up to 
600 Da was applied to prevent detector saturation. Spectra were acquired in linear 
positive ion mode by accumulation of 300-500 laser shots. The instrument was controlled 
using Bruker FlexControl software. Calibration was performed externally using 
apomyoglobin and cytochrome c. MALDI-TOF-MS spectra were processed using 
FlexAnalysis 2.0 software from Bruker Daltonics and cleavage peptides assigned using 
Paws version 8.5.0.3 (ProteoMetrics, New York, NY). 
NMR Spectroscopy 
NMR spectra for the backbone assignment of CaM were acquired from 0.35 ml samples 
of 0.4 mM calmodulin in a 20 mM Tris, 140 mM sodium chloride, 10mM CaCl2, 0.2mM 
AEBSF and 0.02% (w/v) sodium azide buffer at pH 7.5, containing 5% D2O/95% H2O. All 
NMR experiments were acquired at 298K and were performed on Bruker DRX or AvanceII 
spectrometers operating at either 600 or 800MHz that were fitted with cryogenically 
cooled probe-heads. The 2D and 3D spectra recorded to obtain sequence specific 
assignments for CaM were: 15N/1H HSQC; NOESY-HSQC with an NOE mixing time of 
100 ms; 13C/1H HSQC and 15N/13C/1H HNCACB, CBCA(CO)NH, HNCA and HN(CO)CA 
((Bax 1994), and references therein). Typical acquisition times in F1 and F2 for the 3D 
experiments were 20 ms for 15N, 6.6-9.6ms for 13C and 18ms for 1H and with an 
acquisition time of 80 ms in F3 (
1H). The majority of the 3D spectra were collected over 
approximately 48 hours and 15N/1H and 13C/1H HSQC spectra over about 1 hour. Typical 
acquisition times in 2D experiments were either 60 ms (15N), 9 ms (13C) and 80 ms in F2 
(1H). Water suppression was achieved using the gradient based WATERGATE method 
(Sklenar et al. 1993). The 3D NMR data were processed using NMRPipe (Delaglio et al. 
1995) with linear prediction used to extend the effective acquisition times by up to 2 fold in 
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F1 and F2. The resulting spectra analysed using the program Sparky (T.D. Goddard and 
D.G. Kneller, Sparky 3, University of California, San Francisco). 
NMR chemical shift mapping of binding sites 
15N/1H TROSY (Pervushin et al. 1997) spectra of calmodulin were acquired in the 
presence and absence of mEAG1 552-724 to identify the changes in the positions of 
signals induced by CNB-homology domain binding. In these experiments, amounts of 
unlabeled mEAG1 552-724 were added to 100 μM 15N-labelled calmodulin to achieve 
30% and 90% saturation of calmodulin based on the determined KD. Experiments were 
performed in the same buffer as used for calmodulin assignment but with the addition of 
2mM DTT. Typical acquisition times for the TROSY experiments were 80 ms in F2 (
1H), 
and 30 ms in F1 (
15N), with the spectra collected over approximately 3 hours. Perturbation 
of backbone amide chemical shifts in the presence of mEAG1 552-724 was calculated 
relative to calmodulin alone using the minimum chemical shift procedure (Williamson et al. 
1997; Farmer et al. 1996) and then used to identify the intramolecular interface of mEAG1 
552-724 on calmodulin. 
Electrophysiological measurements and data analysis 
Recording and data analysis were described previously (Schönherr et al. 1999). In brief, 
stage V Xenopus oocytes were injected with 50 nL mRNA and currents were recorded at 
20–23 °C, 2 to 4 days after injection. A two-electrode voltage clamp amplifier (Turbo-TEC 
10CD, NPI electronic, Tamm, Germany) was controlled by PatchMaster software (HEKA 
Elektronik, Lambrecht, Germany). A P/n method was used for leak correction. The bath 
solution contained (in mM): 115 NaCl, 2.5 KCl, 1.8 CaCl2, 10 HEPES; pH 7.2 (NaOH). 
Data were analyzed with FitMaster software (HEKA Elektronik). Normalized conductances 
were obtained by fitting the following equation to the current-voltage data:  
I(V)=GV(1-e-((V-Erev)/25mV))/(1-e-(V/25mV))*1/(1+e-((V-V1/2)/k)) 
G is the maximal conductance and Erev the estimated reversal potential. The second term 
describes the channel open probability (or relative conductance), characterized by V1/2, 
the voltage of half-maximal activation, and a slope factor, k. 
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RESULTS 
Biochemical analysis of the self-liganded conformation 
An underlying implication of the proposal that CNB-homology domain adopts a self-
liganded conformation is that an unliganded conformation might exist, however no 
evidence for this other conformation has been provided. In this context it is interesting to 
realize that in our structure the C-terminal tail includes a significant amino acid stretch 
(residues 702 to 707) of the previously identified low affinity BDC1 calmodulin binding site 
(residues 702 to 712) (Figure 13) (Ziechner et al. 2006). This CaM binding sequence does 
not exist in the CNB-homology domain of zELK or agERG. The site starts immediately 
after the two residues (Y699 and L701) bound in the pocket and is partially occluded by 
steric contacts with residues on the surface of the domain. Considering the molecular 
volume of calmodulin it becomes clear that the steric occlusion of the BDC1 site will affect 
binding of calmodulin and that tight interaction between the two proteins will only occur 
when the site becomes accessible upon displacement of most of the C-terminal tail away 
from the domain. This new conformation would correspond to an unliganded state. 
Importantly, in an unliganded conformation the apparent affinity of Ca2+-calmodulin will be 
higher than in the self-liganded state and therefore mutations that destabilize the self-
liganded conformation would increase calmodulin affinity.  
 
Figure 13 - Stereo view of the CNB-homology domain with the two conserved residues 
bound in the binding pocket. β-roll is shown as surface representation. Residues from C-
terminal tail that reside in the pocket (Y699 and L701) are show in white stick; residue 
L697 is shown in yellow stick. Section of the calmodulin BDC1 binding site present in the 
structure is shown in red sticks. 
 
To explore the existence of an unliganded state we performed a series of biochemical 
experiments using dansylated-calmodulin, a fluorescent form of the protein (Kincaid et al. 
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1988). Dansylated-calmodulin has previously been reported to have similar properties to 
native calmodulin and we ensured that the calmodulin used in our experiments had on 
average just over 1 dansyl group per protein molecule, as evaluated by mass 
spectrometry.  We first determined the affinity of Ca2+/dansyl-calmodulin for BDC1 (KD 1.0 
± 0.1 μM, Figure 14a) by fusing the peptide sequence (residues 696 to 736 of mEAG1) to 
maltose-binding protein (MPB-BDC1) through a long linker. A competition experiment with 
wild-type (WT) calmodulin confirmed that both labeled and unlabeled forms of calmodulin 
have similar binding properties (KD 1.2 ± 0.1 µM for Ca
2+/WT-calmodulin, Figure 14a) and 
we made use of the modified calmodulin for the rest of our study. We also verified that 
calmodulin does not bind to MBP alone and that in the absence of Ca2+ binding to BDC1 is 
not detectable (Figure 15c and d). Taken together, these results confirmed previous 
reports of weak calmodulin binding at the BDC1 site (Ziechner et al. 2006). 
 
We then measured the affinity of Ca2+/dansyl-calmodulin for two different constructs 
spanning the complete CNB-homology domain and the whole BDC1 site (residues 552-
724 and 552-736). Calmodulin affinity to these constructs is 10- to 20-fold lower than that 
 
Figure 14 - Fluorescence binding curves with dansylated-calmodulin. a) Titration with 
calmodulin binding site BDC1 fused to MBP (blue ●, N=7). Competition experiment with 
WT calmodulin (blue ○, N=6). MBP-BDC1 fusion with mutations L697A/Y699A (green ●, 
N=3) and Y699A/L701A (red ▲, N=3). b) Titration with mouse EAG1 protein fragments 
that span the CNB-homology domain and the calmodulin binding site BDC1. Wild-type 
mEAG1 spanning residues 552 to 724 (blue ■, N=4) and spanning residues 552-736 (blue 
□, N=4). mEAG1 552-724 with mutations in the calmodulin binding site: 
R702N/R704N/R708N/K709N (cyan◄, N=2) and I705A/V706A/F707A (grey ◊, N=3). Error 
bars represent mean standard deviation. 
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measured for the BDC1 site alone, with KD values of 12.1 ± 1.4 μM and 16 ± 2.6 µM for 
the shorter and longer constructs, respectively (Figure 14b). This is consistent with our 
observation in the structure of partial steric occlusion of BDC1. From this point onward we 
used the smaller CNB-homology domain-BDC1 construct (residues 552-724). 
 
Figure 15 - Emission fluorescence spectra from dansyl-calmodulin titrated with different 
protein constructs. Red curve is spectra for dansyl-calmodulin alone and blue curve for 
dansyl-calmodulin titrated with maximum concentration of protein, as indicated on each 
graph. a) Titration with CNB-homology domain (CNBhD) triple BDC1 site mutant up to 60 
μM causes a shift of the emission maximum from 503 nm to 485 nm and an increase in 
intensity of more than 2-fold. b) Titration with fusion Maltose binding protein-BDC1 site 
(MBP-BDC1 up to 10 μM) causes a shift of the emission maximum from 504 nm to 482 
nm and an increase in intensity of ~2.5-fold. c) Titration with MBP alone (up to 50 μM) 
causes a minor shift of the emission maximum from 505 nm to 493 nm and an increase in 
intensity of just ~1.4-fold. The very small blue shift and small increase in fluorescence are 
an indication of a very weak interaction, much weaker than the interaction measured in a) 
which has a KD ~40 μM. d) Titration with MBP-BDC1 in the presence of EGTA (up to 40 
μM) does not cause any change in the fluorescence, indicating that calmodulin does not 
bind to this protein in the absence of Ca2+. 
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By mutating residues that appear to hold the C-terminal tail in position we should 
destabilize the self-liganded conformation and thus increase the apparent affinity for 
calmodulin. In the CNBhD-BDC1 construct we generated the C-terminal tail double-
mutants L697A/Y699A and Y699A/L701A. Y699 and L701 are the two residues in the 
domain structure which interact with the domain pocket (Figure 9b, 13); L697 is not in the 
pocket but has extensive contacts with residues in the β-roll (Figure 13). As was predicted 
above, the affinity of calmodulin for these mutant domains is higher than that of the wild-
type domain (Figure 16a), KD 2.6 ± 0.2 μM for L697A/Y699A and 3.8 ± 0.5 μM for 
Y699A/L701A. 
 
We also analyzed the same double mutants (L697A/Y699A and Y699A/L701A) as MBP-
BDC1 fusions using dansyl-CaM. As shown in Figure 14a, the mutants show similar 
affinities (L697A/Y699A has a KD of 3.1 ± 0.2 μM, and Y699A/L701A has a KD of 3.2 ± 0.4 
μM) to the ones determined above for the same mutants in the domain. This similarity 
supports the notion that in these mutant domains the BDC1 site is as accessible as in the 
MBP fusion and therefore that the C-terminal tail has peeled away from the domain and is 
exposed. In addition, the small but significant effect of the double mutations in MBP-BDC1 
relative to the wild-type MBP fusion (Figure 14a) shows that calmodulin binding to BDC1 
extends all the way to these residues. 
 
Figure 16 - Fluorescence binding curves with dansylated-calmodulin. a) Titration with C-
terminal tail mutants of mEAG1 552-724, comparison with WT (blue ■). Mutants 
L697A/Y699A (green ●, N=3), Y699A/L701A (red ▲, N=3) and Y699W (black ○, N=3). b) 
Titration with binding pocket mutants of mEAG1 552-724, comparison with WT (blue ■). 
Mutants V628A (magenta, N=3) and V628L (purple ◊, N=3). Error bars are mean standard 
deviation. 
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Other mutations that are expected to destabilize the self-liganded conformation were also 
analyzed. The single-residue change Y699W, in the C-terminal tail, also increased the 
apparent calmodulin affinity but had a milder effect, KD ~ 6 µM (Figure 16a). Importantly, 
mutations of a residue in the pocket, which in the structure interacts with Y699, also lead 
to an increase in apparent calmodulin affinity: V628A and V628L have KD values of 2.3 
and 5 µM, respectively (Figure 16b).  
To better understand the weak interaction between calmodulin and the CNBhD-BDC1 
channel fragment our collaborator Dr. Frederick Muskett at the University of Leicester, UK 
used NMR and performed a minimal chemical shift mapping with 15N-labeled calmodulin 
(Farmer et al. 1996; Williamson et al. 1997). In this experiment we looked exclusively at 
the changes that occur in calmodulin upon interaction with the domain. Plotting of the 
minimal chemical shift data (i.e. the sum of the root-mean-square differences in nitrogen 
and proton chemical shift between free and bound Ca2+-calmodulin) shows that upon 
binding, the large changes (mean chemical shift difference ≥ 0.08 ppm) are mainly 
concentrated in residues of the N-terminal lobe of calmodulin (Figure 17a). We mapped 
the chemical shift data onto a representative structure of calmodulin bound to a peptide 
stretch (PDB 3OXQ, chain A) (Kim et al. 2010). Our model shows that the large chemical 
shifts occur in residues directly involved in the interaction with the peptide (Figure 17b). In 
contrast, in the C-lobe the major change occurs in T146, which does not interact directly 
with the bound helix (Figure 17c). These results indicate that binding to BDC1 occurs 
through the calmodulin N-lobe with little participation of the C-lobe, providing an 
explanation for the low affinity of Ca2+-calmodulin to the BDC1 site. This type of single 
lobe interaction has been described in the literature for calmodulin interaction with sites in 
voltage-gated calcium channels (Kim et al. 2010) and in voltage-gated sodium channels 
(Sarhan et al. 2012). Importantly, the data strongly supports the idea that, despite being 
weak, the in vitro interaction of the N-lobe of calmodulin with BDC1 has the hallmarks of a 
canonical interaction between a calmodulin lobe and a protein segment and is extensive 
since it involves residues across the binding surface of the N-lobe. 
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Figure 17 - Structural changes induced by calmodulin binding. a) Plot of backbone residue 
chemical shift changes that occur upon binding to mEAG1 552-724. Horizontal line marks 
cutoff of 0.08 ppm used for large changes. b) Mapping of chemical shifts onto the 
structure of calmodulin N-lobe bound to a helical peptide (from PDB code 3OXQ). 
Calmodulin residues are rainbow colored (dark-blue to red) according to chemical shift 
difference (0.0-0.22ppm). c) Structure of calmodulin C-lobe bound to helical peptide (from 
PDB code 3OXQ) colored as in b). d) Western-blot analysis of aliquots from pegylation 
reaction. Pegylation of wild-type mEAG1 552-724 was performed in the presence (+) and 
absence (-) of saturating concentrations of Ca2+-calmodulin and stopped at 5 min and 10 
min. Unmodified mEAG1 552-724 (lane C) is indicated by arrow. Western probed with an 
anti-His-tag monoclonal antibody. 
 
Overall, the data confirms our expectation that the occlusion of BDC1 weakens the 
interaction between the domain and calmodulin. Moreover, destabilization of the self-
liganded conformation can be achieved through mutagenesis of residues that in the 
structure appear to hold the C-terminal tail in position. Importantly, the data also shows 
that much of the stability of the self-liganded conformation results from the residues that 
interact in the pocket of the domain since mutation of these residues caused the largest 
increase in calmodulin affinity. However, these experiments do not demonstrate that 
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calmodulin binding to the domain causes destabilization of the self-liganded state. We 
cannot rule out that the interaction of calmodulin with the CNBhD-BDC1 channel fragment 
involves only part of the binding site.  It could happen that the interaction is occurring just 
with the C-terminal end of the site. In this position calmodulin is away from the domain 
and it may not affect its conformation. Binding to the whole BDC1 site would occur only 
upon destabilization of the self-liganded conformation by mutagenesis which would result 
in the release of the C-terminal tail and exposure of the site.   
To address this issue we performed two different biochemical experiments. First, we 
showed that the calmodulin interaction with the CNBhD-BDC1 does involve residues that 
are in the amino acid stretch partially occluded and that immediately follow the two 
conserved residues in the pocket (residues 702 to 707 - Figure 13). Consistent with that, 
combined mutations of the large apolar residues (I705A, V706A and F707A) present in 
the occluded stretch resulted in a lower binding affinity (KD ~41 µM) (Figure 14b). These 
values are most likely an underestimation, as in these experiments we could not reach the 
high protein concentrations necessary for saturation (≥ 60 µM, Figure 15b). Mutations of 
the positively charged residues in a slightly longer stretch, residues 702 to 709, also 
showed a contribution to the interaction, although to a lesser extent (KD ~28 μM for 
R702N, R704N, R708N and K709N - Figure 14b). 
Second, we showed that calmodulin binding to the domain has a direct effect on the 
domain structure. For this we made use of the 7 cysteines in the CNB-homology domain, 
while both the C-terminal tail (including the calmodulin binding site BDC1) and calmodulin 
have none.  We monitored changes in cysteine accessibility due to WT-calmodulin binding 
with maleimide-PEG5000, which reacts with free-thiol groups and adds ≥10 kDa to the 
apparent mass of a protein for each modified cysteine (Lu & Deutsch 2001). We reasoned 
that if calmodulin binding alters the structure of the CNB-homology domain we would 
expect to observe changes in the accessibility of the cysteines and therefore changes in 
the rate of cysteine reaction with the reagent. Western blot analysis of a reaction time 
course clearly shows differences in the pattern of bands consistent with changes in 
cysteine accessibility resulting from calmodulin binding (Figure 17d); in the sample with 
saturating amounts of calmodulin the larger molecular weight bands show up at earlier 
time points. 
Taken together these two approaches demonstrate that 1) calmodulin binding to the CNB-
homology domain occurs very close to the body of the domain, involving residues in the 
stretch immediately after the two residues that are essential for stabilizing the self-
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liganded state (Y699/L701), and 2) calmodulin binding results in conformational and/or 
dynamical changes in the structure of the domain.   
Our biochemical and structural experiments show that in vitro destabilization of the self-
liganded conformation, through mutations of residues involved in contacts between the C-
terminal tail and the rest of the domain, results in an increase on the apparent affinity of 
calmodulin binding to BDC1. Crucially, they also show that calmodulin binding to the 
domain is dependent on residues that are on the occluded stretch of the BDC1 site. A 
simple consideration of the molecular bulk of calmodulin suggests that this most likely 
involves the release of the C-terminal tail from the CNB-homology domain pocket. 
Consistent with this we show that binding of calmodulin results in structural changes in the 
body of the domain. Overall, our biochemical characterization suggests the existence of 
an unliganded conformation in the CNB-homology domain, a structural counter-part to the 
self-liganded conformation observed in the domain crystal structure. 
Functional analysis 
The CNB domains of CNG and HCN channels are involved in regulation of channel 
activation. It is therefore reasonable to ask if the CNB-homology domain also has a similar 
role in KCNH channels. Our collaborators Dr. Nirakar Sahoo and Dr. Roland Schönherr at 
the Jena University Hospital, Jena, Germany performed electrophysiological recordings 
on the human EAG1 channel expressed in Xenopus oocytes to explore the role of the 
CNB-homology domain and the intrinsic ligand on channel function. The amino acid 
sequence of the sequence stretch spanning the CNB-homology domain and the two C-
terminal calmodulin binding sites is identical in the mouse and the human EAG1 channels 
however, the human channel has been better functionally characterized (Schönherr et al. 
2000; Ziechner et al. 2006).  
Strikingly, whole cell two-electrode measurements showed that the destabilization of the 
self-liganded conformation by mutagenesis is reflected in the gating properties of the 
channel. Currents elicited at different voltages from wild-type and C-terminal tail mutant 
channels are shown in Figure 18a. It is immediately apparent that the double mutation 
Y672A/L674A, equivalent to Y699A/L701A in the mouse EAG1, has effects on channel 
gating. The rise time to reach 80% current amplitude at +50 mV is longer (251.5 ± 26.8 ms 
(n=15)) for this double mutants than for the WT channel (31.9 ± 3.9 ms (n=17)). From 
these currents we also extracted V1/2 of activation (Figure 18b and 18c), and the 
respective slope factor (Figure 18d). While the slope factors of the activation dependence 
on voltage were unchanged, the V1/2 values for activation were different: -16 mV for the 
WT channel, 0 mV for the single mutant L670A (equivalent to L697A in mEAG1), -24 mV 
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and -23 mV, respectively for the mutants Y672A and L674A (equivalent to Y699A and 
L701 in mEAG1). The double mutants revealed drastic differences in their effect; the V1/2 
value for L670A/Y672A mutant was right shifted to ~2mV, while the Y672A/L674A mutant 
is left shifted to -34 mV. The results for the double mutants are surprising since our 
biochemical experiments with the isolated domain showed that both sets display similar 
biochemical properties, involving the release of the C-terminal tail.  However, in the 
channel the double mutants have opposite effects to each other: L670A/Y672A stabilized 
the closed state over the open, while Y672A/L674A caused a stabilization of the open 
state over the closed. 
 
Figure 18 - Functional experiments. a) Two-electrode voltage-clamp current traces of 
human EAG1 (hEAG1) and indicated mutants expressed in Xenopus oocytes. Residue 
numbering of mutations in human channel and numbering for equivalent residues in the 
mouse channel (in parenthesis) are indicated. Currents were elicited by 2 s depolarizing 
pulses from a holding voltage of -90 mV in 10 mV increments between 80 mV and +50 
mV. b) Plot of relative conductance as a function of voltage for WT hEAG1 and the 
indicated mutants c) Plot of V1/2 of activation for WT hEAG1 (-15.8 ± 1.7 mV) and mutants 
(L670A, -0.1 ± 2.3 mV; Y672A, -23.5 ± 1.8 mV; L674A, -22.9 ± 2.9 mV; L670A•Y672A, 1.7 
± 1.3 mV; Y672A•L674A, -34.3 ± 3.8 mV). d) Plot of values for slope factors 
corresponding to the V1/2 data in c) (WT, 16.0 ± 0.4 mV; L670A, 18.6 ± 0.7 mV; Y672A, 
17.4 ± 0.7 mV; L674A, 17.4 ± 0.9 mV; L670A•Y672A, 18.1 ± 0.6 mV; Y672A•L674A, 19.7 
± 1.9 mV). 
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We also evaluated if channel inhibition by calmodulin is altered in the double mutants. 
Measurements with excised-patches exposed to Ca2+-calmodulin revealed no changes in 
the sensitivity to Ca2+-calmodulin (Figure 19); inhibition levels as well as on- and off-rates 
of calmodulin binding were indistinguishable from wild-type channels. The same 
experiments were not possible with the other double-mutant (Y672A/L674A, equivalent to 
the mouse Y699A/L701A) due to low expression levels. The lack of effect on inhibition by 
the mutations that increase in vitro calmodulin affinity for BDC1 may be a reflection of the 
low importance of this site in the inhibition mechanism. Alternatively, it could be that the 
relatively small increase (10- to 20-fold) in calmodulin apparent affinity, measured by us 
with the isolated domain, is difficult to detect in an inhibition process that has a half-
maximal inhibition concentration (IC50) of 6 nM for calmodulin (Sahoo et al. 2010) and 100 
nM for Ca2+ (Schönherr et al. 2000). 
Figure 19 - Ca2+/calmodulin inhibition of human EAG1 channel. a) At time 0 excised 
patches expressing hEAG1 channel were exposed to a solution containing 500 nM 
calmodulin and 250 nM Ca2+. Reduction in current elicited from wildtype channel (black 
triangles) and mutant L670A/Y672A (blue circles). b) Remaining current after exposure, 
average from 3 experiments. 
 
Crystallization trials of CNB-homology domain/CaM complexes 
Incubation of wild type CNB-homology domain containing BDC1 (mEAG1 552-724) with 
Ca2+-calmodulin in concentrations that should result in ~90% saturation, according to the 
determined KD, did not result in a shift in size-exclusion chromatography profile that would 
suggest complex formation. Additionally, no crystals could be obtained with a 1:1 molar 
ratio of CNB-homology domain and calmodulin, probably due to the transient nature of 
this interaction. 
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In contrast, C-terminal tail double mutant L697A/Y699A CNBhD (that has a slightly higher 
affinity for calmodulin) mixed with an equimolar amount of calmodulin is eluted in size-
exclusion chromatography as a species of higher molecular weight than either CNB-
homology domain or calmodulin alone (Figure 20). The peak is not symmetric though, 
which can be due to the weak binding affinity (KD ~ 2 µM) of the complex.  Fractions 2, 3 
and 4 (that contained both proteins on SDS-PAGE analysis, Figure 20) were pooled for 
crystallization trials, to get as much calmodulin into complex formation as possible, but no 
crystals were obtained. Shorter CNB-homology domain mutants ending in residue 715 
and 718 also showed the same size-exclusion chromatography profile when incubated 
with calmodulin but once again no crystals were obtained. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 20 - Superposition of size-exclusion chromatography traces of mEAG 552-724 
L697A/Y699A (dashed line), calmodulin (dotted line) and equimolar amounts of mEAG 
552-724 L697A/Y699A and calmodulin (continuous line). Inset: 17% SDS-PAGE of 
fractions labeled 1 to 4 in the size-exclusion chromatography trace. Fractions 2 to 4 were 
pooled for crystallization trials. 
 
DISCUSSION 
The CNB-homology domain from KCNH channels has raised a lot of interest. These 
domains have high sequence similarity with the CNB domains in CNG and HCN channels, 
however, KCNH channel function is not affected by cyclic nucleotide exposure (Brelidze et 
al. 2009). A comparison of the structures of the CNB-homology domain from KCNH 
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channels with structures of CNB domains clearly shows that these KCNH channel 
domains share many of the structural features present in CNB domains. The comparison 
also reveals crucial sequence and structural differences in the pocket of the CNB-
homology domain relative to CNB domains which provide an explanation for the very low 
affinity of CNB-homology domain for cyclic nucleotides.  
Importantly, our structure shows that the C-terminal tail of the domain extends over its 
surface and that two well-conserved residues (Y699 and L701, the “intrinsic ligand”) in the 
tail occupy the same space that cyclic nucleotides inhabit in CNB domains. This self-
liganded conformation is also present in the recently determined structures of the CNB-
homology domains of the other two channel subfamilies ELK and ERG (Brelidze et al. 
2012; Brelidze et al. 2013), strongly suggesting that it is a conserved feature of these 
KCNH channel domains. The C-terminal tail of the mEAG1 CNB-homology domain 
structure also includes a partially occluded stretch of a previously described calmodulin 
binding site (CaM BDC1) that does not exist in the remaining KCNH channel subfamilies 
(Ziechner et al. 2006). 
By characterizing the CNB-homology domain conformation as self-liganded it becomes 
implicit that there is also an unliganded state. A central aspect of this work is that we have 
provided biochemical evidence that supports the existence of an unliganded conformation, 
where the C-terminal tail peels away from the domain. For this we made use of the affinity 
of calmodulin to the partially occluded binding site at the end of the C-terminal tail. Indeed 
we established that CaM BDC1 is a weak binding site for calmodulin and we 
demonstrated that mutagenesis of the residues that in the domain structure appear to hold 
the C-terminal tail in position result in an increase in the calmodulin apparent affinity, 
consistent with a release of the tail and increased exposure of the calmodulin binding site. 
In addition, we showed that the calmodulin interaction involves mostly the N-lobe and it 
extends to residues in the occluded stretch of the CaM BDC1 since, mutation of some of 
these residues decreased calmodulin affinity. These residues are immediately after Y699 
and L701 and the molecular volume of calmodulin requires a peeling away of the C-
terminal tail so that the interaction can occur. Consistent with this interpretation we 
showed also that calmodulin binding causes a structural change in the CNB-homology 
domain as reflected in changes in cysteine accessibility. Interestingly, the sequence and 
structural parallels between CNB-homology domain and CNB domains lead naturally to a 
conclusion that the tail movement is reminiscent of the repositioning of the C-helix away 
from the ligand-binding pocket which occurs in CNB domains upon release of cyclic 
nucleotide (Rehmann et al. 2007; Clayton et al. 2004; Sharma et al. 2009).  
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Our functional analysis suggests that the CNB-homology domain has a role in channel 
gating since mutations that destabilize the self-liganded conformation by releasing the C-
terminal tail also affect the voltage dependence of activation. Strikingly, these functional 
effects are not what would be expected from the parallel between the release of the C-
terminal tail in the CNB-homology domain and the movement of the C-helix away from its 
bound-state position that occurs in CNB domains upon release of cyclic nucleotide. In 
CNG and HCN channels this CNB domain conformational change favors closure of the 
channel gate (Craven & Zagotta 2006; Kaupp & Seifert 2002). In the human EAG1 
channel the two double-mutants, both of which lead to the release the C-terminal tail, 
have very different effects, stabilizing either the open or the closed states of the channel. 
This contrasting result indicates that in the full-length channel the intrinsic ligand residues 
have as yet unidentified individual roles besides the shared function of holding the C-
terminal tail in its position. This outcome reveals that despite the sequence, structural and 
even biochemical similarities the role of CNB-homology domain in gating of KCNH 
channels is not identical to the role of CNB domains in HCN and CNG channels. 
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IV. CHARACTERIZATION OF THE INTERACTION OF CALMODULIN WITH 
THE EAG1 K+ CHANNEL CYTOPLASMIC REGIONS 
 
The work described in this chapter is in preparation to be submitted for publication. 
 
INTRODUCTION 
The molecular mechanism of EAG1 channel inhibition by Ca2+-CaM is unknown. Three 
CaM binding sequences (BDN, BDC1 and BDC2) were identified in a peptide array screen 
spanning the entire EAG1 cytoplasmic regions. All three sites appear to be functionally 
important for CaM inhibition of these channels, since channels with mutations in any of 
these sites show severely diminished CaM sensitivity (Schönherr et al. 2000; Ziechner et 
al. 2006). The affinities of CaM for these sites were determined using fluorescence 
correlation spectroscopy. However, this technique relies on a large difference between the 
mass of the isolated labeled protein and of the complex formed. In this case this size ratio 
is low, raising doubts about the accuracy of the measurements. In particular, variation in 
the KDs determined for CaM BDC1 were observed, that depended on the used 
fluorophore and on whether CaM or the channel fragment were labeled (Ziechner et al. 
2006). 
In this chapter, we revisited the binding properties of CaM to BDN, BDC1 and BDC2 using 
isothermal titration calorimetry (ITC). ITC is a label-free technique which provides 
thermodynamic parameters and gives insights into the nature of the non-covalent 
interactions involved in binding. The contribution of the CaM lobes to the interaction with 
the EAG1 sites was also evaluated by using isolated lobes or full-length CaM with 
mutations in the EF-hands. We also assessed the impact of the PAS and CNB-homology 
domains on the binding of CaM to BDN, BDC1 and BDC2. Finally, we used X-ray 
crystallography to obtain a structure of CaM in complex with BDC2. 
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METHODS 
Expression and purification of the maltose binding protein fusions with mEAG1 
CaM BDs 
Different versions of the calmodulin binding sequences BDN, BDC1 and BDC2 were 
cloned into the plasmid vector pRSF Duet1 (Novagen) as C-terminal fusions of maltose 
binding protein (MBP). These sequences included the amino acid stretches previously 
identified by (Ziechner et al. 2006), underlined in table 2. MBP contains an N-terminal 
hexa-histidine tag for purification by Immobilized-metal affinity chromatography (IMAC) 
and a TEV protease recognition sequence on the C-terminal, before the CaM binding 
sequences. 
Table 2 – Amino acid sequences of the short and long versions of the CaM binding sites 
BDN, BDC1 and BDC2  
Short BDN (mEAG1 145-168) CKGWGKFARLTRALTSSRGVLQQL 
Long BDN (mEAG1 138-174) QPIEDDSCKGWGKFARLTRALTSSRGVLQQLAPSVQK 
Short BDC1 (mEAG1 696-718) ILTYNLRKRIVFRKISDVKREE 
Long BDC1 (mEAG1 690-724) SFSRNLILTYNLRKRIVFRKISDVKREEEERMKRK 
Short BDC2 (mEAG1 733-757) PDHPVRRLFQRFRQQKEARLAAERG 
Long BDC2 (mEAG1 727-764) APLILPPDHPVRRLFQRFRQQKEARLAAERGGRDLDDL 
 
Escherichia coli BL21 (DE3) competent cells transformed with an expression vector were 
grown in Luria broth medium supplemented with kanamycin (50 mg/L) at 37 ºC with 
agitation until the 600 nm optical density reached 0.6–0.8. At this point, IPTG was added 
to a final concentration of 0.5 mM for overnight induction at 18 ºC (12–16 h). Cultures 
were harvested by centrifugation at 4785xg for 20 min at 4 ºC and the resulting pellet was 
resuspended in buffer A (1 L pellet in 20 mL 50 mM HEPES pH 7.5, 250 mM KCl) 
supplemented with protease inhibitors: 1 mM PMSF, 1 mg/mL leupeptin, 1 mg/mL 
pepstatin. Cell lysis was performed in a cooled cell cracker (Emulsiflex-C5, Avestin) and 
the lysate was centrifuged at 32 800xg for 45 min at 4 ºC to remove cell debris. The 
supernatant was loaded onto His-select Nickel Affinity Gel (Sigma) pre-equilibrated with 
buffer A and washed with buffer A until the 280 nm optical density (OD280) stabilized. 
While monitoring the OD280 of the eluate, the beads were washed with buffer A with extra 
KCl (500 mM). Most of the fusion protein was eluted from the resin with buffer A 
containing 20 mM imidazole. The remaining His-tagged protein was eluted with buffer A 
containing 250 mM imidazole. 
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The protein fraction eluted with 20 mM imidazole was dialyzed against buffer B containing 
50 mM HEPES pH 7.5, 150 mM NaCl, 2 mM CaCl2 and 1 mM TCEP and loaded onto an 
S200 size-exclusion chromatography column (GE Healthcare), pre-equilibrated with the 
same buffer. 
Expression and purification of PAS and CNB-homology domain constructs 
containing CaM binding sites 
Some of the constructs containing CaM binding sites suffer proteolysis during expression 
in bacteria. To overcome this problem, these constructs were cloned into multiple cloning 
site (MCS) 1 of co-expression vector pRSFDuet-1 (Novagen) with a N-terminal His6-tag 
and CaM was cloned into MCS2 of the same vector without any affinity tag. By co-
expressing both proteins, CaM will bind to these CaM binding sequences shielding them 
from proteases. 
Expression and IMAC purification was done as described in (Marques-Carvalho et al. 
2012), except that the buffering agent was 50 mM HEPES pH 7.5 instead of Tris-HCl. 
Despite purifying in calcium-less buffer, CaM still came attached to the eluted protein. The 
eluted protein was dialyzed against buffer containing 1 mM EDTA to disrupt the complex. 
Taking advantage of the large difference in isoelectric point (pI) between acidic CaM 
(pICaM=4) and the basic PAS and CNB-homology domain constructs (pI~9), a step of anion 
exchange chromatography was added. The dialysed protein was loaded onto a 5 mL 
Hitrap Q HP (GE Healthcare) equilibrated with 50 mM HEPES pH 7.5, 150 mM NaCl, 5 
mM DTT (buffer A). Monitoring OD280, the mEAG1 enriched flow-through was collected, 
and a gradient to 100% buffer B (50 mM HEPES pH 7.5, 1 M NaCl) was performed, with 
CaM being eluted between 35-45% B. 
Coupling of calmodulin to HiTrap NHS-Activated HP – “CaMTrap” column 
HiTrap NHS-Activated HP 5 mL (GE Healthcare) was derivatized with CaM as described 
in the manual. Briefly, the column was washed with 1 mM ice-cold HCl immediately before 
ligand coupling. A solution containing 750 µmol of CaM in 0.2 M NaHCO3 pH 8.5, 0.5 M 
NaCl (coupling buffer) was injected onto the column and left incubating at room 
temperature for 1h. The unbound protein was washed with of coupling buffer. Coupling 
efficiency was estimated to be around 75%, with ~500 µmol of CaM coupled to the 5 mL 
column (“CaMTrap”). This CaMTrap column was stored at 4ºC in 50 mM HEPES pH 7.5, 
150 mM NaCl, 2 mM CaCl2 (calcium binding buffer) supplemented with 0.05%(w/v) of the 
preservative azide. 
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Purification of channel fragments with CaMTrap 
The CaMtrap column was used as an extra purification step whenever a channel fragment 
containing a CaM binding site showed proteolysis or other contaminants. A maximum of 
500 µmol of partially purified protein was loaded into CaMTrap equilibrated in calcium 
binding buffer (50 mM HEPES pH 7.5, 150 mM NaCl, 2 mM CaCl2). Monitoring the 
OD280, the CaMTrap was washed with calcium binding buffer and the CaM binding site-
containing protein was eluted with 50 mM HEPES pH 7.5, 150 mM NaCl, 2 mM EDTA, 
followed by a more stringent elution with 50 mM HEPES pH 7.5, 500 mM NaCl, 2 mM 
EDTA. 
Expression and purification of the MBP fusions with CaM N- and C-lobe 
CaM lobes were cloned as His6-tagged MBP fusions and purified as described for the 
other MBP fusions. Briefly, cleared bacterial lysate was loaded into a Nickel column. TEV 
protease was added to the eluted protein to cleave the MBP from the CaM lobes and 
dialysed overnight against buffer containing 50 mM HEPES pH 7.5, 150 mM NaCl, 2 mM 
CaCl2, 1 mM TCEP. After cleavage, the protein solution was further purified using another 
round of IMAC to bind the TEV protease and MBP and the flow-through containing the 
lobe was kept. This flow-through was then loaded into an affinity column MBPtrap (GE 
Healthcare) to remove any MBP contaminants. The flow-through containing the CaM 
lobes was run on a size-exclusion column in 50 mM HEPES pH 7.5, 150 mM NaCl, 5 mM 
CaCl2. 
Isothermal Titration Calorimetry  
Purified CaM (or its individual lobes) and channel constructs spanning CaM the binding 
sequences were dialyzed overnight against 50 mM HEPES pH 7.5, 150 mM NaCl, 1 mM 
TCEP-HCl containing 5 mM CaCl2 (or 5 mM EDTA). CaM and the channel fragments were 
extensively dialysed in the same beaker to avoid buffer mismatch. CaM concentration was 
determined by measuring absorbance at 277 nm and the extinction coefficient ε277nm=3029 
M-1 cm-1 (Strasburg et al. 1988). Channel fragment concentration was determined by 
measuring absorbance at 280 nm using the calculated extinction coefficients from the 
ExPASy tool Protparam. In general, the channel fragment was placed in the sample cell 
and CaM (or lobe) was placed in the syringe at least 10-times more concentrated than the 
protein in the cell. CaM was degassed for 5 min before the experiment using the 
Thermovac. Isothermal titration calorimetry (ITC) was carried out using the VP-ITC 
instrument (MicroCal) at 25 ºC (unless mentioned otherwise), with a first injection of 2 µL, 
followed by 28x10 µL injections. Data were analyzed using Origin 7 (MicroCal) or 
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AFFINImeter. For each titration, the first 2-µl injection was ignored and correction for the 
heat of dilution was made by subtracting the average of the last four injection areas to all 
injection points. Fitting was done with the appropriate binding model which provided 
values for stoichiometry (N), association constant (KA), enthalpy (ΔH) and entropy (ΔS) of 
binding. The obtained KA was converted to KD. 
Complex purification 
To crystallize the complexes of CaM with peptides, mEAG1 CaM binding sequences were 
cloned into multiple cloning site (MCS) 1 of co-expression vector pRSFDuet-1 (Novagen) 
as a His6-tagged maltose binding protein fusion (cleavable with TEV protease) and CaM 
was cloned into MCS2 of the same vector without any affinity tag. This approach had the 
objective of forming the complex of CaM with the peptides before cleaving off the MBP, to 
ensure that the peptide remained soluble throughout the purification. 
In brief, protein expression and IMAC purification was similar to the other MBP-fusions, 
except it was done in the presence of 5 mM CaCl2, to maintain the CaM-peptide complex. 
After elution from IMAC, protein was quantified and a 1:10 mass ratio of TEV protease to 
MBP fusion was added to cleave the MBP overnight while dialyzing out the imidazole. On 
the following day two extra steps of purification allowed to separate the CaM-peptide 
complex from the MBP and TEV protease. A first step of IMAC served to bind most MBP 
and TEV protease, which are both His6-tagged. The flow-through (FT) that contained the 
CaM-peptide complex was then loaded onto an affinity column MBPtrap (GE Healthcare) 
to get rid of any remaining MBP. Once again, the FT was kept and the protein complex 
was run on a S200 size-exclusion column (GE Healthcare) in buffer with 20 mM HEPES 
pH 7.5, 150 mM NaCl, 1 mM CaCl2, 1 mM TCEP to make sure that CaM stayed calcified 
at the high protein concentrations needed to set drops. 
Crystallization, data collection and refinement 
Crystals were grown at 20 °C using sitting-drop vapour diffusion by mixing a 1:1 (v/v) ratio 
of protein mixture and a reservoir solution containing 0.2 M di-ammonium citrate pH 5, 
20% PEG 3350. A dataset was collected at the Proxima 2A beamline of the Soleil 
Synchrotron to 2.85 Å resolution. Data was integrated using the program XDS (Kabsch 
2010) and scaled using Aimless (Evans & Murshudov 2013), from the CCP4 program 
suite (Winn et al. 2011). The structure was solved by molecular replacement with Phaser 
(McCoy et al. 2007) using several ensembles of calmodulin N- and C-lobes as search 
models (PDB codes: 1CFD, 1CLL, 2BE6, 3DVM, 3OXQ chain A, 3OXQ chain B, 4DJC 
and 4GOW). Model refinement was done in PHENIX (Adams et al. 2010); TLS refinement 
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was applied (Painter & Merritt 2006). Model building was performed in Coot (Emsley & 
CoWTan 2004) and figures were created using PyMOL (DeLano 2002). 
Fluorescence anisotropy 
PAS domain (mEAG1 1-137) was cloned into a pET15b vector with Ampicillin resistance, 
and the expression and purified protocol was performed as described in the first chapter. 
Fluorescein labelling of the endogenous cysteines of the PAS domain (F-PAS) was done 
as described previously (Taraska et al. 2009). 
Briefly, PAS was incubated 1 mM TCEP for 1h at 4 °C to reduce the cysteines. It was 
passed through a desalting column equilibrated with 20 mM Tris HCl pH 8.0, 150 mM 
NaCl to remove the TCEP and incubated with fluorescein-5-maleimide (Molecular Probes) 
at molar ratios 1:5 and 1:10 for 1h at room temperature protected from light. After 1h the 
reaction was stopped with 5 mM DTT and the free dye was dialysed out with 20 mM Tris 
HCl pH 8.0, 150 mM NaCl, 5 mM DTT using a 3.5 kDa cutoff dialysis membrane. 
F-PAS at 100 nM was incubated with different concentrations of CNB-homology domain in 
the dialysis buffer described above for at least 20 min. Fluorescence anisotropy 
measurements done at 25 °C using a Horiba Fluoromax-4 spectrofluorimeter using an 
excitation wavelength of 492 nm and emission of 514 nm, with slit widths of 1 or 2 nm. 
To estimate binding affinity, plots of the anisotropy versus total CNB-homology domain 
concentration were fit considering a first-order reaction: 
Anisotropy = 𝛼 [
(𝑅𝑡+𝐾𝐷+𝐿𝑡)− √(−𝑅𝑡−𝐾𝐷−𝐿𝑡)2−4 ×𝑅𝑡 ×𝐿𝑡
2
] +  𝛽  
in which R, L and RL are concentrations of the free receptor, free ligand, and receptor–
ligand complex, respectively, Rt and Lt are total receptor and total ligand concentrations, 
respectively, KD is the ligand-binding affinity, and α and β are a scaling factor and an 
offset factor, respectively (Haitin et al. 2013b). 
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RESULTS 
Characterization of CaM binding to EAG1 CaM binding domains 
CaM BDC1 and CNBhD-BDC1 – importance of BDC1 
Mutations in CaM BDC1 severely compromised the effect of CaM in EAG1 currents 
(Ziechner et al. 2006). However, the importance of CaM BDC1 in EAG1 channel inhibition 
by CaM is not well established since: 1) this sequence displayed lower affinity for CaM 
than the remaining CaM binding sites (Ziechner et al. 2006); 2) a FRET study showed that 
no CaM binding was detected to the EAG1 channel if CaM binding sites BDN and BDC2 
were mutated (Gonçalves & Stühmer 2010); 3) BDC1 is partially occluded due to the self-
liganded conformation of CNBhD-BDC1 and the KD for CaM is only 12 µM (Marques-
Carvalho et al. 2012), which is rather modest in the context of a process with an IC50 of 6 
nM (Sahoo et al. 2010). 
We set out to dissect the CaM binding properties of BDC1 using isothermal titration 
calorimetry (ITC). To study the interaction of CaM with this region we generated two 
different channel fragments: a 35 aminoacid stretch centered on BDC1 fused to MBP and 
another which includes the whole CNB-homology domain and BDC1 (the same construct 
used in chapter one), Table 3. 
Titration of Ca2+-CaM into BDC1 peptide (mEAG1 690-724) reveals an endothermic 
process (ΔH = 2.24 ± 0.03 kcal/mol) with a KD of 143 ± 9 nM (Figure 21a). We also tested 
the effect of the CNB-homology domain on the CaM interaction with BDC1. Titration of 
Ca2+-CaM into CNBhD-BDC1 (mEAG1 552-724) is also endothermic (ΔH = 1.74 ± 0.34 
kcal/mol) but with lower affinity (KD of 6.5 ± 0.8 µM) (Figure 21b). This KD agrees with the 
12 µM that had been obtained with fluorescently labelled CaM (Marques-Carvalho et al. 
2012). Both interactions are entropically driven with a ΔS ~ 39 cal/mol/deg for BDC1 and 
ΔS ~ 30 cal/mol/deg for CNBhD-BDC1. This is indicative of water molecules being 
released from the complex surface or of an increase in the protein conformational freedom 
upon complex formation. The difference in KD fits well with the observation that BDC1 is 
partially occluded in the structures of the CNB-homology domains (Marques Carvalho et 
al. 2012; Haitin et al. 2013a), resulting in low affinity towards CaM. 
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Table 3 - Thermodynamic parameters for titration of Ca2+-CaM into protein fragments 
containing BDC1. 
CaM 
BD 
Cell N KD (nM) 
ΔH 
(kcal mol-1) 
ΔS 
(cal mol-1 deg-1) 
n 
 
MBP-BDC1 
0.86 ± 
0.03 
142.8 ± 8.8 2.24 ± 0.03 38.9 ± 0.2 3 
CNBhD-BDC1 
0.80 ± 
0.03 
6.5x103  ± 
0.8x103 
1.74 ± 0.34 29.7 ± 1.2 3 
 
 
Figure 21 – a) Example of an ITC titration of 250 µM Ca2+-CaM into 25 µM MBP- BDC1. 
b) Example of an ITC titration of 500 µM Ca2+-CaM into 50 µM CNBhD-BDC1. The top 
panel shows the raw heat evolved after each injection and the bottom panel shows the 
integrated heats of injection per mole of injectant. 
 
It has been suggested that the BDC1 site is not physiologically important. However, 
mutations on the BDC1 sequence that lower the affinity for CaM (Marques-Carvalho et al. 
2012), have a dramatic effect on EAG1 channel inhibition by Ca2+-CaM (Ziechner et al. 
2006). The recent structure of the complex between PAS domain and CNB-homology 
domain (Haitin et al. 2013b) shows that the post-CNBhD region that comprises BDC1 
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interacts with the PAS domain (Figure 22). We wondered if mutations on BDC1 
destabilize the PAS/CNB-homology domain complex, leading to changes in channel 
properties.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 22 – Interface of the complex between mEAG1 PAS domain (cyan and grey) and 
CNB-homology domain (CNBhD, blue and grey). The CaM BDC1 region is depicted in red 
sticks, and PAS domain residues that interact with this protein stretch are also 
represented in stick model (Haitin et al. 2013b). 
 
We used the fluorescence anisotropy assay described by (Haitin et al. 2013b) to study the 
effect of BDC1 mutations on the interaction between PAS domain and CNB-homology 
domain. We obtained a KD ~ 16 µM, for the interaction of WT CNBhD-BDC1 with PAS 
domain (Figure 23), similar to the published KD. Strikingly, the CNBhD-BDC1 mutants 
R702N/R704N/R708N/K709N and I705A/V706A/F707A do not form a complex with 
fluorescently-labelled PAS domain, as can be seen by the lack of change in fluorescein-
PAS anisotropy on Figure 23. We propose that the functional effect on CaM inhibition of 
the channels with BDC1 mutations might be caused by a disruption of the gating 
machinery through the destabilization of the complex between PAS and CNB-homology 
domain. 
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CaM BDN and PAS-BDN 
CaM BDN starts less than 20 residues after the PAS domain and previous studies showed 
a KD for Ca
2+-CaM in the range of 100-200 nM using fluorescence correlation 
spectroscopy, as well as surface plasmon resonance spectroscopy (Ziechner et al. 2006). 
A short version of BDN (mEAG1 145-168) showed several proteolysis products in SDS-
PAGE analysis after purification (grey arrows, Figure 24a). This fusion was co-expressed 
with calmodulin with the intent to form the complex in the bacterial cytoplasm, shielding 
BDN from proteases. Mass spectrometry analysis confirmed that co-expression 
decreased C-terminal degradation, although not completely (black arrow on Figure 24a). 
Thus, we used a CaMtrap column (which has CaM crosslinked to an agarose resin) to 
separate full-length protein from proteolysis fragments (Figure 24a). 
Figure 23 - Fluorescence anisotropy of fluorescein labelled PAS domain titrated with 
CNBhD-BDC1 WT (squares) and BDC1 mutants R702N/R704N/R708N/K709N (circles) 
and I705A/V706A/F707A (crosses). 
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Figure 24 – a) Short BDN sequence with the proteolysis products identified by MALDI-
TOF-TOF. Arrows indicate the site of proteolytic cleavage (grey: expression in the 
absence of CaM; black: co-expressed with CaM) and 15% SDS-PAGE of MBP-short BDN 
purification with CaM affinity resin (before CaM resin, flow-through (FT), wash (W) and 
elution (E) with EGTA). b) ITC titration of 60 µM Ca2+-CaM into 6 µM MBP-short BDN. 
 
ITC was used to analyze binding of CaM to this short BDN fragment. It has a KD of 184 ± 
12 nM for Ca2+-CaM (Figure 24b) and an enthalpy of binding of -4.14 ± 0.15 kcal/mol. 
A longer version of BDN (mEAG1 138-174) was also created. This channel fragment did 
not suffer proteolysis and a more detailed characterization was done using this protein. 
The ITC experiments showed that Ca2+-CaM binds this BDN with an KD of 18.1 ± 1.1 nM 
and with a ΔH = -4.92 ± 0.06 kcal/mol (Figure 25a). The ten-fold higher affinity relative to 
the short BDN is achieved through an increase in the entropy of the system (Table 4). 
CaM binding to this fragment is Ca2+-dependent, since no binding could be detected with 
apo-CaM (in the presence of 5 mM EDTA) at 15 or 25 ºC (Figure 25b). 
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Figure 25 – a) ITC titration of 60 µM Ca2+-CaM into 6 µM MBP-BDN. b) ITC titration of 500 
µM apo-CaM into 50 µM MBP-BDN, in the presence of 5 mM EDTA. 
 
In order to get further insights into the CaM binding mode, we investigated the contribution 
of each lobe of CaM to the interaction with BDN. For this we used CaM’s individual lobes 
lobes and CaM with mutations on the N-lobe EF-hands. 
ITC characterization of the binding of the CaM lobes to BDN gave a KD of 8.9 ± 0.4 µM for 
Ca2+-N-lobe (ΔH = -9.61 ± 0.76 kcal/mol, Figure 26a) and a KD of 1.4 ± 0.1 µM for Ca
2+-C-
lobe (ΔH = -3.34 ± 0.11 kcal/mol, Figure 26b). The 100-fold drop in affinity for the N- and 
C-lobe suggests that CaM binding to BDN involves both lobes, just like in the canonical 
binding mode. Titration of full-length CaM with mutations that disrupt binding of calcium to 
EF-hands 1 and 2 (CaM D21A/D57A = CaM EF12 mut) into BDN gives thermodynamic 
parameters very similar to C-lobe alone – KD = 1.4 ± 0.1 µM and ΔH = -2.62 ± 0.03 
kcal/mol (Figure 26c), showing that the N-lobe needs to have Ca2+ bound in order for CaM 
to tightly interact with BDN. 
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Figure 26 – a) ITC titration of 253 µM Ca2+-N-lobe into 23 µM MBP-long BDN. b) ITC 
titration of 258 µM Ca2+-C-lobe into 23 µM MBP-long BDN. c) ITC titration of 135 µM Ca2+-
CaM EF12 mutant into 13 µM MBP-long BDN. 
 
To determine if the PAS domain influences the binding of CaM to BDN, two protein 
constructs were designed, encompassing the EAG1 N-terminal regions PAS domain and 
BDN. The longer construct (CAP-PAS-BDN, mEAG1 6-174) included a stretch of amino 
acids before the PAS domain that have been shown to have a role in channel function 
(Terlau et al. 1997) – the PAS CAP. The shorter version (PAS-BDN, mEAG1 28-174) 
does not include the CAP region. 
These constructs suffered C-terminal degradation, even when co-expressed with CaM. 
For this reason, four purification steps were necessary to obtain full-length protein: IMAC, 
ion exchange, CaMTrap and size-exclusion chromatography, as described in the methods 
section. 
The interaction of CaM with both PAS domain constructs has similar thermodynamic 
signatures. CaM binds with a KD of 162.1 ± 6.5 nM and ΔH = 7.71 ± 0.08 kcal/mol to CAP-
PAS-BDN (Figure 27a) and KD = 105.9 ± 14.9 nM and ΔH = 7.47 ± 0.18 kcal/mol to PAS-
BDN (Figure 27b), revealing that the CAP region has no influence on this interaction. The 
CaM affinities for both PAS-BDN constructs are almost 10-fold lower than for the BDN 
peptide, indicating that the globular domain affects CaM binding to BDN. The more 
negative enthalpy is indicative of an increase in the bonding network with the PAS-BDN 
fragments. However, this is accompanied by an increased order of the system (lower 
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entropy change) which results in a lower affinity. We speculate that CaM might be 
establishing interactions with the surface of the PAS domain. 
 
Figure 27 – a) ITC titration of 60 µM Ca2+-CaM into 6 µM CAP-PAS-BDN. b) ITC titration 
of 60 µM Ca2+-CaM into 6 µM PAS-BDN. 
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Table 4 – Thermodynamic parameters for CaM interaction with protein fragments containing BDN. 
CaM BD Titrant Cell N KD (nM) ΔH (kcal mol
-1) ΔS (cal mol-1 deg-1) n 
BDN 
Ca2+-CaM MBP-short BDN 0.77 ± 0.02 179.6 ± 16.6 -4.14 ± 0.15 17.1 ± 0.6 4 
Ca2+-CaM MBP-long BDN 0.84 ± 0.01 17.8 ± 1.1 -4.92 ± 0.06 19.4 ± 0.2 11 
Apo-CaM MBP-long BDN no detectable binding at 15 °C and 25 °C 2 
Ca2+-N-lobe MBP-long BDN 0.85 ± 0.07 4.5x103 ± 1.5x103 -9.61 ± 0.76 -9.1 ± 2.5 2 
Ca2+-C-lobe MBP-long BDN 0.80 ± 0.06 1.4x103  ± 0.1x103 -3.34 ± 0.11 15.7 ± 0.2 3 
Ca2+-CaM EF12 mut MBP-long BDN 0.68 ± 0.07 1.4x103  ± 0.1x103 -2.62 ± 0.03 18.0 ± 0.2 2 
Ca2+-CaM CAP-PAS-BDN 0.77 ± 0.02 162.1 ± 6.5 -7.71 ± 0.08 5.1 ± 0.3 5 
Ca2+-CaM PAS-BDN 0.79 ± 0.02 105.9 ± 14.9 -7.47 ± 0.18 7.0 ± 0.6 3 
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CaM BDC2 
CaM BDC2 was the first EAG1 CaM binding sequence to be identified (Schönherr et al. 
2000) and it starts approximately 30 residues downstream of the CNB-homology domain 
(Schönherr et al. 2000; Ziechner et al. 2006).  
Titration of a short BDC2 fragment (mEAG1 733-757) with Ca2+-CaM, using ITC, gave a 
KD = 439 ± 25 nM (Figure 28). This is on the same range of KD that had been previously 
determined by fluorescence correlation spectroscopy using a peptide spanning residues 
734-752 (Ziechner et al. 2006). We noticed that the MBP tag could not be removed by 
digestion with TEV protease after assembling the complex with CaM. This suggested that 
the CaM binding sequence could extend beyond the previously defined region. Thus, the 
BDC2 fragment was extended on both ends for further studies. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 28 - ITC titration of 60 µM Ca2+-CaM into 6 µM MBP-short BDC2. 
 
A longer version of BDC2 (mEAG1 727-764) had a KD of 68 ± 3 nM when titrated with 
Ca2+-CaM (Figure 29a); the reverse titration – BDC2 titrated into Ca2+-CaM – had a similar 
affinity, 74 ± 14 nM (Figure 29b), as expected for a simple 1:1 binding event. These KD’s 
are 6-fold lower than for the shorter version of BDC2, and the enthalpy change is more 
negative (ΔH (long BDC2) = -14.43 ± 0.21 kcal/mol and ΔH (short BDC2) = -8.71 ± 0.19 
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kcal/mol) confirming that extra residues are interacting with CaM. In the absence of 
calcium CaM bound to BDC2 with a KD larger than 30 µM at 15 ºC and 25 ºC (Figure 29c). 
 
Once again we evaluated the contributions of the CaM lobes to the interaction. 
Interestingly, CaM N-lobe binds to BDC2 with a KD of 2.2 ± 0.1 µM and ΔH = -2.74 ± 0.15 
kcal/mol (Figure 30a) whereas the C-lobe binds almost as well as full-length CaM, with an 
affinity of 108 ± 10 nM and ΔH = -9.84 ± 0.30 kcal/mol (Figure 30b). Titration of BDC2 into 
CaM EF12 mutant is almost undistinguishable from the titration with the C-lobe (KD = 124 
± 9 nM and ΔH = -8.75 ± 0.52 kcal/mol, Figure 30c). These experiments demonstrated 
that the interaction of CaM with BDC2 is dominated by the C-lobe, with little contribution 
from the N-lobe. 
 
Figure 29 – a) ITC titration of 60 µM Ca2+-CaM into 6 µM MBP-long BDC2. b) ITC titration 
of 60 µM of MBP-long BDC2 into 6 µM of Ca2+-CaM. c) ITC titration of 500 µM apo-CaM 
into 50 µM MBP-long BDC2 (in the presence of 5 mM EDTA) 
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Figure 30 – a) ITC titration of 180 µM Ca2+-N-lobe into 19 µM MBP-long BDC2. b) ITC 
titration of 100 µM Ca2+-C-lobe into 10 µM MBP-long BDC2. c) ITC titration of 60 µM 
MBP-long BDC2 into 6 µM Ca2+-CaM EF12 mutant. 
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Table 5 - Thermodynamic parameters for CaM interaction with protein fragments containing BDC2. 
CaM BD Titrant Cell N KD (nM) ΔH (kcal mol
-1) ΔS (cal mol-1 deg-1) n 
BDC2 
Ca2+-CaM MBP-short BDC2 0.76 ± 0.01 438.8 ± 24.9 -8.71 ± 0.19 0.1 ± 0.8 8 
Ca2+-CaM MBP-long BDC2 0.80 ± 0.01 67.9 ± 3.5 -14.43 ± 0.21 -15.5 ± 0.8 6 
MBP-long BDC2 Ca2+-CaM 1.02 ± 0.03 74.2 ± 14.2 -9.02 ± 0.18 2.5 ± 0.2 2 
apo-CaM MBP-long BDC2 binding detected but not quantifiable 2 
Ca2+/N-lobe MBP-long BDC2 0.74 ± 0.02 2.2x103  ± 0.1x103 -2.74 ±0.15 16.7 ± 0.5 3 
Ca2+/C-lobe MBP-long BDC2 0.94 ± 0.00 107.7 ± 9.5 -9.84 ± 0.30 1.1 ± 0.9 3 
MBP-long BDC2 Ca2+-CaM EF12 mut 1.12 ± 0.02 124.3 ± 9.5 -8.75 ± 0.52 2.3 ± 1.8 3 
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CaM/BDC2 structure 
A complex between CaM and BDC2 (mEAG1 727-764) was assembled and purified. In an 
S200 size-exclusion column this complex migrates as a species larger than CaM alone, 
with a difference of more than 1 mL in elution volume (Figure 31), which cannot be simply 
attributed to the peptide molecular weight. Instead, since we have established that the 
interaction with BDC2 is dominated by the C-lobe, it most likely means that CaM is in an 
elongated conformation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 31 – Superposition of S200 size-exclusion chromatogram of CaM (dotted line) 
CaM/BDC2 complex (black line). Inset: 15% Tris-tricine SDS-PAGE of CaM/BDC2 
complex fraction used for crystallization trials (highlighted in grey). 
 
Crystals of the complex CaM/BDC2 were obtained at 20 ºC in a condition with 0.2 M di-
ammonium citrate pH 5 and 20% PEG 3350 (Figure 32a and b). 
Diffraction experiments showed that the protein complex crystallized in space group 
C2221 with unit cell dimensions 53.6, 121.1, 73.9 Å/90 90 90°. Data extended to 2.85 Å 
resolution and crystallographic data and statistics are reported in Table 6. The structure 
was solved by molecular replacement using the apo-N-lobe from PDB code 1CFD and 
Ca2+-C-lobe from PDB code 3OXQ (chain A) as template, containing one molecule of 
CaM and BDC2 per asymmetric unit The structure was refined to a final Rwork = 20.6% 
and Rfree = 26.5%. 
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Figure 32 – CaM/BDC2 crystals grown with 0.2 M di-ammonium citrate pH 5, 20% PEG 
3350. a) Original condition, from the commercial screen; b) crystals reproduced with a 
finescreen around the original condition. 
 
Table 6 – Crystallographic statistics 
Crystal data  
      Space group C2221 
      Unit cell parameters 
            a (Å) 
            b (Å) 
            c (Å) 
            α=β=γ(°) 
 
53.62 
121.14 
73.86 
90 
Data-collection details  
      Diffraction source Soleil Proxima 2A 
      Wavelength (Å) 0.9765 
      Resolution range (Å) 46.83-2.85 (2.95-2.85) 
      No unique reflections 5816 (564) 
      No measured reflections 23869 (3540) 
      Multiplicity 4.1 (4.2) 
      Completeness (%) 98.74 (98.95) 
      I/σI 15.28 (2.68) 
      Rmeas (%) 8.2 (70.0) 
      CC1/2 (%) 99.9 (79.5) 
Refinement data  
      Resolution range 46.83-2.85 (2.95-2.85) 
      No reflections 5816 
      Rwork/Rfree (%) 20.6/26.5 (28.5/34.8) 
      No of atoms in model: protein 
                                         solvent 
                                         ligand 
1249 
10 
2 
      Average B-value (Å2): protein 
                                        solvent 
                                        ligand 
51.7 
39.9 
37.8 
      RMSD bond length (Å) 0.002 
      RMSD bond angles (°)    0.44 
 
61 
 
The CaM structure was built in an extended conformation, with the central linker forming a 
long α-helix (Figure 33a). The N-lobe of CaM is in the apo form, without calcium ions in 
EF-hands 1 or 2; in contrast, C-lobe’s EF-hands 3 and 4 contain Ca2+ bound. This feature 
was unexpected given that high Ca2+ concentrations were kept throughout the purification 
and crystal freezing. As a consequence of the absence of Ca2+, residues 57-59 from the 
second EF-hand from the N-lobe were very ill-defined and were not modelled. The last 
aminoacid of CaM, K148 was also not visible.  
 
Figure 33 – a) Structure of CaM/BDC2 (CaM is in red cartoon representation and BDC2 in 
cyan. Calcium ions are represented by black spheres); b) Horizontal view of CaM/BDC2 
complex in surface representation. 
 
Importantly, extra electron density, corresponding to the BDC2 peptide, was detected in 
close proximity to the C-lobe. Residues 727-743 from the long BDC2 peptide 
(mEAG1 727-764), corresponding to the sequence APLILPPDHPVRRLFQR (Figure 34) 
were built into this density. No electron density could be seen for the C-terminal half of the 
peptide, probably due to crystal packing restraints. The modelled sequence is different 
from the sequence previously reported to be the binding site for Ca2+-CaM (underlined in 
Table 2). The sequence is instead shifted towards the N terminus. These extra residues 
on the N-terminal explain why the affinity of CaM for the longer BDC2 fragment is higher 
than for the short version and the inability of TEV protease to cleave off the MBP tag after 
assembling the complex short BDC2/CaM. 
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The channel fragment sits on the C-lobe’s hydrophobic cleft. In addition, some of the N-
terminal residues lie in a groove between the C-lobe of one CaM, and the N-lobe of a 
symmetry related CaM (Figure 34). The conformation of the channel fragment starts with 
a 5-residue segment in extended conformation that bends and turns into a small helix. 
The helix includes part of the sequence previously reported to form BDC2 (Ziechner et al. 
2006). This fold is uncommon for CaM binding peptides, which in the majority of structures 
deposited in the Protein Data Bank are entirely α-helical. From a collection of more than 
80 structures of CaM in complex with small peptides and large proteins (Tidow & Nissen 
2013), only two are bound to a short helical peptide with a bend (PDB codes 1IWQ and 
4EHQ). 
We submitted the CaM/BDC2 structure to the servers PIC: Protein Interactions Calculator 
(http://pic.mbu.iisc.ernet.in) and PISA (Protein interfaces, surfaces and assemblies) 
(Krissinel & Henrick 2007), from the European Bioinformatics Institute, 
(http://www.ebi.ac.uk/pdbe/prot_int/pistart.html), a method based on physical-chemical 
models of macromolecular interactions and chemical thermodynamics, to define what 
residues form the interacting surface between CaM and BDC2 as well as the type of 
interactions established between them and to determine the extent of the interface (Figure 
34 and Table 7). 
There is a hydrogen bond between the peptide’s L729 backbone and CaM N111 
backbone and between the peptide’s R739 sidechain and the main chain of CaM M145 
(Figure 34 and 36, Table 7). Out of the 17 mEAG1 residues modelled into the electron 
density, 12 are involved in the interface with CaM with a total interface area of 531 Å2 and 
520 Å2 for peptide and CaM, respectively. Of these residues, H735, P736, V737 and L740 
are the ones with a larger percentage of buried surface area upon complex formation 
(between 50-100%) and the last three are involved in an extensive hydrophobic 
interaction network with the CaM C-lobe (Figure 36 and Table 7). 
 
Table 7 – Interaction network between BDC2 and CaM. 
Residues making hydrogen bonds are underlined and the remaining residues are involved 
in hydrophobic interactions. 
 
BDC2 (mEAG1) CaM 
P728 G113 
L729 L112 
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N111 
L731 L112 
P736 
I85 
M145 
V737 
A88 
F92 
L112 
M145 
R739 M145 
L740 
M124 
M144 
M145 
F741 
L112 
E114 
 
The analysis also revealed that the bend in BDC2 is probably stabilized by an intra-
peptide main chain-main chain hydrogen bond network involving residues P732, P733, 
D734 and H735 (Figure 36). Furthermore, several interactions between the N-terminal 
extended stretch of BDC2 and a symmetry related CaM N-lobe which include a hydrogen 
bond between mEAG1 I730 and CaM S38 might stabilize this conformation (Figure 34).  
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The structure was also analyzed with the Protein structure comparison service Fold at 
European Bioinformatics Institute 
(http://www.ebi.ac.uk/msd-srv/ssm), PDBeFold (Taraska et al. 2009). This server does 
pairwise secondary-structure match (through the α-carbon, αC) with all structures 
deposited on the Protein Data Bank and displays hits ordered by a “Q-score” which takes 
into account the root mean standard deviation (RMSD) of the superposition as well as its 
residue length. Values range from 0 to 1, where a score of 1 indicates a perfect match. 
The top 3 hits for our CaM structures have Q-scores around 0.5, which is indicative of 
significant differences in the structural arrangement, In general, there is a good match 
between our structure and the top 3 hits along the central linker and C-lobe region, but in 
the N-lobe region there are significant differences, particularly in the Ca2+ binding loops 
and in the angles between the helices, since all three structures have Ca2+ bound to the N-
lobe (Figure 35a, b, c). The structure with the most similar fold to our CaM is a CaM 
“trapped intermediate” (PDB code 1Y6W, Figure 35a), a conformation in which the N-lobe 
has Ca2+ bound but is kept in a closed (apo-like) conformation, due to the introduction of 
two cysteines that form a disulfide bond, preventing the exposure of the N-lobe’s 
hydrophobic pocket that occurs upon binding of Ca2+.  
 
Figure 34 – Close up view of the crystal contacts on the interface between BDC2 and 
CaM. CaM is in red cartoon representation and the N-lobe from a symmetry related CaM 
is in grey. The residues in the interface of the complex are in stick representation. BDC2 is 
in cyan stick model with the corresponding electron density map in grey mesh contoured 
at 1.0 σ. 
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Figure 35 – Superposition of CaM from the CaM/BDC2 complex (red) with the top 3 hits 
obtained from PDBeFold. a) trapped intermediate of CaM (PDB code 1Y6W, green). b) 
CaM in complex with a fragment from a Na+/H+ exchanger (PDB code 2YGG, blue). c) 
CaM in complex with calcineurin (PDB code 2W73, yellow). 
 
Submission of just the N-lobe of CaM from our structure into PDBeFold results in more 
than 700 hits with Q-scores starting in 0.58. The most similar structures are EF-hand 
containing-proteins like troponin C and calcium binding protein 1. The first CaM structure 
in the list is found at number 10 and is a soybean CaM N-lobe bound to Mg2+ (PDB code 
2KSZ) with a Q-score of 0.49. This analysis showed that our apo-N-lobe conformation is 
significantly different from other deposited structures. 
Overall the CaM/BDC2 structure explains well the ITC data, confirming that the interaction 
of CaM with BDC2 is dominated by the C-lobe. 
BDC2 mutants 
To assess the contributions of the different residues discussed above (Figure 36) to the 
stability of the CaM/BDC2 complex we performed alanine-scanning analysis on BDC2, 
using ITC. The thermodynamic parameters for binding of the different mutants to Ca2+-
CaM are summarized in Table 7. Our collaborators Johannes Oppermann and Dr. Roland 
Schönherr, at Jena University Hospital, performed preliminary experiments on the 
functional impact of some BDC2 mutations on the Ca2+-dependent inhibition of the hEAG1 
channels expressed in Xenopus oocytes. 
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Figure 36 - Stick representation of the 
modelled BDC2 residues (mEAG1 727-
743), labelled with the corresponding 
primary sequence. CaM residues that 
interact with BDC2 are in lines. Grey 
circles identify residues involved in 
hydrophobic interactions with CaM and 
the hydrogen bonds with CaM are 
marked with orange dashes.  
 
We tested the importance of the interactions formed by the two leucines from the 
peptide’s extended region. These residues make hydrophobic interactions with the C-lobe 
of CaM and L729 makes a main chain-main chain hydrogen bond with CaM’s N111. The 
affinity for CaM dropped 4.5-fold, with a KD ~ 300 nM, both in the direct and reverse 
titrations (Figure 37a and b). Although the affinity drop is minor, the same mutants in the 
context of the whole channel reveal altered Ca2+ sensitivity. When exposed to the calcium 
ionophore ionomycin, that raises the intracellular concentration of Ca2+, the currents of 
hEAG1 channels with the double mutation are less inhibited relative to WT channels.  
We also generated the BDC2 mutant L729A/L731A/R739A. The R739 is well defined on 
the electron density map and makes a hydrogen bond between the guanine group and the 
main-chain carbonyl oxygen from CaM’s M145 (Figure 36). This triple mutant showed a 
much larger effect on ITC, the affinity dropped over 30-fold relative to the WT BDC2, to 
2.1 ± 0.1 µM (Figure 37c). 
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Figure 37 - a) ITC titration of 100 µM Ca2+-CaM into 10 µM MBP-BDC2 mutant 
L729A/L731A. b) ITC titration of 80 µM MBP-BDC2 mutant L729A/L731A into 7 µM Ca2+-
CaM. c) ITC titration of 100 µM Ca2+-CaM into 10 µM MBP-BDC2 mutant 
L729A/L731A/R739A. 
 
Residues D734 and H735 are located on the BDC2 bend and make intra-peptide 
interactions (Figure 36). Although these residues are not directly interacting with CaM, we 
wanted to see if truncating their sidechains would destabilize the peptide bend 
conformation and consequently alter binding of BDC2 to CaM. A double mutation to 
alanine did not alter affinity towards CaM (KD = 102.3 ± 11.1 nM) but the thermodynamic 
parameters were very different (Figure 38). This interaction is now much less enthalpically 
driven with a ΔH = -5.5 ± 0.1 kcal/mol, relative to the ΔH = -14.4 ± 0.2 kcal/mol for the WT. 
The enthalpic penalty was compensated by a large increase in entropy from -15.5 to 13.6 
cal/mol/deg. It is possible that the mutations destabilized the peptide bend conformation, 
allowing more conformational freedom to the CaM complex increasing the entropy of the 
system. Strikingly, channels with this double mutation are less sensitive Ca2+. This 
suggests that the BDC2 bend is mechanistically important. 
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Figure 38 - ITC titration of 60 µM Ca2+-CaM into 6 µM MBP-BDC2 mutant D734A/H735A. 
 
We also investigated the impact of residues on the helical region of the peptide that face 
the hydrophobic cleft of CaM. Double mutant P736A/V737A hardly alters binding to CaM, 
with a KD of 118.2 ± 4.4 nM (Figure 39a), ΔH of -9.5 ± 0.3 kcal/mol and ΔS around zero.  
Nevertheless, hEAG1 channels with these mutations show decreased Ca2+ sensitivity. 
Quadruple mutant P736A/V737A/L740A/F741A that truncates one of the phenylalanine 
thought to be important for the interaction between CaM and BDC2 displays a mere 3-fold 
drop in affinity for CaM, with a KD of 204.0 ± 20.0 nM, and ΔH and ΔS values 
indistinguishable from mutant P736A/V737A (Figure 39b, Table 7), indicating that there 
were no significant readjustments in the CaM-mutant BDC2 interface. 
Double mutation of the most buried residues V737 and L740 also does not affect the CaM 
affinity (Figure 40a and Table 8).  
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Figure 39 – a) ITC titration of 60 µM Ca2+-CaM into 6 µM MBP-BDC2 mutant 
P736A/V737A. b) ITC titration of 60 µM Ca2+-CaM into 6 µM MBP-BDC2 mutant 
P736A/V737A/L740A/F741A 
 
The very small impact of these mutations was surprising, since many of these residues 
make extensive interactions with the C-lobe (Figure 36). To exclude the possibility that 
some of these BDC2 mutants are now interacting with the N-lobe of CaM, we performed a 
titration with CaM EF12 mutant and BDC2 mutant V737A/L740A. BDC2 V737A/L740A 
binds CaM EF12 mutant as well as WT BDC2 (KD ~ 100 nM and similar ΔH and ΔS, 
Figure 40b), showing that truncation of sidechains buried in CaM apolar pocket still results 
in a interaction dominated by the C-lobe. To further explore the role of V737 and L740 on 
the interaction with CaM we substituted by the polar amino acid serine. We determined 
that the affinity for CaM is severely affected, with a KD of 15.6 ± 0.7 µM (Figure 40c), 
supporting that those apolar sidechains are important for the complex, as seen in the 
structure. 
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Figure 40 – a) ITC titration of 60 µM Ca2+-CaM into 6 µM MBP-BDC2 mutant 
V737A/L740A. b) ITC titration of 60 µM Ca2+-CaM EF12 mutant into 6 µM MBP-BDC2 
mutant V737A/L740A. c) ITC titration of 170 µM Ca2+-CaM into 17 µM MBP-BDC2 mutant 
V737S/L740S. 
 
It had previously been reported that two phenylalanines in BDC2 were essential for CaM 
inhibition of the full-length channel (Schönherr et al. 2000). Additionally, a channel 
fragment containing mutations to serine in these two phenylalanines had shown a 6-fold 
decrease in affinity for fluorescently labelled CaM (Ziechner et al. 2006). Although we only 
see the first phenylalanine in our structure (F741 and F744, in mEAG1), we investigated 
their role on CaM binding using ITC. BDC2 mutant F741S showed a 28-fold drop in affinity 
towards CaM (KD = 1.9 ± 0.1 µM, Figure 41a), which is comparable to the triple mutant 
L729A/L731A/R739A, whereas the double mutant F741S/F744S revealed an even more 
drastic effect (Figure 42b) with a KD that is now over 500-fold higher than the WT. The 
further drop in affinity with the double mutant confirms that the second phenylalanine is 
important for CaM binding and the fact that it is not visible in the structure might be related 
to crystal packing restraints. 
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Figure 41 – a) ITC titration of 200 µM Ca2+-CaM into 20 µM MBP-BDC2 mutant F741S. b) 
ITC titration of 336 µM Ca2+-CaM into 31 µM MBP-BDC2 mutant F741S/F744S 
 
Overall, mutations in the BDC2 residues which make interactions with CaM in the crystal 
structure consistently result an increase in ΔH when titrated with CaM, indicative of a 
weaker bonding network. While these mutations had moderate effects in the binding of 
CaM in solution, several of them caused a decrease in Ca2+-dependent inhibition, in the 
context of the full-length hEAG1 channel. Importantly, we were able to show that the 
residues in the extended stretch of our peptide structure, which had not been described in 
the literature, are involved in CaM binding. Mutations on that region have an effect on 
binding to CaM and as well as on channel inhibition by Ca2+-CaM. These results support 
the proposition of a new BDC2 sequence, which is extended towards residue L729. 
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Table 8 - Thermodynamic parameters for CaM interaction with long BDC2 mutants. 
MBP-long BDC2 KD (nM) 
𝐊𝐃 𝐦𝐮𝐭
𝐊𝐃 𝐖𝐓
 ΔH (kcal mol
-1) ΔS (cal mol-1deg-1) N n 
WT 
(reverse) 
67.9 ± 3.5 
74.2 ± 14.2 
1 
-14.43 ± 0.21 
-9.02 ± 0.18 
-15.5 ± 0.8 
2.5 ± 0.2 
0.80 ± 0.01 
1.02 ± 0.03 
6 
2 
L729A/L731A 
(reverse) 
296.8 ± 21.8 
303.7 ± 9.8 
4.4 
4.5 
-8.87 ± 0.11 
-7.73 ± 0.50 
0.2 ± 0.3 
3.9 ± 1.7 
0.84 ± 0.00 
0.95 ± 0.02 
4 
2 
D734A/H735A 102.3 ± 11.1 1.5 -5.53 ± 0.14 13.6 ± 0.7 0.86 ± 0.02 4 
P736A/V737A 118.2 ± 4.4 1.7 -9.46 ± 0.33 0.0 ± 1.2 0.91 ± 0.02 3 
P736A/V737A/L740A/F741A 204.0 ± 20.0 3.0 -9.39 ± 0.26 -0.8 ± 1.0 0.87 ± 0.04 3 
L729A/L731A/R739A 2.1x103 ± 0.1x103 31.0 -9.14 ± 0.09 -4.7 ± 0.4 0.94 ± 0.01 3 
V737A/L740A 73.8 ± 9.5 1.1 -10.76 ± 0.23 3.3 ± 0.8 0.93 ± 0.01 3 
V737S/L740S 15.6x103 ± 0.7 x103 230.1 -11.08 ± 1.25 -15.2 ± 4.3 0.77 ± 0.08 2 
F741S 1.9x103 ± 0.1x103 28.4 -6.72 ± 0.15 3.6 ± 0.5 0.70 ± 0.02 3 
F741S/F744S > 40000 > 500 ND ND ND 1 
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CNBhD-BDC1-BDC2 
After dissecting the binding properties of the individual CaM binding regions and of PAS-
BDN and CNBhD-BDC1 – we studied a longer construct, comprising the CNB-homology 
domain and the two C-terminal CaM binding sites BDC1 and BDC2 (mEAG1 552-764). 
This longer construct had to be co-expressed with CaM for protection against proteolysis. 
In addition, it required extra purification steps that included ion exchange chromatography 
(Figure 42) and CaMTrap affinity chromatography 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 42 - HitrapQ ion exchange chromatogram of the separation of CNBhD-BDC1-
BDC2 from CaM. Inset: 17% SDS-PAGE of fractions before and after ion exchange 
purification. 
 
Size-exclusion chromatography profiles show that CNBhD-BDC1-BDC2 elutes at 15.2 mL, 
and CaM at 16.5 mL (Figure 43). Calibration of this S200 column with protein standards 
showed that a globular protein with the same molecular weight as CNBhD-BDC1-BDC2 
(~27 kDa) elutes at 16 mL. CNBhD-BDC1-BDC2 in complex with CaM suffers a large shift 
in the elution profile, eluting at 14 mL. In the same S200 column, MBP fusions of ~45 KDa 
that consist of two globular domains with a small peptide extension on the C-terminal are 
eluted at 15 mL. The elution volume of the CNBhD-BDC1-BDC2/CaM complex is 
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suggestive of either a species larger than 44 kDa (the sum of the CaM and CNBhD-
BDC1-BDC2 molecular weights) or of an elongated species. 
 
The isotherm of the interaction between CNBhD-BDC1-BDC2 and CaM showed two steps 
with different slopes that occur at sub-stoichiometric molar ratios (Figure 44a). This 
isotherm could not be properly explained with the single set of sites model for 1:1 
interactions implemented in the Origin for ITC software package. Reversing the titration 
(CNBhD-BDC1-BDC2 into CaM) resulted in an even more complicated isotherm, with 
three different steps (Figure 44b), and heats of reaction (ΔH) that are less than half of 
those of the direct titration. These isotherms suggested that there were several species in 
equilibrium. 
Our collaborators Dr. Guillaume Gabant and Dr. Martine Cadene at CNRS, France 
performed native mass spectrometry to determine the oligomeric state of CNBhD-BDC1-
BDC2 in isolation and in complex with CaM. This technique allows the study of intact 
proteins or protein complexes through the use of mild ionization conditions in the 
Figure 43 - Superposition of S200 size exclusion chromatograms of mEAG 552-764 
(dashed line), CaM (dotted line) and equimolar amounts of mEAG 552-764 and CaM 
(continuous line). 
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presence of a volatile buffer that preserves the sample’s quaternary structure (Heck 
2008). It can be used to determine stoichiometry, topology and dynamics of protein 
complexes and has a large sensitivity. The native mass spectrometry analysis showed 
that the major CNBhD-BDC1-BDC2 species is a monomer; however, a residual amount of 
CNBhD-BDC1-BDC2 dimer could be observed. In the presence of CaM, the 1:1 complex 
was the major species but minor species of complex forms 1:2 and 2:2 were also detected 
(CNBhD-BDC1-BDC2:CaM). 
 
Figure 44 – a) ITC titration of 187 µM Ca2+-CaM into 17 µM CNBhD-BDC1-BDC2 (direct). 
b) ITC titration of 60 µM CNBhD-BDC1-BDC2 into 6 µM Ca2+-CaM (reverse). The different 
binding steps are indicated by grey arrows. 
 
In an attempt to gain some insights into the complicated interaction of full-length CaM with 
this protein fragment, we performed ITC titrations with the isolated CaM lobes. CNBhD-
BDC1-BDC2 binds to the CaM N-lobe with a KD of 1.3 ± 0.1 µM and ΔH = -4.43 ± 0.09 
kcal/mol (Figure 45a) and to the C-lobe with KD = 75.0 ± 8.4 nM and ΔH = -13.13 ± 0.26 
kcal/mol for the C-lobe (Figure 45b). This channel fragment interacts with the CaM lobes 
with distinct affinities and enthalpies, binding more tightly to the C-lobe than to the N-lobe, 
like we observed for BDC2. Titration of CaM EF12 mutant into CNBhD-BDC1-BDC2 has a 
KD of 38.8 ± 4.4 nM and ΔH = -10.36 ± 0.32 kcal/mol and the reverse titration (CNBhD-
BDC1-BDC2 into EF12 mut) gave a KD ~ 62 nM and ΔH ~ -7.6 kcal/mol (Figure 45 c and 
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d, respectively), confirming that there is a parallel between CNBhD-BDC1-BDC2 and 
BDC2. 
Interestingly, none of the titrations of the single lobes or CaM EF12 mutant with CNBhD-
BDC1-BDC2 exhibited the two slopes that are observed with full-length CaM, indicating 
that the Ca2+-N-lobe is involved in this behavior. Moreover, these titrations were easily 
fitted with a single binding site model with a stoichiometry close to 1, suggesting that the 
two slopes in the titration with full-length CaM correspond to separate interactions of N- 
and C-lobe. 
Since we have shown before that BDC2 interacts preferentially with the C-lobe and BDC1 
with the N-lobe (Marques-Carvalho et al. 2012), we wondered if BDC1 could be involved 
in the interaction of this longer channel fragment with CaM. To assess this, a quadruple 
mutation on BDC1 (R702N/R704N/R708N/K709N) that decreases the affinity of CaM for 
BDC1 even further was created on CNBhD-BDC1-BDC2. Titration with CaM still showed 
two slopes (Figure 46a), indicating that BDC1 is not responsible for this feature. 
We also created MBP fusions with two channel fragments that do not include the CNB-
homology domain: BDC1-BDC2 (mEAG1 696-764) and a fragment that starts just after 
BDC1 and includes BDC2 (mEAG1 712-764). Both fusions displayed a binding isotherm 
with two slopes when titrated with CaM (Figure 46b and 46c), demonstrating that the 
CNB-homology domain region is not involved in this multistep binding. The observation 
that mEAG1 712-764 still shows two steps confirms that BDC1 does not play a role in the 
second binding event. Overall, these experiments indicate that N- and C-lobe are 
interacting with a mEAG1 channel fragment that starts after BDC1 and extends towards 
BDC2. 
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Figure 45 – a) ITC titration of 140 µM Ca2+-N-lobe into 14 µM CNBhD-BDC1-BDC2. b) 
ITC titration of 100 µM Ca2+-C-lobe into 10 µM CNBhD-BDC1-BDC2. c) ITC titration of 
100 µM Ca2+-CaM EF12 mutant into 100 µM CNBhD-BDC1-BDC2 (direct). d) ITC titration 
of 40 µM CNBhD-BDC1-BDC2 into 6 µM Ca2+-CaM EF12 mutant (reverse). 
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Thus, with the help of Dr. Eva Muñoz from AFFINImeter (www.affinimeter.com), we fitted 
the CNBhD-BDC1-BDC2/CaM data to an independent site model that allows the 
extraction of site-specific binding constants, using this online isothermal titration 
calorimetry software. In this model, CaM is considered a two-site receptor, where the N- 
and C-lobe bind separately and independently to the channel fragment, as shown in 
Figure 47. 
 
Figure 47 – Diagram of the binding equilibrium between CaM (two site receptor) and 
CNBhD-BDC1-BDC2 (ligand) using an independent site approach. k represents the 
binding site constants to each lobe (N- or C-), that are converted into KDs. 
 
Figure 46 – a) ITC titration of 60 µM Ca2+-CaM into 6 µM CNBhD-BDC1-BDC2 BDC1 
mutant R702N/R704N/R708N/K709N. b)  ITC titration of 60 µM Ca2+-CaM into 6 µM MBP-
BDC1-BDC2. c)  ITC titration of 70 µM Ca2+-CaM into 6 µM MBP-mEAG1 712-764.  
Arrows point towards the two steps in the binding isotherms. 
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The fit of the data was very good (Figure 48a) and shows that there is an event with low 
affinity and low enthalpy (KD = 1.3 ± 0.1 µM and ΔH = -4.25 ± 0.17 kcal/mol) and a second 
event with high affinity and high enthalpy (KD = 6.5 ± 0.5 nM and ΔH = -14.27 ± 0.22 
kcal/mol). Importantly, these thermodynamic parameters are in good agreement with the 
ones obtained for the titrations of the N- and C-lobe, respectively (Figure 45 a and b, 
Table 9). The species distribution plot (Figure 48b) shows the formation of two species 
throughout the titration: at the beginning of the titration, while there is excess of the 
CNBhD-BDC1-BDC2 (ligand), both lobes bind to the ligand. As the molar ratio of 
CaM:ligand approaches 1 and the availability of free CNBhD-BDC1-BDC2 drops, the 
higher affinity C-lobe displaces the N-lobe and by the end of the titration all CNBhD-
BDC1-BDC2 is bound to the C-lobe. 
Figure 48 – a) ITC titration of 187 µM Ca2+-CaM into 17 µM CNBhD-BDC1-BDC2 (same 
as Figure 44a) fitted with an independent site model using the software AFFINImeter. b) 
Species distribution plot that represents the fraction of lobes bound throughout the course 
of the titration. 
 
To show that the lobes compete for the same binding sequence and confirm this model, 
we designed a displacement experiment. In this experiment, a mixture of CNBhD-BDC1-
BDC2 pre-mixed with a saturating concentration of N-lobe was titrated with C-lobe. This 
titration shows a single transition (Figure 49). Fit to the single-site model provided by the 
Origin software, gives us an apparent KD for C-lobe between 230-400 nM, and an 
apparent ΔH around -6 kcal/mol. The affinity drop and change in enthalpy in the presence 
of N-lobe shows that both lobes compete for the same site in CNBhD-BDC1-BDC2. 
Inputting the concentration and binding parameters determined for the N-lobe into a 
competition model gave us back thermodynamic parameters that are similar to the ones 
determined from the C-lobe direct titrations (KD ~ 6.6 nM and ΔH ~ -16 kcal/mol, Figure 
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50a and b). The species distribution plot shows that with these concentrations, the C-lobe 
was able to compete out all the N-lobe. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 49 – ITC titration of 100 µM Ca2+-C-lobe into 7 µM CNBhD-BDC1-BDC2 and 35 µM 
Ca2+-N-lobe 
 
 
Figure 50 - a) ITC titration of 100 µM Ca2+-C-lobe into 7 µM CNBhD-BDC1-BDC2 and 35 
µM Ca2+-N-lobe (same as Figure 49) fitted with an independent site model using the 
software AFFINImeter. b) Species distribution plot that represents the fraction of lobes 
bound throughout the course of the titration. 
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This model implies that reversing the titration (i.e., injecting the ligand into the two-site 
receptor CaM), will benefit the formation of the C-lobe complex that has higher affinity and 
more negative enthalpy of binding. N-lobe/channel complex will only start to form at molar 
ratios above 1, after all the C-lobe is saturated (Figure 51b). 
A simulation of this titration, entering the binding parameters of the single lobes towards 
CNBhD-BDC1-BDC2 (Table 9) into the independent site model, reveals a single transition 
as can be seen in Figure 51a.  This simulated curve is different from what we observed for 
the CNBhD-BDC1-BDC2 reverse titration (Figure 44b) because that protein fragment is 
heterogeneous at the high concentrations needed for the reverse titration, as evidenced 
by native mass spectrometry. 
We performed reverse titrations using both extended BDC2 fusions and both of them 
displayed a single transition with parameters resemble the C-lobe’s: KD of 13.8 ± 2.2 nM, 
ΔH = 9.75 ± 1.06 kcal/mol for BDC1-BDC2 (Figure 52a) and KD of 76.1 ± 1.0 nM, ΔH = 
9.46 ± 1.47 kcal/mol for mEAG1 712-764 (Figure 52b). The plateau at the beginning and 
end of the titration is not symmetric: at the end, the reaction heats take longer to reach the 
baseline due to the contribution of the N-lobe small heats of binding, as can be followed 
on Figure 51b. 
 
 
Figure 51 – a) Simulated binding isotherm for reverse titration CNBhD-BDC1-BDC2 into 
CaM using the concentrations from figure 44b and. b) species distribution plot of the 
species formed during the titration. 
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Figure 52- a) ITC titration of 60 µM MBP-BDC1-BDC2 into 6 µM Ca2+-CaM. B) ITC titration 
of 70 µM MBP-mEAG1 712-764 into 7 µM Ca2+-CaM. 
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Table 9 - Thermodynamic parameters for CaM interaction with protein fragments containing BDC1-BDC2. 
CaM BD Titrant Cell N KD (nM) ΔH (kcal mol
-1) 
ΔS (cal mol-1 
deg-1) 
n 
BDC1- 
BDC2 
Ca2+-CaM CNBhD-BDC1-BDC2 0.76 ± 0.02 
1.3x103 ± 0.1x103 
6.5 ± 0.5 
-4.25 ± 0.17 
-14.27 ± 0.22 
ND 7 
Ca2+/N-lobe CNBhD-BDC1-BDC2 0.80 ± 0.03 1.3x103 ± 0.1x103 -4.43 ± 0.09 12.2 ± 0.5 3 
Ca2+/C-lobe CNBhD-BDC1-BDC2 0.80 ± 0.02 75.0 ± 8.4 -13.13 ± 0.26 -11.4 ± 0.9 3 
Ca2+-CaM EF12 mut CNBhD-BDC1-BDC2 0.94 ± 0.03 38.8 ± 4.4 -10.36 ± 0.32 0.7 ± 0.9 3 
CNBhD-BDC1-BDC2 Ca2+-CaM EF12 mut 1.20 62.5  -7.65 7.3 1 
Ca2+-CaM MBP-BDC1-BDC2 ND ND ND ND 3 
MBP-BDC1-BDC2 Ca2+-CaM 1.13 ± 0.03 13.8 ± 2.2 -9.75 ± 1.06 3.3 ± 3.2 2 
Ca2+-CaM 
MBP-end of BDC1-
BDC2 
ND ND ND ND 
 
2 
MBP-end of BDC1-
BDC2 
Ca2+-CaM 0.99 ± 0.01 76.1 ± 1.0 -9.46 ± 1.47 0.9 ± 4.9 2 
Ca2+-CaM 
CNBhD-mut BDC1-
BDC2 
ND ND ND ND 3 
Ca2+/C-lobe 
CNBhD-BDC1-BDC2 
+ Ca2+/N-lobe 
ND 11.1 ± 3.2 -14.25 ± 1.25 ND 2 
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DISCUSSION 
It was almost two decades ago that the inhibition of EAG1 currents by Ca2+ was described 
for the first time (Stansfeld et al. 1996). This process is mediated by CaM binding to the 
channel (Schönherr et al. 2000; Ziechner et al. 2006) and three sites for CaM binding 
were identified: one in the N terminus (BDN), after the PAS domain, and two on the C 
terminus (BDC1 and BDC2) after the CNB-homology domain. Mutations in each of these 
sites severely affected Ca2+-CaM inhibition (Ziechner et al. 2006) suggesting that all sites 
were important. However, the affinity of CaM for the BDC1 site is not consensual and the 
functional relevance of this site has been questioned (Gonçalves & Stühmer 2010; 
Marques-Carvalho et al. 2012). As to this date, the molecular mechanism of inhibition of 
EAG1 channels by Ca2+-CaM is not fully understood. 
Using a combination of isothermal titration calorimetry and X-ray crystallography, we 
characterized the binding of calmodulin to several channel fragments encompassing the 
calmodulin binding sequences BDN, BDC1 and BDC2. We also assessed the contribution 
of the individual CaM lobes and evaluated the effect of the PAS and CNB-homology 
domains on CaM binding to these sites. 
CaM has high affinity for CaM BDC1, an interaction that is entropically driven. The 
presence of the CNB-homology domain drastically lowers the affinity of CaM for BDC1 
due to a decrease in the entropy of the system. The low affinity of BDC1 agrees with the 
observation that this site is occluded in the PAS/CNB-homology domain structure (Haitin 
et al. 2013b), which is consistent with a reduced conformational freedom (entropy). Our 
data shows that mutations in the BDC1 region that lower CaM’s affinity (Marques-
Carvalho et al. 2012) and make EAG1 channels nearly insensitive to Ca2+-CaM (Ziechner 
et al. 2006), disrupt the interaction of the CNB-homology domain with the PAS domain. 
Altogether, the data available on the BDC1 region leads us to propose that, with a KD in 
the micromolar range, BDC1 is not important for CaM inhibition, a process that has an 
IC50 ~ 6 nM for CaM. BDC1 might instead have a different regulatory role through the 
interaction with the PAS domain. 
We also demonstrated that CaM binds to BDN with high affinity using both lobes, in a 
Ca2+-dependent fashion. The presence of the PAS domain slightly lowers the affinity of 
CaM for BDN. The interaction of CaM with PAS-BDN has a more negative enthalpy 
change which is accompanied by an increase in the order of the system, suggesting that 
CaM might also interact with the surface of the PAS domain. 
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Interestingly, CaM binds to BDC2 in a non-canonical manner – the C-lobe has a much 
higher affinity for BDC2 than the N-lobe. The structure of the CaM/BDC2 complex shows 
that CaM is in an elongated conformation, with the C-lobe interacting with the channel 
sequence and the N-lobe without Ca2+. The observation that the N-lobe does not contain 
any Ca2+ bound is most likely related to not being engaged in this interaction. The BDC2 
peptide is bent, with an extended conformation at the N terminus before turning into a 
small α-helix. It includes residues that had not been previously described to be involved in 
binding to CaM. Mutations in the extended N-terminal stretch that decreased the CaM 
affinity also decreased Ca2+ sensitivity of full-length channels, supporting the importance 
of these residues for CaM modulation. The C-terminal part of the peptide is disordered in 
our structure, despite including residues that are important for CaM binding (Schönherr et 
al. 2000). This can be attributed to crystal packing restraints, since there is a symmetry 
related peptide in close proximity. The bent conformation of the peptide is unusual and 
may result from the positioning of BDC2 in a groove formed by the C-lobe of one CaM and 
the N-lobe of a symmetry related CaM, making interactions with both. While the 
physiological relevance of the bend is not clear, channels with mutations aimed at 
disrupting intra-peptide interactions at the bend were less sensitive to Ca2+, leading us to 
suggest that the bend is important for this mechanism. It is not known how CaM binding 
results in channel inhibition but a possibility is that the bend formation could be a part of 
the gating mechanism, by introducing rearrangements in the disposition of the channel’s 
cytoplasmic domains that would lead to channel closure. 
Finally, we observed that CaM binding to a longer channel fragment that includes CNB-
homology domain, BDC1 and BDC2 exhibits an isotherm with two slopes. We established 
that this interaction is also dominated by the C-lobe, but that the Ca2-N-lobe is involved in 
this behavior. These binding isotherms could only be explained if CaM was described as 
having two independent binding sites for this region - its individual N- and C-lobes. We 
were able to show that both lobes bind in a competitive manner to the same residue 
stretch, with parameters that resemble the titrations with the single lobes. We narrowed 
down the region to which both lobes bind to a stretch that starts after the BDC1 and 
extends to BDC2, reinforcing the observation that residues between BDC1 and the 
previously described BDC2 sequence are also important for this CaM binding. With this 
new knowledge, a subtle bump at the beginning of the CaM into BDC2 titration could also 
be detected upon a closer look, although much less accentuated than when the protein is 
extended towards the N-terminal. This feature is more subtle given that the heats 
associated with binding of the N-lobe to BDC2 are lower. Because of this, fit to the 
independent sites model was not successful, but it explains the difference in enthalpies for 
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direct and reverse titration observed for BDC2. Consistent with the competitive model, 
reverse titrations of the extended BDC2 peptides into CaM revealed a single transition, 
with binding parameters that are close to the C-lobe’s. At the start of the titration, CaM is 
in excess and the equilibrium is shifted towards the more enthapically driven, higher 
affinity interaction (C-lobe/channel fragment). Species of N-lobe/channel fragment only 
start to form after all the C-lobe is saturated (at molar ratios above 1). The reverse titration 
of CNBhD-BDC1-BDC2 into CaM displayed a more complicated behavior because of the 
heterogeneity of the sample at high concentrations.  
In summary, we have established that each EAG1 CaM binding site has very distinct CaM 
binding properties and that the affinity towards CaM is affected by the presence of the 
globular domains PAS and CNB-homology domain. 
 
V. CONCLUDING REMARKS 
The work described in this dissertation represents a structural, biochemical and 
biophysical characterization of the cytoplasmic regions of the EAG1 channels, focusing on 
their interaction with calmodulin. 
KCNH channels contain large cytoplasmic regions on the N- and C-terminal that are 
involved in channel gating. It has been well established that the PAS domain interacts with 
the CNB-homology domain in KCNH channels (Gustina & Trudeau 2013; Haitin et al. 
2013b) and that this interaction is important for the channel’s gating properties. 
Structures of KCNH CNB-homology domains showed a self-liganded conformation with an 
intrinsic ligand bound in the pocket. The C-terminal tail of the mEAG1 CNB-homology 
domain includes a previously identified CaM binding sequence (BDC1) that does not exist 
in the other KCNH channel subfamilies. This region is partially occluded as a result of the 
self-liganded state and is also part of the interface of the PAS/CNB-homology domain 
complex (Haitin et al. 2013b). We explored the existence of an unliganded conformation, 
making use of CaM as well as by introducing mutations that destabilize the self-liganded 
conformation. We showed that CaM BDC1 is a weak binding site for CaM and that 
mutations that released the C-terminal tail resulted in higher affinities towards CaM. We 
also demonstrated that CaM binding causes structural changes in the CNB-homology 
domain, suggesting that the C-terminal tail peels away from the surface of the domain. 
Mutations in the intrinsic ligand affected the voltage-dependence of EAG1 channels, 
suggesting that the CNB-homology domain has a role in channel gating. A possibility is 
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that the effect of the intrinsic ligand mutations is related to the destabilization of the 
PAS/CNB-homology domain complex. However, the role of the individual intrinsic ligand 
residues is not understood since opposite effects are found among different KCNH 
subfamilies. 
Using ITC, we performed a comprehensive characterization of CaM binding to the EAG1 
CaM binding sequences and evaluated the effect of the globular domains PAS and CNB-
homology domain on this interaction. We propose that BDC1 is not important for CaM 
modulation and that the effect that BDC1 mutations have on Ca2+-CaM inhibition is due to 
the destabilization of the complex between PAS and CNB-homology domain. CaM binds 
to BDN in a Ca2+-dependent manner, involving both lobes and it might also interact with 
the surface of the PAS domain. CaM BDC2 site shows a non-canonical binding mode to 
CaM, involving mainly the C-lobe, with little contribution from the N-lobe. Channel 
fragments that included BDC2 and were extended towards the N terminus showed 
complicated binding isotherms to CaM which could not be explained with a simple 1:1 
model. Using a combination of ITC, structural data and electrophysiology we have 
redefined the limits of the BDC2 site. The extended site spans from the end of BDC1, until 
the end of the previously identified BDC2. CaM binds to this region using both lobes 
independently and competitively, with different KDs and ΔH, with the C-lobe binding tighter 
than the N-lobe.  
It is easy to imagine that there is a very high local concentration of CaM binding sites 
below the EAG1 pore, given that the EAG1 channel is tetrameric, with large cytoplasmic 
regions that include more than one site for CaM binding per subunit. An implication of the 
weak binding of the N-lobe to the C terminus of the channel is that it is free to engage with 
other parts of the channel, BDN or a CaM binding site from a neighbor subunit, for 
instance. 
The lack of CaM inhibition of channels with the entire N terminus deleted or channels with 
mutations on BDC1 (Ziechner et al. 2006), together with new data on the PAS/CNB-
homology domain complex stability seem to suggest that the integrity of this complex is 
necessary for Ca2+-CaM to exert its inhibitory function. It is possible that this complex is 
required to bring together certain channel regions, important for CaM modulation. 
All the functional analysis on Ca2+-CaM inhibition of EAG1 was performed at constant 
voltage and it would be very interesting to study if this process is voltage-dependent. 
Moreover, it would be of great interest to evaluate whether CaM induces conformational 
changes on the EAG1 globular domains. Extensive crystallization attempts were made of 
complexes between CaM and different sized CaM binding peptides, as well as with CNB-
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homology domain or PAS-containing fragments but no crystals of the complexes were 
ever obtained, apart from CaM/BDC2. The high solubility and flexibility of CaM might 
underlie the low success rate, so it would be interesting to explore this further using 
another structural biology technique like NMR. 
The present work has provided more detailed insights into binding of CaM to EAG1 
cytoplasmic regions but we are far from understanding the molecular mechanisms of 
EAG1 channel inhibition by Ca2+-CaM. 
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KCNH channels are voltage-gated potassium channels with important
physiological functions. In these channels, a C-terminal cytoplasmic
region, known as the cyclic nucleotide binding homology (CNB-
homology) domain displays strong sequence similarity to cyclic nucleotide
binding (CNB) domains. However, the isolated domain does not bind
cyclic nucleotides. Here, we report the X-ray structure of the CNB-
homology domain from the mouse EAG1 channel. Through comparison
with the recently determined structure of the CNB-homology domain
from the zebrafish ELK (eag‐like K+) channel and the CNB domains from
the MlotiK1 and HCN (hyperpolarization‐activated cyclic nucleotide‐
gated) potassium channels, we establish the structural features of CNB-
homology domains that explain the low affinity for cyclic nucleotides. Our
structure establishes that the “self-liganded” conformation, where two
residues of the C-terminus of the domain are bound in an equivalent
position to cyclic nucleotides in CNB domains, is a conserved feature of
CNB-homology domains. Importantly, we provide biochemical evidence
that suggests that there is also an unliganded conformation where the
C-terminus of the domain peels away from its bound position. A functional
characterization of this unliganded conformation reveals a role of the
CNB-homology domain in channel gating.
© 2012 Elsevier Ltd. All rights reserved.
Introduction
The KCNH channel family includes EAG (ether-a-
go-go) channels, ERG (eag‐related gene) channels,
and ELK (eag‐like K+) channels.1 KCNH channels
are voltage-gated potassium channels that have
important roles in cardiac repolarization,2 neuronal
excitability,3 and cellular proliferation and tumor
*Corresponding author. E-mail address:
jcabral@ibmc.up.pt.
Abbreviations used: CNB, cyclic nucleotide binding;
EAG, ether‐a‐go‐go; ELK, eag‐like K+; CNG, cyclic
nucleotide‐gated; HCN, hyperpolarization‐activated
cyclic nucleotide‐gated; mEAG1, mouse EAG1; wt, wild
type; PDB, Protein Data Bank; 3D, three‐dimensional;
HSQC, heteronuclear single quantum coherence.
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growth.4 They are tetrameric potassium channels
with six transmembrane helices per subunit; similar
to other voltage-gated potassium channels, the
membrane‐buried regions are organized as four
voltage sensor domains surrounding a central pore
domain.1 KCNH channels are also characterized by
having large N- and C-terminal cytoplasmic regions,
which include a Per-Arnt-Sim domain at the very
N-terminus and a domain displaying sequence
homology to cyclic nucleotide binding domains
(the CNB-homology domain) on the C-terminal
region, just after the last transmembrane helix.
The functional role of the cytoplasmic regions
remains unclear. It is thought that they are involved
in regulation of channel function and act as in-
terfaces for cellular signaling networks; there is
evidence showing that these regions include phos-
phorylation sites, 5 sites for interaction with
kinases,6 integrins,7 and calmodulin.8 Ca2+/cal-
modulin regulation has been well established in the
human EAG1 channel8; the channel is inhibited by
increasing Ca2+ concentration, an effect that is
mediated through calmodulin binding to the chan-
nel. Three different calmodulin binding sequences
have been identified, one in the cytoplasmic
N-terminal region (BD-N) and two in the C-terminal
region (BD-C1 and BD-C2), immediately after the
CNB-homology domain.9 The in vitro affinity for
Ca2+/calmodulin has been determined for the three
sites: 100–200 nM for BD-N and BD-C2, while for
BD-C1, the reported affinity varied between
~300 nM and more than 5 μM, depending on the
approach used. Fluorescence resonance energy
transfer analysis of the interaction between calmod-
ulin and the human EAG1 channel in culture cells
revealed that calmodulin binds to BD-N both in low
and in high cytosolic Ca2+ concentrations, while
binding of calmodulin to site BD-C2 appears to occur
only in high Ca2+ concentrations.10 A channel with
mutations in BD-N and BD-C2 (reducing their
calmodulin affinity) and an intact BD-C1 site showed
no fluorescence resonance energy transfer signal,
consistent with a low‐affinity site. Importantly,
mutations that reduce calmodulin affinity at any of
the three sites also drastically reduce channel
inhibition by Ca2+/calmodulin, supporting the
functional importance of all three sites for Ca2+/
calmodulin regulation.9
The CNB-homology domains in the KCNH
channels are particularly intriguing. These domains
have strong sequence similarity to cyclic nucleotide
binding (CNB) domains of cyclic nucleotide‐gated
(CNG) channels and hyperpolarization-activated
cyclic nucleotide-gated (HCN) channels.1 In HCN
and CNG channels, binding of cAMP or cGMP to
the CNB domain induces a conformational change
in the domain, which is propagated to the gate of the
channel favoring channel activation.11–13 However,
it has been shown that the in vitro affinity of the
CNB-homology domain of mouse EAG1 (mEAG1)
and human ERG channels for cyclic nucleotides is
very low (Kd≥50 μM) and that the function of
KCNH channels is not altered upon exposure to
cyclic nucleotides.14
Very recently, the structure of the CNB-homology
domain from a zebrafish ELK (zELK) channel was
reported by Brelidze et al.15 This structure reveals
the typical fold of CNB domains as expected.
Surprisingly, the domain adopts a self-liganded
conformation, where side chains from two con-
served residues at the C-terminus interact with the
domain region that is equivalent to the ligand
binding pocket in CNB domains. The structure
raises many questions: Is the self-liganded confor-
mation a conserved feature of CNB-homology
domains? Does an “unliganded” state exist in
CNB-homology domains? Are the many similarities
between bona fideCNB domains and CNB-homology
domains also reflected at the functional level?
With the purpose of better understanding the
structural and functional properties of the CNB-
homology domain of the KCNH channels, we have
determined the crystal structure of this domain from
the mEAG1 channel and have performed a bio-
chemical and functional characterization.
Results
Structure of the CNB-homology domain
from mEAG1
We have determined the structure of the CNB-
homology domain from the mEAG1 channel at
2.2 Å (Fig. 1a and b and Supplementary Fig. 1;
Table 1); it shows the typical fold of a CNB domain,
with three helices (αA, αB, and αC) lying on the
surface of a β-roll. Residues immediately after the
αC helix (residues 696 to 707), which we designate
as the C-terminal tail of the domain, adopt an
extended conformation and snake over the surface
of the structure. The structure also includes part of
the C-linker (helices αD′, αE′, and αF′) that connects
the domain to the last transmembrane helix of the
channel.
Superposition through the β-roll of our CNB-
homology structure with the CNB-homology struc-
ture from the zELK channel shows the strong
similarities (Fig. 2a). The domain helices are
differently positioned on the surface of the β-roll
but maintain the same relative disposition between
each other (Fig. 2b). Importantly, the two structures
adopt the same “self-liganded” conformation. In
both structures, two residues in the C-terminal tail
(Y699 and L701 in the mEAG1 channel), which are
conserved across KCNH channels (Supplementary
Fig. 1), occupy the volume taken up by cAMP in the
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CNB domains of the HCN and MlotiK1 channels
(Fig. 2c and d). The presence of the same conforma-
tion in the twodifferent crystal structures, determined
fromdomain constructswith very different limits (the
mEAG1 domain includes only part of the C-linker
while the domain from zELK has the whole linker)
and originating from different KCNH channel sub-
families (with just ~40% identity over the domain
sequence), supports the proposal that this conforma-
tion is a significant feature of KCNH channels.
The pocket in the CNB-homology domains
To better understand the structural underpinnings
of the low affinity of cyclic nucleotides for the CNB-
homology domains, we compared the structures of
CNB-homology domains and CNB domains. Similar
to CNB domains, there is a shallow “binding
pocket” in CNB-homology domains (Fig. 3a and b
and Supplementary Fig. 2a). This pocket is more
open than the CNB domain binding pockets. For
example, in the bound or unbound conformations of
the CNB domains from the MlotiK1 channel, the
Cα–Cα distance between F296 and S308 is 10.6 Å
(Fig. 3b), while in the HCN2 channel CNB domain,
the equivalent distance is 10.8 Å (F580 to T592); in
contrast, in the CNB-homology domains, the dis-
tance between equivalent residues [F644 to C658 in
mEAG1 (Fig. 3a); I683 to N697 in zELK] is 12.5 Å
and 12.1 Å, respectively. There is also an interesting
aspect in the conservation of residues of the pocket.
Many of the residues that surround the base of the
nucleotide in the MlotiK1 CNB domain (V282, L290,
F296, and V311) (Fig. 3b), and which are fairly
conserved across CNB domains, are basically
unchanged in the mEAG1 CNB-homology domain
(V628, L638, F644, and V661) (Fig. 3a) and in zELK
(V667, L677, I683, and V700) (Supplementary Fig. 1).
In contrast, the residues that interact with the ribose
and phosphate groups of the nucleotide, and which
are conserved in the CNB domains, are very
different from the ones present in the equivalent
region of the mEAG1 channel (Fig. 3a and b). Even
when there is chemical similarity between residues
in this region, such as E298 in MlotiK1 (highly
conserved across all CNB domains) and D646 in
mEAG1, the structures diverge, resulting in a very
different disposition of the side chains (Fig. 3a and
b). Moreover, the key arginine that interacts with the
phosphate group in CNB domains (R307 inMlotiK1)
and determines much of the affinity for the ligand16
is not present in the homology domains and its
Fig. 1. Structure of the CNB-
homology domain from the mEAG1
channel. (a and b) Cartoon represen-
tations of theCNB-homologydomain
(two different views rotated ~90°).
C-linker stretch is depicted in cyan,
CNB-homology domain helices are
in dark blue, and β-roll is in gray.
Table 1. Crystallographic statistics
Crystal data
Space group P3121
Unit cell parameters
a=b (Å) 60.3
c (Å) 85.4
α=β (°) 90
γ (°) 120
Data collection details
Diffraction source ESRF beamline ID14_4
Wavelength (Å) 0.9765
Resolution range (Å) 52.3–2.2 (2.31–2.2)
No. of unique reflections 9566 (1356)
No. of measured reflections 59,240 (7118)
Multiplicity 6.2 (5.2)
Completeness (%) 99.4 (97.5)
I/σI 4.8 (2.2)
Rsym (%) 8.9 (25.1)
Refinement data
Resolution range 52.3–2.2 (2.34–2.2)
No. of reflections 9540
Rwork/Rfree (%) 18.6/21.8 (28.7/34.0)
No. of atoms in model
Protein 1151
Solvent 49
Average B value (Å2)
Protein 56.5
Solvent 58.2
RMSD bond length (Å) 0.008
RMSD bond angles (°) 1.085
The values in parentheses correspond to statistics for data in the
highest‐resolution shell.
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space is now shared between two residues (Y609
and V615) in mEAG1 (Fig. 3a and b) or three
residues (I648, L654, and T696) in zELK.
Another clear structural difference between the
binding pockets is the absence of the αP helix in the
CNB-homology domain (Supplementary Fig. 2). This
helix is part of the phosphate-binding cassette in the
CNB domain. It has been shown to readjust upon
ligand binding and to establish essential contactswith
the helix αB for the mechanism of ligand‐induced
conformational change.13,17 In the CNB-homology
domains, αP is replaced by a long loop, and as a
consequence, the packing between residues in the
pocket and residues in αB is very different.
Overall, the differences in the structure and amino
acid composition of the pocket of CNB-homology
domains relative to CNB domains can explain the
very low affinity of the homology domains for cyclic
nucleotides.
Strikingly, in the mEAG1 CNB-homology do-
main, the two conserved residues (Y699 and L701)
bound in the pocket occupy the same volume cyclic
nucleotides take up in CNB domains (Fig. 2c).
Moreover, the two residues establish an extensive
network of interactions with residues in the pocket
(Fig. 2d) and some of these interactions are similar to
the ones established by cyclic nucleotides in CNB
domains. The aromatic ring of the tyrosine is
Fig. 3. Comparing binding
pockets. (a) Close‐up of binding
pocket in the CNB-homology do-
main. (b) Close‐up of cAMP bind-
ing pocket in CNB domain from
MlotiK1; cAMP in yellow stick.
PDB code: 1VP6. Some of the
residues that line the cAMP binding
pocket in MlotiK1, and correspond-
ing residues in the CNB-homology
domain, are shown in stick and are
labeled. Dotted lines indicate dis-
tances measured across the pockets,
between equivalent residues: 10.6 Å
for the MlotiK1 domain and 12.5 Å
for the mEAG1 domain.
Fig. 2. Structural features of CNB-
homology domains. Superpositions
of the mEAG1 CNB-homology do-
main (in gray, cyan, and blue) and the
zELK CNB-homology domain (PDB
code: 3UKN) (in gray and orange)
through theβ-roll (a) and through the
α-helices (b). Both CNB-homology
domain structures share a self-
liganded conformation. Residues
bound in the pocket are shown in
stick model and are indicated by
arrows. (c) Close‐up view (viewed
from binding pocket) of residues
Y699 and L701 in the CNB-homology
domain from mEAG1 superimposed
with cAMP molecule (in yellow
stick) from the MlotiK1 CNB domain
(PDB code: 1VP6). Superposition of
structures was done through resi-
dues in β-roll. (d) Residues of CNB-
homology domain binding pocket
interacting with Y699 and L701 (in
white). Residues were selected with
a 4‐Å radius. View is rotated 180°
relative to (c).
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roughly at the same position as the aromatic base of
the cyclic nucleotide and interacts with some of the
residues conserved across CNB and CNB-homology
domains; the leucine side chain overlaps with the
cyclic phosphate group and interacts with Y609 and
V615 (in mEAG1) that take up the position of the
arginine conserved in CNB domains.
Biochemical analysis of the self-liganded
conformation
An underlying implication of the proposal that the
CNB-homology domain adopts a self-liganded
conformation is that an unliganded conformation
might exist; however, no evidence for this other
conformation has been provided. In this context, it is
interesting to realize that in our structure, the
C-terminal tail includes a significant amino acid
stretch (residues 702 to 707) of the previously
identified low‐affinity BD-C1 calmodulin binding
site (residues 702 to 712) (Fig. 4a and Supplementary
Fig. 1).9 This site is not present in the CNB-homology
domain of zELK. The site starts immediately after
the two residues (Y699 and L701) bound in the
pocket and is partially occluded by steric contacts
with residues on the surface of the domain.
Considering the molecular volume of calmodulin,
it becomes clear that the steric occlusion of the BD-
C1 site will affect binding of calmodulin and that
tight interaction between the two proteins will only
occur when the site becomes accessible upon
displacement of most of the C-terminal tail away
from the domain. This new conformation would
correspond to an unliganded state. Importantly, in
an unliganded conformation, the apparent affinity
of Ca2+/calmodulin will be higher than in the
self-liganded state and therefore mutations that
destabilize the self-liganded conformation would
increase calmodulin affinity.
To explore the existence of an unliganded state,
we performed a series of biochemical experiments
using dansylated calmodulin, a fluorescent form of
the protein.18 Dansylated calmodulin has previous-
ly been reported to have similar properties to native
calmodulin, and we ensured that the calmodulin
used in our experiments had, on average, just over
one dansyl group per protein molecule, as evaluated
by mass spectrometry. We first determined the
affinity of Ca2+/dansyl calmodulin for BD-C1 (Kd=
1.0±0.1 μM, Fig. 5a) by fusing the peptide sequence
(residues 696 to 736 of mEAG1) to maltose-binding
protein (MPB-BD-C1) through a long linker. A
competition experiment with wild-type (wt) calmod-
ulin confirmed that both labeled and unlabeled forms
of calmodulin have similar binding properties
(Kd=1.2±0.1 μM for Ca
2+/wt calmodulin, Fig. 5a),
and we made use of the modified calmodulin for the
rest of our study. We also verified that calmodulin
does not bind to MBP alone (Supplementary Fig. 3).
These results confirmed previous reports of weak
calmodulin binding at the BD-C1 site.9
We then measured the affinity of Ca2+/dansyl
calmodulin for two different constructs spanning the
complete CNB-homology domain and the whole BD-
C1 site (residues 552–724 and 552–736). Calmodulin
affinity to these constructs is 10- to 20-fold lower than
thatmeasured for the BD-C1 site alone,withKd values
of 12.1±1.4 μM and 16±2.6 μM for the shorter and
longer constructs, respectively (Fig. 5b). This is
consistent with our observation in the structure of
partial steric occlusion of BD-C1. From this point
onward, we used the smaller CNB-homology do-
main/BD-C1 construct (residues 552–724).
By mutating residues that appear to hold the
C-terminal tail in position, we should destabilize
the self-liganded conformation and thus increase
the apparent affinity for calmodulin. In the CNB-
homology/BD-C1 construct, we generated the
C-terminal tail double mutants L697A/Y699A and
Y699A/L701A. Y699 and L701 are the two residues
in the domain structure that interactwith the domain
pocket (Fig. 2); L697 is not in the pocket but has
Fig. 4. View of self-liganded con-
formation and calmodulin binding
site. (a) Stereo view of the CNB-
homology domain with the two
conserved residues bound in the
binding pocket. β-Roll is shown as
surface representation. Residues
from the C-terminal tail that reside
in the pocket (Y699 and L701) are
shown in white stick; residue L697
is shown in yellow stick. Section of
the calmodulin BD-C1 binding site
present in the structure is shown in
red sticks.
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extensive contacts with residues in the β-roll (Fig. 4).
As was predicted above, the affinity of calmodulin
for these mutant domains is higher than that of the
wt domain (Fig. 5c), Kd=2.6±0.2 μM for L697A/
Y699A and 3.8±0.5 μM for Y699A/L701A.
We also analyzed the same double mutants
(L697A/Y699A and Y699A/L701A) as MBP-BD-C1
fusions. As shown in Fig. 5a, the mutants show
similar affinities (L697A/Y699A has a Kd of 3.1±
0.2 μM, and Y699A/L701A has a Kd of 3.2±0.4 μM)
to the ones determined above for the same mutants
in the domain. This similarity supports the notion
that in these mutant domains, the BD-C1 site is as
accessible as in theMBP fusion and therefore that the
C-terminal tail has peeled away from the domain
and is exposed. In addition, the small but significant
effect of the double mutations in MBP-BD-C1
relative to the wt MBP fusion (Fig. 5a) shows that
calmodulin binding to BD-C1 extends all the way to
these residues.
Other mutations that are expected to destabilize
the self-liganded conformation were also analyzed.
The single-residue change Y699W, in the C-terminal
tail, also increased the apparent calmodulin affinity
but had a milder effect, Kd ~6 μM (Fig. 5c).
Importantly, mutations of a residue in the pocket,
which in the structure interacts with Y699, also lead
to an increase in apparent calmodulin affinity:
Fig. 5. Fluorescence binding curves with dansylated calmodulin. (a) Titration with calmodulin binding site BD-C1
fused to MBP (blue ●, N=7). Competition experiment with wt calmodulin (blue ○, N=6). MBP-BD-C1 fusion with
mutations L697A/Y699A (green ●, N=3) and Y699A/L701A (red ▲, N=3). (b) Titration with mEAG1 protein fragments
that span the CNB-homology domain and the calmodulin binding site BD-C1. wt mEAG1 spanning residues 552 to 724
(blue ■, N=4) and spanning residues 552–736 (blue □, N=4). mEAG 552–724 with mutations in the calmodulin bind-
ing site: R702N/R704N/R708N/K709N (cyan ◄, N=2) and I705A/V706A/F707A (gray ◊, N=3). (c) Titration
with C-terminal tail mutants of mEAG1 552–724, comparison with wt (blue■). Mutants L697A/Y699A (green●, N=3),
Y699A/L701A (red ▲, N=3), and Y699W (black ○, N=3). (d) Titration with binding pocket mutants of mEAG1 552–724,
comparison with wt (blue ■). Mutants V628A (magenta ♦, N=3) and V628L (purple ◊, N=3). Error bars are mean±
standard deviation.
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V628A and V628L have Kd values of 2.3 and 5 μM,
respectively (Fig. 5d).
To better understand the weak interaction be-
tween calmodulin and the CNB-homology/BD-C1
channel fragment, we used NMR and performed a
minimal chemical shift mapping with 15N-labeled
calmodulin.19,20 In this experiment, we looked
exclusively at the changes that occur in calmodulin
upon interaction with the domain. Plotting of the
minimal chemical shift data (i.e., the sum of the root-
mean-square differences in nitrogen and proton
chemical shift between free and bound Ca2+/
calmodulin) shows that upon binding, the large
changes (mean chemical shift difference≥0.08 ppm)
are mainly concentrated in residues of the
N-terminal lobe of calmodulin (Supplementary Fig.
4a). We mapped the chemical shift data onto a
representative structure of calmodulin bound to a
peptide stretch [Protein Data Bank (PDB) code:
3OXQ, chain A].21 Our model shows that the large
chemical shifts occur in residues directly involved in
the interaction with the peptide (Supplementary Fig.
4b and c). In contrast, in the C-lobe, the major change
occurs in T146, which does not interact directly with
the bound helix (Fig. 4d). These results indicate that
binding to BD-C1 occurs through the calmodulin
N-lobe with little participation of the C-lobe,
providing an explanation for the low affinity of
Ca2+/calmodulin to the BD-C1 site. This type of
single‐lobe interaction has been described in the
literature for calmodulin interaction with sites in
voltage-gated calcium channels21 and in voltage-
gated sodium channels.22 Importantly, the data
strongly support the idea that, despite being weak,
the in vitro interaction of the N-lobe of calmodulin
with BD-C1 has the hallmarks of a canonical
interaction between a calmodulin lobe and a
protein segment and is extensive since it involves
residues across the binding surface of the N-lobe.
Overall, the data confirm our expectation that the
occlusion of BD-C1 weakens the interaction between
the domain and calmodulin. Moreover, destabiliza-
tion of the self-liganded conformation can be
achieved through mutagenesis of residues that in
the structure appear to hold the C-terminal tail in
position. Importantly, the data also show that much
of the stability of the self-liganded conformation
results from the residues that interact in the pocket of
the domain since mutation of these residues caused
the largest increase in calmodulin affinity. However,
these experiments do not demonstrate that calmod-
ulin binding to the domain causes destabilization of
the self-liganded state. We cannot rule out that the
interaction of calmodulin with the CNB-homology/
BD-C1 channel fragment involves only part of the
binding site. It could happen that the interaction is
occurring just with the C-terminal end of the site. In
this position, calmodulin is away from the domain
and it may not affect its conformation. Binding to the
whole BD-C1 site would occur only upon destabili-
zation of the self-liganded conformation by muta-
genesis, which would result in the release of the
C-terminal tail and exposure of the site.
To address this issue, we performed two different
biochemical experiments. First, we showed that the
calmodulin interaction with the CNB-homology/
BD-C1 does involve residues that are in the amino
acid stretch partially occluded and that immediately
follow the two conserved residues in the pocket
(residues 702 to 707; Fig. 4). Consistent with this,
combined mutations of the large apolar residues
(I705A, V706A, and F707A) present in the occluded
stretch resulted in a lower binding affinity (Kd
~41 μM) (Fig. 5b). These values are most likely an
underestimation, because we could not reach the
high protein concentrations necessary for saturation
in these experiments (≥60 μM). Mutations of the
positively charged residues in a slightly longer
stretch, residues 702 to 709, also showed a contri-
bution to the interaction, although to a lesser extent
(Kd ~28 μM for R702N, R704N, R708N, and K709N;
Fig. 5b).
Second, we showed that calmodulin binding to
the domain has a direct effect on the domain
structure. For this, we made use of the seven
cysteines in the CNB-homology domain (Supple-
mentary Fig. 5), while both the C-terminal tail
(including the calmodulin binding site BD-C1) and
calmodulin have none. We monitored changes in
cysteine accessibility due to wt calmodulin binding
with maleimide–polyethylene glycol 5000, which
reacts with free-thiol groups and adds ≥10 kDa to
the apparent mass of a protein for each modified
cysteine.23 We reasoned that if calmodulin binding
alters the structure of the CNB-homology domain,
we would expect to observe changes in the
accessibility of the cysteines and therefore changes
in the rate of cysteine reaction with the reagent.
Western blot analysis of a reaction time course
clearly shows differences in the pattern of bands
consistent with changes in cysteine accessibility
resulting from calmodulin binding (Fig. 6); in the
sample with saturating amounts of calmodulin, the
larger molecular weight bands show up at earlier
time points.
Taken together, these two approaches demon-
strate that (1) calmodulin binding to the CNB-
homology domain occurs very close to the body of
the domain, involving residues in the stretch
immediately after the two residues that are essential
for stabilizing the self-liganded state (Y699/L701),
and (2) calmodulin binding results in conformational
and/or dynamical changes in the structure of the
domain.
Our biochemical and structural analyses show
that destabilization of the self-liganded conforma-
tion, through mutations of residues involved in
contacts between the C-terminal tail and the rest of
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the domain, results in an increase on the apparent
affinity of calmodulin binding to BD-C1. Crucially,
they also show that calmodulin binding to the
domain is dependent on residues that are on the
occluded stretch of the BD-C1 site. A simple
consideration of the molecular bulk of calmodulin
suggests that this can only occur if this C-terminal
tail region peels away from the body of the domain.
Consistent with this, we show that binding of
calmodulin results in structural changes in the
body of the domain. Overall, our biochemical
characterization suggests the existence of an unli-
ganded conformation in the CNB-homology do-
main, a structural counterpart to the self-liganded
conformation observed in the domain crystal
structure.
Functional analysis
The CNB domains of CNG and HCN channels are
involved in regulation of channel activation. It is
therefore reasonable to ask if the CNB-homology
domain also has a similar role in KCNH channels.
To explore this role, we performed electrophysio-
logical recordings on the human EAG1 channel
expressed in Xenopus oocytes. The amino acid
sequence of the sequence stretch spanning the
CNB-homology domain and the two C-terminal
calmodulin binding sites is identical in the mouse
and the human EAG1 channels (Supplementary Fig.
1); however, the human channel has been better
functionally characterized.8,24
Strikingly, whole‐cell two-electrode measure-
ments showed that the destabilization of the self-
liganded conformation by mutagenesis is reflected
in the gating properties of the channel. Currents
elicited at different voltages from wt and C-terminal
tail mutant channels are shown in Fig. 7a. It is
immediately apparent that the double mutation
Y672A/L674A, equivalent to Y699A/L701A in the
mEAG1, has effects on channel gating. The rise time
to reach 80% current amplitude at +50 mV is longer
[251.5±26.8 ms (n=15)] for this double mutant than
for the wt channel [31.9±3.9 ms (n=17)]. From these
currents, we also extracted V1/2 of activation (Fig. 7b
and c) and the respective slope factor (Fig. 7d).
While the slope factors of the activation dependence
on voltage were unchanged, the V1/2 values for
activation were different: −16 mV for the wt
channel, 0 mV for the single mutant L670A (equiv-
alent to L697A in mEAG1), and −24 mV and
−23 mV, respectively, for the mutants Y672A and
L674A (equivalent to Y699A and L701 in mEAG1).
The double mutants revealed drastic differences in
their effect; the V1/2 value for the L670A/Y672A
mutant was right shifted to ~2 mV, while the
Y672A/L674A mutant is left shifted to −34 mV.
The results for the double mutants are surprising
since our biochemical experiments with the isolated
domain showed that both sets display similar
biochemical properties, involving the release of the
C-terminal tail. However, in the channel, the double
mutants have opposite effects to each other: L670A/
Y672A stabilized the closed state over the open state,
while Y672A/L674A caused a stabilization of the
open state over the closed state.
We also evaluated if channel inhibition by
calmodulin is altered in the double mutants.
Measurements with excised patches exposed to
Ca2+/calmodulin revealed no changes in the sensi-
tivity to Ca2+/calmodulin (Supplementary Fig. 6);
inhibition levels as well as on- and off-rates of
calmodulin binding were indistinguishable from wt
channels. The same experiments were not possible
with the other double mutant (Y672A/L674A,
equivalent to the mouse Y699A/L701A) due to
low expression levels. The lack of effect on inhibition
by the mutations that increase in vitro calmodulin
affinity for BD-C1 may be a reflection of the low
importance of this site in the inhibition mechanism.
Alternatively, it could be that the relatively small
increase (10- to 20-fold) in calmodulin apparent
affinity that we measured, with the isolated domain,
is difficult to detect in an inhibition process that has
a half-maximal inhibition concentration (IC50) of
6 nM for calmodulin25 and 100 nM for Ca2+.8
Discussion
The CNB-homology domain from KCNH chan-
nels has raised a lot of interest. These domains have
high sequence similarity with the CNB domains in
CNG and HCN channels; however, KCNH channel
function is not affected by cyclic nucleotide
Fig. 6. Structural changes induced by calmodulin
binding. Western blot analysis of aliquots from pegylation
reaction. Pegylation of wt mEAG1 552–724 was performed
in the presence (+) and absence (−) of saturating
concentrations of calmodulin and stopped at 5 min and
10 min. Unmodified mEAG1 552–724 (lane C) is indicated
by an arrow. Western blot was probed with an anti-His-
tag monoclonal antibody.
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exposure.14 We have now determined the structure
of the CNB-homology domain of the mEAG1
channel. A comparison of our structure with the
recently reported structure of the CNB-homology
domain from the zELK channel and with structures
of CNB domains clearly shows that these KCNH
channel domains share many of the structural
features present in CNB domains. The comparison
also reveals crucial sequence and structural differ-
ences in the pocket of the CNB-homology domains
relative to CNB domains, which provide an expla-
nation for the very low affinity of theCNB-homology
domain for cyclic nucleotides. In particular, the
CNB-homology domain pocket is more wide open
than the ligand binding pocket of CNB domains. In
addition, the residues that interact with the cyclic
phosphate in CNB domains are absent in CNB-
homology domains. Interestingly, the residues that
interact with the base of the cyclic nucleotide in CNB
domains are conserved in CNB-homology domains.
Importantly, our structure shows that theC-terminal
tail of the domain extends over its surface and that two
well-conserved residues (Y699 and L701) in the tail
occupy the same space that cyclic nucleotides inhabit
in CNB domains. This self-liganded conformation is
also present in the recently determined structure of the
CNB-homology domain of the ELK channel from
zebrafish,15 strongly suggesting that it is a conserved
feature of these KCNH channel domains. In our
domain, the C-terminal tail also includes a partially
occluded stretch of a previously described calmod-
ulin binding site.9
By characterizing the CNB-homology domain
conformation as self-liganded, it becomes implicit
that there is also an unliganded state but there is no
evidence for this other conformation. A central aspect
of this work is that we have provided biochemical
evidence that supports the existence of an unliganded
conformation, where the C-terminal tail peels away
from the domain. For this, wemade use of the affinity
of calmodulin to the partially occluded binding site at
the end of the C-terminal tail. We demonstrated that
mutagenesis of the residues that in the domain
structure appear to hold theC-terminal tail in position
results in an increase in the apparent affinity of
calmodulin, consistent with a release of the tail and
increased exposure of the calmodulin binding site. In
addition, we showed that calmodulin interaction
extends to residues in the occluded stretch of the
calmodulin binding site since mutation of some of
these residues decreased calmodulin affinity. These
residues are immediately after Y699 andL701, and the
molecular volume of calmodulin requires a peeling
away of the C-terminal tail so that the interaction can
occur. Consistent with this interpretation, we showed
also that calmodulin binding causes a structural
change in the domain as reflected in changes in
cysteine accessibility.
Interestingly, the sequence and structural parallels
between CNB-homology domains and CNB domains
lead naturally to a conclusion that the tail movement
is reminiscent of the repositioning of the C-helix away
from the ligand-binding pocket, which occurs in CNB
domains upon release of cyclic nucleotide.13,26,27
Fig. 7. Functional experiments.
(a) Two-electrode voltage-clamp
current traces of human EAG1
(hEAG1) and indicated mutants
expressed in Xenopus oocytes. Res-
idue numbering of mutations in
human channel and numbering for
equivalent residues in the mouse
channel (in parentheses) are indi-
cated. Currents were elicited by 2‐s
depolarizing pulses from a holding
voltage of −90 mV in 10 mV in-
crements between −80 mV and
+50 mV. (b) Plot of relative conduc-
tance as a function of voltage for wt
hEAG1 and the indicated mutants.
(c) Plot of V1/2 of activation for wt
hEAG1 (−15.8±1.7 mV) and mu-
tants (L670A, −0.1±2.3 mV; Y672A,
− 23.5 ± 1.8 mV; L674A, − 22.9 ±
2.9 mV; L670A ⋅Y672A, 1.7 ±
1.3 mV; Y672A ⋅L674A, −34.3 ±
3.8 mV). (d) Plot of values for
slope factors corresponding to the
V1/2 data in (c) (wt, 16.0±0.4 mV; L670A, 18.6±0.7 mV; Y672A, 17.4±0.7 mV; L674A, 17.4±0.9 mV; L670A⋅Y672A, 18.1±
0.6 mV; Y672A⋅L674A, 19.7±1.9 mV).
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Our functional analysis suggests that the CNB-
homology domain has a role in channel gating since
mutations that destabilize the self-liganded confor-
mation by releasing the C-terminal tail also affect the
voltage dependence of activation. Strikingly, these
functional effects are not what would be expected
from the parallel between the release of the
C-terminal tail in the CNB-homology domain and
the movement of the C-helix away from its bound-
state position that occurs in CNB domains upon
release of cyclic nucleotide. In CNG and HCN
channels, this CNB domain conformational change
favors closure of the channel gate.11,12 In the human
EAG1 channel, the two double mutants, both of
which lead to the release the C-terminal tail, have
very different effects, stabilizing either the open
or the closed state of the channel. This contrasting
result indicates that in the full-length channel,
these residues have as yet unidentified individual
roles besides the shared function of holding the
C-terminal tail in its position. This outcome
reveals that despite the sequence, structural, and
even biochemical similarities, the role of CNB-
homology domain in gating of KCNH channels is
not identical with the role of CNB domains in
HCN and CNG channels. The properties of these
domains still require further investigation.
Materials and Methods
Expression and purification of mEAG1 constructs
mEAG1 552–707 (mEAG1—accession codes NP_034730.1
and GI:6754422) was cloned into expression vector pET-15b
(Novagen). Construct mEAG1 552–724 and 552–736 were
cloned into co-expression vector pRSFDuet-1 (Novagen). A
fusion of maltose‐binding protein with mEAG1 BDC1
(residues 696–736) was cloned into pRSFDuet-1. Mutants
were created using the QuikChange Site-Directed Mutagen-
esis Kit (Stratagene).
mEAG1 constructs were expressed in Escherichia coli
BL21(DE3) cells, overnight at 18 °C. Protein was purified
by histidine-tag affinity and size-exclusion chromatogra-
phy, as previously described.28 The fusion MBP-BD-C1
was expressed and purified with the same basic procedure
except 250 mMKCl was used instead of NaCl to minimize
aggregation. Protein for crystallization trials was dialyzed
overnight at 4 °C against gel‐filtration buffer (20 mM Tris–
HCl, pH 7.5, 150 mM NaCl, and 5 mM DTT) in the
presence of thrombin. Protein for fluorescence binding
assays was dialyzed against fluorescence buffer [50 mM
Tris–HCl, pH 7.5, 150 mM NaCl, 5 mM MgCl2, 0.1 mM
ethylene glycol bis(β‐aminoethyl ether) N,N′‐tetraacetic
acid, and 2 mM CaCl2 (1.9 mM free Ca
2+)] without
cleaving the tag. In both situations, dialyzed protein was
loaded onto a gel‐filtration Superdex 200 column (Phar-
macia). Protein concentration was determined by measur-
ing absorbance at 280 nm and using the calculated
extinction coefficients determined from the ExPASy tool,
ProtParam.
Crystallization, data collection, and refinement
Protein was crystallized by mixing 1:1 volumes of
protein (at 10 mg/ml in 20 mM Tris–HCl, pH 8, 150 mM
NaCl, and 5 mM DTT) and precipitant solution (0.2 M tri-
sodium citrate dihydrate, 20% polyethylene glycol
3350).28 A data set was collected at the ID14-4 beamline
of the European Synchrotron Radiation Facility (ESRF),
and the structure was solved by molecular replacement.
Model refinement was done in PHENIX29; TLS refinement
was applied.30 Model building was performed in Coot31
and figures were created using PyMOL.32
Expression and purification of calmodulin
BL21(DE3) competent cells were transformed with
expression vector (pT7-7 human calmodulin) and grown
until they reached an OD600 (optical density at 600 nm) of
0.6–0.8. IPTG (0.5 mM) was added, followed by a 3‐h
induction at 37 °C. Cells were resuspended in 50 mMTris–
HCl, pH 7.5, 100 mM NaCl, 5 mM DTT, and 2 mM
ethylenediaminetetraacetic acid, supplemented with pro-
tease inhibitors. Cell lysis was done in an Emulsiflex-C5
(Avestin), and the lysate was centrifuged. Supernatant
was loaded onto a phenyl Sepharose CL-4B (Sigma-
Aldrich) column and calmodulin was eluted with 50 mM
Tris–HCl, pH 7.5, 2 mM ethylenediaminetetraacetic acid,
and 5 mM DTT. Concentration was determined by
measuring absorbance at 277 nm and using the extinction
coefficient ε277nm=3029 M
− 1 cm− 1.33
Derivatization of calmodulin with the fluorophore
Dansyl-Cl
wt human calmodulin was derivatized with 5-
(dimethylamino)naphthalene-1-sulfonyl chloride (Dan-
syl-Cl, Molecular Probes), a reagent that reacts with
primary amines, as previously described.18,34
Fluorescence assay
Dansylated calmodulin at 400 nM was incubated with
different protein concentrations at room temperature, for at
least 20 min, in fluorescence buffer [50 mM Tris–HCl,
pH 7.5, 150 mM NaCl, 5 mM MgCl2, 0.1 mM ethylene
glycol bis(β‐aminoethyl ether) N,N′‐tetraacetic acid, and
2 mM CaCl2 (1.9 mM free Ca
2+)]. Fluorescent measure-
ments were done at 26 °C using a Horiba Fluoromax-4
spectrofluorimeter. All emission spectra were obtained
using an excitation wavelength of 340 nm, with slit widths
of 4 or 5 nm.18 For each titration curve, fluorescence was
measured at the wavelength corresponding to the maxi-
mum shift in the emission spectra. The data were
normalized using Fnorm=(F−F0)/(Fmax−F0), where F is
the measured fluorescence value for each concentration,
Fmax is the maximummeasured fluorescence, and F0 is the
measured fluorescence before adding any mEAG1 protein.
Fnorm was plotted as a function of total protein concentra-
tion using OriginPro8. Data were fitted to a modified
hyperbolic function of the form: Fnorm=F/(1+2/(−1− (1/
Kd)[dansyl-CaM]+ (1/Kd)[mEAG1] + sqrt ((1 + (1/Kd)
[dansyl-CaM]− (1/Kd)[mEAG1])2 +4(1/Kd)[mEAG1]))),
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where Kd is the dissociation constant, [dansyl-CaM] is the
total concentration of dansylated calmodulin, [mEAG1] is
the total concentration of the mEAG1 domain, and F is an
adjusting factor.
The competition experiment was performed in the
presence of 4 μM wt calmodulin, and data were fitted to
the function35
Fnorm = F 2cos d = 3ð Þsqrt a2−3b
 
−a
 
= 3 1 = Kddansyl
 
+ 2cos d = 3ð Þsqrt a2−3b −a  
a = 1 =Kddansyl
 
+ 1 = KdWTð Þ + dansyl−CaM
 
+ WT−CaM½  + mEAG1½ 
b = 1 = KdWTð Þ dansyl−CaM
 
− mEAG1½  
+ 1 =Kddansyl
 
WT−CaM½ − mEAG1½ ð Þ
+ 1 = Kddansyl
 
1= KdWTð Þ
c = − 1 =Kddansyl
 
1 = KdWTð Þ mEAG1½ 
d = acos −2a3 + 9ab−27c
 
= 2sqrt a2−3b
 3   
where Kd dansyl is the dissociation constant for dansy-
lated calmodulin, KdWT is the dissociation constant for wt
calmodulin, [dansyl-CaM] is the total concentration of
dansylated calmodulin, [WT-CaM] is the total concentra-
tion of wt calmodulin, [mEAG1] is the total concentration
of the mEAG1 domain, and F is an adjusting factor.
Pegylation assay
wt mEAG1 552–724 was diluted to 2 μM in fluores-
cence buffer with 1 mM TCEP and incubated at room
temperature for 1 h in the presence and absence of 50 μM
calmodulin. Methoxypolyethylene glycol maleimide
(Fluka/Sigma-Aldrich) was added to the protein mixture
at 5 mM and incubated at 4 °C for 5 or 10 min. Reactions
were stopped by addition of DTT to a final concentration
of 200 mM, incubation for 30 min, and addition of SDS-
PAGE loading buffer. Samples were run on a 15% SDS-
PAGE and analyzed by Western blot. Proteins were
probed with an anti-His-tag monoclonal antibody
(Qiagen).
Mass spectrometry
Proteins were analyzed by MALDI-TOF MS (matrix‐
assisted laser desorption/ionization time‐of‐flight mass
spectrometry). The matrix solution consisted of saturated
4-hydroxy-α-cyano-cinnamic acid in 66.5% H2O, 33.3%
CH3CN, and 0.1% trifluoroacetic acid. Analytes in the
micromolar range were prepared by 20-fold to 200-fold
dilution into the matrix solution. The analyte-matrix
samples were spotted onto a gold-plated sample probe
using theultrathin layermethodas previouslydescribed36,37
and analyzed in linear positive ion mode. Spots were
washed with 0.1% trifluoroacetic acid before acquisition.
Analyseswereperformedusing anAutoflex I or anUltraflex
I mass spectrometer (Bruker Daltonics, Germany) equipped
with a 337‐nm nitrogen laser and a gridless delayed
extraction ion source. An accelerating voltage of 20 kV
was used and delay was optimized between 500 and
650 ns to achieve a mass resolution greater than 1000 over
the mass range of interest (10,000–20,000 Da). A deflection
of matrix ions up to 600 Da was applied to prevent
detector saturation. Spectra were acquired in linear
positive ion mode by accumulation of 300–500 laser
shots. The instrument was controlled using Bruker
FlexControl software. Calibration was performed externally
using apomyoglobin and cytochrome c. MALDI-TOF-MS
spectra were processed using FlexAnalysis 2.0 software
from Bruker Daltonics and cleavage peptides were
assigned using Paws version 8.5.0.3 (ProteoMetrics, New
York, NY).
NMR spectroscopy
NMR spectra for the backbone assignment of CaM were
acquired from 0.35‐ml samples of 0.4 mM calmodulin in a
20 mM Tris, 140 mM sodium chloride, 10 mM CaCl2,
0.2 mM AEBSF, and 0.02% (w/v) sodium azide buffer at
pH 7.5, containing 5% D2O/95% H2O. All NMR experi-
ments were acquired at 298 K and were performed on
Bruker DRX or AvanceII spectrometers operating at either
600 or 800 MHz that were fitted with cryogenically cooled
probe heads. The two‐dimensional (2D) and three‐dimen-
sional (3D) spectra recorded to obtain sequence‐specific
assignments for CaM were as follows: 15N/1H hetero-
nuclear single quantum coherence (HSQC); nuclear Over-
hauser enhancement spectroscopy-HSQC with a nuclear
Overhauser enhancement mixing time of 100 ms; 13C/1H
HSQC and 15N/13C/1H HNCACB, CBCA(CO)NH,
HNCA, and HN(CO)CA (Ref. 38 and references therein).
Typical acquisition times inF1 andF2 for the 3Dexperiments
were 20 ms for 15N, 6.6–9.6 ms for 13C, and 18 ms for 1H,
with an acquisition time of 80 ms in F3 (
1H). Themajority of
the 3D spectra were collected over approximately 48 h, and
15N/1H and 13C/1H HSQC spectra were collected over
about 1 h. Typical acquisition times in 2D experiments were
60 ms (15N), 9 ms (13C), and 80 ms in F2 (
1H). Water
suppression was achieved using the gradient‐based WA-
TERGATE method.39 The 3D NMR data were processed
using NMRPipe40 with linear prediction used to extend the
effective acquisition times by up to twofold in F1 and F2. The
resulting spectra were analyzed using the program Sparky
(T. D. Goddard and D. G. Kneller, Sparky 3, University of
California, San Francisco).
NMR chemical shift mapping of binding sites
15N/1H transverse relaxation optimized spectroscopy41
spectra of calmodulin were acquired in the presence and
absence of mEAG1 552–724 to identify the changes in the
positions of signals induced by CNB-homology domain
binding. In these experiments, amounts of unlabeled
mEAG1 552–724 were added to 100 μM 15N-labeled
calmodulin to achieve 30% and 90% saturation of
calmodulin based on the determined Kd. Experiments
were performed in the same buffer as used for calmodulin
assignment but with the addition of 2 mM DTT. Typical
acquisition times for the transverse relaxation optimized
spectroscopy experiments were 80 ms in F2 (
1H) and
30 ms in F1 (
15N), with the spectra collected over
44 Characterization of the CNB Homology Domain
approximately 3 h. The perturbation of backbone amide
chemical shifts in the presence of mEAG1 552–724 was
calculated relative to calmodulin alone using the mini-
mum chemical shift procedure19,20 and then used to
identify the intramolecular interface of mEAG1 552–724
on calmodulin.
Electrophysiological measurements and data
analysis
Recording and data analysis were described pre-
viously.42 In brief, stage V Xenopus oocytes were injected
with 50 nl of mRNA and currents were recorded at
20–23 °C, 2 to 4 days after injection. A two-electrode
voltage clamp amplifier (Turbo-TEC 10CD, npi electronic,
Tamm, Germany) was controlled by PatchMaster soft-
ware (HEKA Elektronik, Lambrecht, Germany). A P/n
method was used for leak correction. The bath solution
contained (in millimolar): 115 NaCl, 2.5 KCl, 1.8 CaCl2,
and 10 Hepes, pH 7.2 (NaOH). Data were analyzed with
FitMaster software (HEKA Elektronik). Normalized con-
ductances were obtained by fitting the following equation
to the current–voltage data:
I Vð Þ = GV 1−e− V−Erevð Þ=25 mVð Þ
 
= 1−e− V =25 mVð Þ
 
∗1
= 1 + e− V−V1 = 2ð Þ= kð Þ
 
G is the maximal conductance and Erev the estimated
reversal potential. The second term describes the channel
open probability (or relative conductance), characterized
by V1/2, the voltage of half-maximal activation, and a
slope factor, k.
Accession numbers
Coordinates and structure factors have been deposited
in the PDB with accession number 4F8A.
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Supplementary Materials 
 
Supplementary figure 1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplementary figure 1 - Amino acid sequence alignment of C-terminal region of ion 
channels mouse EAG1 (mEAG1, NP_034730.1) and human EAG1 (hEAG1, 
NP_758872.1), zebra fish ELK (zELK, XP_001919436.2), human ERG1a (hERG1a, 
NP_000229.1), mouse HCN2 (mHCN2, NP_032252.1) and MlotiK1 (Q98GN8.1), 
graphically enhanced with Espript 
1
. Above the alignment are the secondary structure 
elements of the CNB-homology domain. Bars represent α-helices and arrows β-strands. 
C-linker is colored in cyan, other helices in domain are in dark blue and β-roll in grey. 
Calmodulin BD-C1 binding site sequence is represented in red, where continuous line is 
the region present in the structure and dotted line the region absent from the structure. 
Amino acid numbering is of mouse EAG1.  
 
 
Supplementary figure 2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplementary figure 2 – Pockets in CNB-homology and CNB domains. a) Surface 
representations of binding pockets from: MlotiK1 bound structure (PDB code: 1VP6), 
with nucleotide in sticks; MlotiK1 unbound structure (PBD code: 1U12) and mouse 
EAG1 CNB-homology domain. b) Cartoon representations of binding pockets from 
MlotiK1 bound structure, MlotiK1 unbound structure and mouse EAG1 CNB-
homology domain. αP helix in phosphate binding cassette of CNB domains is shown 
and labeled.  
 
 
 
Supplementary Figure 3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplementary Figure 3 – Emission fluorescence spectra from dansyl-calmodulin 
titrated with different protein constructs. Red curve is spectra for dansyl-calmodulin 
alone and blue curve for dansyl-calmodulin titrated with maximum concentration of 
protein, as indicated on each graph. a) Titration with CNB-homology domain triple BD-
C1 site mutant up to 60 μM causes a shift of the emission maximum from 503 nm to 
485 nm and an increase in intensity of more than 2-fold. b)  Titration with fusion 
Maltose binding protein/BD-C1 site (up to 10 μM) causes a shift of the emission 
maximum from 504 nm to 482 nm and an increase in intensity of ~2.5-fold. c) Titration 
with Maltose binding protein (MBP) alone (up to 50 μM) causes a minor shift of the 
emission maximum from 505 nm to 493 nm and an increase in intensity of just ~1.4-
fold. The very small blue shift and small increase in fluorescence are an indication of a 
very weak interaction, much weaker than the interaction measured in a) which has a KD 
~40 μM.  
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Supplementary Figure 4 – Mapping of interaction between CNB-homology domain 
and calmodulin. a) Plot of backbone residue chemical shift changes that occur upon 
binding to mEAG 552-724. Horizontal line marks cutoff of 0.08 ppm used for large 
changes. Arrow indicates the separation between the N- (to the left of arrow) and C-lobe 
(to the right of arrow). b) and c) Two views related by ~90°, of mapping of chemical 
shifts onto the structure of calmodulin N-lobe bound to a helical peptide (from PDB 
code 3OXQ). Calmodulin residues are rainbow colored (dark-blue to red) according to 
chemical shift difference (0.0-0.22ppm). No change is dark blue, large change is intense 
red. d) Structure of calmodulin C-lobe bound to helical peptide (from PDB code 
3OXQ). Colored as in b). 
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Supplementary Figure 5 – Cartoon representation of the structure of the CNB-
homology domain from mEAG1 channel. Orientation and coloring is identical to Figure 
1. Cysteine residues present in the structure are shown as spheres and are labeled. 
Number in parenthesis indicates the residue number of a cysteine present in the 
crystallized protein but not defined in the structure.   
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Supplementary Figure 6 – Ca2+/calmodulin inhibition of human EAG1 channel. a) At 
time 0 excised patches expressing hEAG1 channel were exposed to a solution 
containing 500 nM calmodulin and 250 nM Ca
2+
. Reduction in current elicited from 
wildtype channel (black triangles) and mutant L670A/Y672A (blue circles). b) 
Remaining current after exposure, average from 3 experiments. 
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ERRATUM 
“Structural and biochemical characterization of the interaction of calmodulin 
with the EAG1 potassium channel cytoplasmic regions” 
Maria João Marques de Carvalho 
 
 In page 50, in the last paragraph the following sentence should be “The ten-fold 
higher affinity relative to the short BDN is achieved through an increase in the 
entropy and decrease in the enthalpy of the system (Table 4).” 
 
 In page 52, in the last paragraph the ΔH values lack the minus. They are -7.71 
± 0.08 kcal/mol for the CAP-PAS-BDN and -7.47 ± 0.18 kcal/mol for PAS-BDN. 
The last sentence should be substituted by “However, this is accompanied by a 
lower entropy change (smaller ΔS) which results in a lower affinity.” 
 
 In page 56, Table 4, the KD for the Ca
2+-N-lobe/long BDN interaction is 8.9 ± 0.4 
µM, not 4.5 ± 1.5 µM. This value is correct in the text. 
 
 In page 77, Figure 45 should be substituted by the one below. The ITC titration 
examples depicted in Figure 45a and b were, by mistake, duplicates of Figure 
30a and b. The interpretation of the data is not altered by this mistake. 
Figure 45 – a) ITC titration of 140 µM Ca2+-N-lobe into 14 µM CNBhD-BDC1-BDC2. b) 
ITC titration of 100 µM Ca2+-C-lobe into 10 µM CNBhD-BDC1-BDC2. c) ITC titration of 
100 µM Ca2+-CaM EF12 mutant into 100 µM CNBhD-BDC1-BDC2 (direct). d) ITC 
titration of 40 µM CNBhD-BDC1-BDC2 into 6 µM Ca2+-CaM EF12 mutant (reverse). 
